Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFGE8,Lactadherin,42490,0.176411824575624,0.0042025866356624,0.168174754769726,0.184648894381522,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42561,-0.123733180548562,0.00320906979426555,-0.130022957345323,-0.117443403751802,1.97284483780619e-308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,40428,0.153701572292645,0.00399286298984662,0.145875560832546,0.161527583752745,1.2521433280303e-304
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42490,-0.122482629020839,0.00321983186057441,-0.128793499467564,-0.116171758574113,1.18318545244937e-300
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS8,Prostasin,42447,0.153817576373863,0.00409367466222988,0.145793974035892,0.161841178711833,1.06452518045066e-293
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF9,Protein turtle homolog A,40411,0.302170183513864,0.00800627267691062,0.28647788906712,0.317862477960609,1.44372189611518e-293
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCG,Pro-glucagon,42229,0.458927152771915,0.0122936692429732,0.434831561055688,0.483022744488143,7.12387274652431e-290
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPY,Pro-neuropeptide Y,42599,0.21198621256174,0.00632673349350021,0.19958581491448,0.224386610209,1.90186917751001e-236
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42649,-0.390348841810868,0.0118576125822125,-0.413589762472005,-0.367107921149732,1.18601916446964e-228
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS15,Enteropeptidase,42466,0.291877063333449,0.00900213880992525,0.274232871265996,0.309521255400903,5.24675238793761e-222
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40352,0.167865442096765,0.00541409381795158,0.15725381821358,0.17847706597995,1.53372599441844e-202
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42554,-0.085930453029998,0.00282810711931393,-0.0914735429838533,-0.0803873630761427,3.829250666447e-196
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADIPOQ,Adiponectin,40440,-0.20657959315354,0.00678766377353373,-0.219883414149667,-0.193275772157414,1.42744927726196e-195
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C9,Complement component C9,40432,-0.157527188570346,0.00524817386360484,-0.167813609343011,-0.14724076779768,1.78361211020132e-190
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOF,Apolipoprotein F,40432,-0.0700622777841493,0.00235010979011112,-0.0746684929727671,-0.0654560625955315,5.01322882050796e-188
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACY1,Aminoacylase-1,42518,0.172787968490734,0.00602571845029134,0.160977560328163,0.184598376653305,1.57807754824398e-175
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PYY,Peptide YY,40019,0.290140608381234,0.0101748844400479,0.27019783487874,0.310083381883728,1.62542392873398e-172
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGRP,Agouti-related protein,42631,0.140614041862327,0.00513877574654805,0.130542041399093,0.150686042325561,1.79868924182563e-160
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42377,0.0822603604434832,0.00303904369712324,0.0763038347971216,0.0882168860898447,4.44156025068793e-157
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42526,0.137133070835768,0.00506916207189249,0.127197513174859,0.147068628496677,5.93678959685598e-157
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CES1,Liver carboxylesterase 1,42543,0.217182623440867,0.00808987272776767,0.201326472894442,0.233038773987292,1.14841964740772e-154
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPM,Carboxypeptidase M,42536,0.089460429205545,0.00336848280260503,0.0828582029124392,0.0960626554986509,1.73269970181517e-151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42590,0.366350742882257,0.0138192867538427,0.339264940844725,0.393436544919788,5.61572382407815e-151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UPB1,Beta-ureidopropionase,40411,0.234539934289616,0.00892772733757492,0.217041588707969,0.252038279871263,1.14157313360512e-147
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INHBC,Inhibin beta C chain,42490,0.106772261259672,0.00408778499359552,0.0987602026722245,0.114784319847119,1.05462855938067e-146
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPL,Lipoprotein lipase,42518,-0.121137534871196,0.00465742635668344,-0.130266090530295,-0.112008979212096,1.60408239603302e-145
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FURIN,Furin,42561,0.0838469585856919,0.00326267996325893,0.0774521058577044,0.0902418113136794,3.32567752686809e-142
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42475,0.137942103925529,0.00538283553015371,0.127391746286428,0.148492461564631,2.06331229554475e-141
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17RB,Interleukin-17 receptor B,42301,-0.136953332825842,0.00534706707058819,-0.147433584284195,-0.126473081367489,3.17519400218663e-141
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MVK,Mevalonate kinase,42256,0.203943776565295,0.00798122985588384,0.188300566047762,0.219586987082827,1.40510823118397e-140
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42237,0.207802117854917,0.00813369165655457,0.19186008220807,0.223744153501764,1.58987114309893e-140
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF21,Fibroblast growth factor 21,42568,0.288808040906627,0.0117274304572932,0.265822277210332,0.311793804602921,5.29390655799446e-131
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHBG,Sex hormone-binding globulin,40432,-0.124363573362933,0.00504953579766178,-0.13426066352635,-0.114466483199515,1.7264917794274e-130
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS4,Galectin-4,42496,0.134066473526581,0.00568210260221436,0.122929552426241,0.145203394626921,1.29498188848273e-120
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42651,-0.146744746104121,0.00622813189205732,-0.158951884612554,-0.134537607595689,2.56368904136649e-120
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,42237,0.125190774898311,0.00540770336498042,0.114591676302949,0.135789873493672,3.12004715328029e-116
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA14,Carbonic anhydrase 14,42599,-0.0832448612649143,0.00362416409786345,-0.0903482228967267,-0.076141499633102,1.51360293833789e-114
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,40187,-0.0716096742947573,0.00312551812231104,-0.0777356898144869,-0.0654836587750276,1.59390860503137e-113
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CKB,Creatine kinase B-type,40428,-0.138191573860291,0.00603670449595504,-0.150023514672363,-0.126359633048219,2.148451129514e-113
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSG2,Desmoglein-2,42490,-0.0611233051495651,0.00273327994996576,-0.066480533851498,-0.0557660764476322,9.10878982069084e-109
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTN4R,Reticulon-4 receptor,42599,0.0773882571986822,0.0034676515692601,0.0705916601229324,0.084184854274432,2.34069954963027e-108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MET,Hepatocyte growth factor receptor,42535,-0.0444615803429429,0.0020055473744258,-0.0483924531968174,-0.0405307074890683,5.74031858170453e-107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42493,0.183654522775813,0.00830903147994433,0.167368821075122,0.199940224476504,2.40354241544275e-106
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR37,Prosaposin receptor GPR37,42237,0.150854425607675,0.0068820549774293,0.137365597851913,0.164343253363436,1.2820877476733e-104
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSD,Cathepsin D,41630,0.0929981998535983,0.00424998861871387,0.0846682221609191,0.101328177546277,3.5165941303833e-104
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPY,Pancreatic prohormone,42483,0.227901261521253,0.0104525010398519,0.207414359483143,0.248388163559363,1.39110311119738e-103
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GHR,Growth hormone receptor,40187,0.0619008077453382,0.00284100898211459,0.0563324301403936,0.0674691853502828,4.45965145723771e-103
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCLY,Selenocysteine lyase,42553,0.10224492937851,0.00470472326427772,0.0930236717805252,0.111466186976494,6.09140721549419e-103
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AFM,Afamin,40440,0.0433955505887229,0.00200043972545273,0.0394746887268356,0.0473164124506103,2.93217805188536e-102
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40364,0.185770118392218,0.00856662070179534,0.168979541816699,0.202560694967737,3.55154618914752e-102
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39920,0.069975182633493,0.00323869278108437,0.0636273447825677,0.0763230204844184,2.24448240566444e-101
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN1,CCN family member 1,42448,0.158361892832037,0.0073887355703223,0.143879971114205,0.172843814549868,3.28410902470768e-100
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42673,0.085156538841223,0.00398397843175955,0.0773479411149743,0.0929651365674717,1.02910643834689e-99
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIP,Gastric inhibitory polypeptide,40125,0.12610701277243,0.0059072813158892,0.114528741393287,0.137685284151573,4.24880045357169e-99
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSB,Cathepsin B,42539,-0.114510694068591,0.00542883402242739,-0.125151208752549,-0.103870179384634,3.52402458607444e-97
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLA,Alpha-galactosidase A,40171,0.0789897853728296,0.00374795493272264,0.0716437937046932,0.086335777040966,1.0837835932783e-96
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42536,0.0691426882258196,0.00332854059499033,0.0626187486596386,0.0756666277920007,2.3646422217955e-94
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MME,Neprilysin,42466,0.170464095176084,0.00821358959208209,0.154365459575603,0.186562730776565,3.51333732626217e-94
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42377,0.0700311391674048,0.00343564916475671,0.0632972668044816,0.0767650115303279,5.8558455846996e-91
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL16,C-C motif chemokine 16,42673,0.107147659384366,0.00527656118517391,0.0968055994614254,0.117489719307307,2.5232260984906e-90
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42561,0.0718781213135213,0.00354854291258649,0.0649229772048518,0.0788332654221908,7.03167788010018e-90
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42568,-0.0686870663781857,0.00339679761166742,-0.0753447896970538,-0.0620293430593175,1.38584882943721e-89
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUC13,Mucin-13,42191,0.10691921499632,0.00528818007939599,0.0965543820407034,0.117284047951936,1.59169767871347e-89
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F9,Coagulation factor IX,42542,0.036789781183372,0.00182669028220907,0.0332094682302422,0.0403700941365018,6.83576859036024e-89
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEP1A,Meprin A subunit alpha,40350,0.146086333661617,0.00729879864151997,0.131780688324238,0.160391978998996,1.38786472580327e-87
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42542,-0.0610119003966845,0.00305304036070146,-0.0669958595036594,-0.0550279412897097,1.4412426003182e-87
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFASC,Neurofascin,42631,0.0585672515607921,0.00293733265878473,0.052810079549574,0.0643244235720102,3.39421683995932e-87
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42490,-0.077164979857867,0.00387048971551568,-0.0847511397002777,-0.0695788200154563,3.64890842559703e-87
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP5,Retinol-binding protein 5,42466,0.111861264125436,0.00564447122150512,0.100798100531286,0.122924427719586,3.66173163273658e-86
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42590,-0.0436100253195801,0.00220592286585465,-0.0479336341366552,-0.039286416502505,9.05903840705196e-86
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCG2,Secretogranin-2,42515,0.0676178663729046,0.00346462202162035,0.0608272072105287,0.0744085255352804,1.16289953904831e-83
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTA3,Glutathione S-transferase A3,42229,0.150221774152965,0.00770945147059877,0.135111249270591,0.165332299035338,2.23138701694414e-83
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42584,0.0919388955466022,0.00474608358588739,0.0826365717182629,0.101241219374941,1.79769570120629e-82
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,40253,0.0518614300357231,0.00268709094687629,0.0465947317798455,0.0571281282916006,1.1690913683875e-81
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TTR,Transthyretin,40325,0.0484554475404401,0.0025409818448916,0.0434751231244525,0.0534357719564276,8.40493088045214e-80
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42673,-0.0646333277683424,0.00345394628003563,-0.0714030624772123,-0.0578635930594726,3.68211120077803e-77
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN3,Contactin-3,42490,0.0589363880152929,0.00315164931306234,0.0527591553616907,0.0651136206688951,4.78940199329914e-77
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42466,0.152221716211589,0.00817059298048788,0.136207353969833,0.168236078453345,1.71572445540869e-76
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOD,Apolipoprotein D,39937,-0.0814613998716029,0.00438997242314493,-0.090065745820967,-0.0728570539222389,1.09924769677051e-75
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,42297,0.153310034547827,0.00834980475616975,0.136944417225735,0.16967565186992,2.30575841194088e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM20A,Pseudokinase FAM20A,40411,0.0523253512474269,0.00284778073823025,0.0467437010004956,0.0579070014943582,2.59471421211392e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42466,0.147257788981755,0.0080388785207914,0.131501587081004,0.163013990882506,4.82962466093131e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42568,-0.0683514586767845,0.00380233949990615,-0.0758040440966006,-0.0608988732569685,2.06982818803892e-71
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KHK,Ketohexokinase,40125,0.113721599208579,0.00633600744466749,0.101303024617031,0.126140173800127,5.1339028551626e-71
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGR3,Anterior gradient protein 3,42209,0.108221525102157,0.00606259032792121,0.0963388480594315,0.120104202144883,1.9685955891364e-70
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42229,0.106169867020178,0.0059823472308187,0.0944444664477735,0.117895267592583,1.1926773342178e-69
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42229,0.115766617708043,0.00652955921270288,0.102968681651145,0.12856455376494,1.61847257359993e-69
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42614,0.0564791124840644,0.00318911115059851,0.0502284546288913,0.0627297703392375,2.15875951239505e-69
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40428,0.0610511375516298,0.00345277915883979,0.0542836904003038,0.0678185847029558,4.97457484880825e-69
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42256,0.099456932990168,0.00563564796440545,0.0884110629799333,0.110502803000403,6.65372924481943e-69
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTH,Parathyroid hormone,40089,0.145994842310028,0.00827404321055448,0.129777717617341,0.162211967002715,1.00160543310635e-68
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOM,Apolipoprotein M,42542,-0.050360002554913,0.00286376150121985,-0.0559729750973039,-0.0447470300125221,1.88571563956414e-68
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40181,0.0827037477219837,0.00469751387297809,0.0734966205309466,0.0919108749130207,1.92575444543301e-68
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42475,0.0488075618307216,0.0027772598186536,0.0433641325861605,0.0542509910752826,2.31007611700824e-68
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42518,0.0542577913627977,0.00310784288949963,0.0481664192993785,0.060349163426217,1.67477860379911e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42466,0.0703526017201171,0.00403859593554147,0.0624369536864558,0.0782682497537784,3.24494310519811e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPIND1,Heparin cofactor 2,40417,0.049188566263136,0.00283479486993103,0.0436323683180712,0.0547447642082008,1.41038412213699e-66
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42599,0.0631616998912796,0.00369196422648118,0.0559254500073765,0.0703979497751828,6.32754247748576e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42464,0.094239848689295,0.00552612909931,0.0834086356546474,0.105071061723943,1.60039600431666e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40352,0.089515537447591,0.00524939629166794,0.0792267207159219,0.0998043541792602,2.18260036452416e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42599,0.215498825884893,0.012675346033116,0.190655147659986,0.240342504109801,3.76456606793138e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORD,Sorbitol dehydrogenase,42537,0.115069771148521,0.00677527287267194,0.101790236318084,0.128349305978958,5.08851927968789e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEP,Leptin,42518,0.114104267799152,0.00672385398744513,0.10092551398376,0.127283021614545,6.40995562060355e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42357,0.258056665230726,0.015221822328517,0.228221893466833,0.28789143699462,8.66738133803216e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HJV,Hemojuvelin,40384,0.0757411405627703,0.0044649630141777,0.066989813054982,0.0844924680705586,9.55916791818183e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KYNU,Kynureninase,42631,0.0763682940150118,0.00450864719970466,0.0675313455035906,0.0852052425264329,1.07633168554182e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42673,-0.0425934945940948,0.00252016992628408,-0.0475330276496116,-0.037653961538578,1.98653960851634e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F11R,Junctional adhesion molecule A,42490,0.0950582888350212,0.00562765381855403,0.0840280873506553,0.106088490319387,2.38396321948542e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42469,0.0857583832974669,0.00510003473308073,0.0757623152206287,0.0957544513743051,8.41478477349073e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OMD,Osteomodulin,42554,-0.071993879824971,0.0042992026804434,-0.0804203170786401,-0.063567442571302,2.61787396743968e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLTP,Phospholipid transfer protein,42632,-0.0606241155139646,0.00363087984967258,-0.0677406400193229,-0.0535075910086064,5.81487693595856e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLUL1,Clusterin-like protein 1,42503,-0.0758618145142879,0.00455130710671815,-0.0847823764434555,-0.0669412525851203,9.43445088597576e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42466,0.11756479664382,0.00708602215919669,0.103676193211794,0.131453400075845,3.33827193199964e-61
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42639,0.084446303002525,0.00512138217631098,0.0744083939369555,0.0944842120680945,1.72671667304845e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HGF,Hepatocyte growth factor,42631,0.058218309766452,0.00353290401776005,0.0512938178916423,0.0651428016412617,2.03513664433044e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40432,0.0368999996788987,0.00224526148491089,0.0324992871684733,0.041300712189324,5.40449498529943e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40385,0.12439683403246,0.00760106878806474,0.109498739207853,0.139294928857066,1.64699648977648e-59
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F7,Coagulation factor VII,42550,0.0512668652246355,0.0031531902748779,0.0450866122858748,0.0574471181633962,7.11356179085763e-59
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40125,0.0940296991975114,0.00579815323193324,0.0826653188629223,0.105394079532101,1.83066579004079e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42229,0.133441508777998,0.00824561031074025,0.117280112568947,0.149602904987048,2.44548965851162e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42631,-0.0417743231107299,0.00258678359203549,-0.0468444189511194,-0.0367042272703403,4.0553560543403e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA4,Kallistatin,40243,0.0393919934270144,0.00243984235931678,0.0346099024027535,0.0441740844512753,5.63300913799923e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELE,E-selectin,42673,0.0828402388324781,0.0051534413194078,0.0727394938464388,0.0929409838185173,1.31532006812336e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42490,-0.0443933797581527,0.00276479878375524,-0.049812385374313,-0.0389743741419925,1.78103769202935e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42466,0.132427629066242,0.00829275701112301,0.116173825324441,0.148681432808043,7.10210099581823e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42466,0.16943760178328,0.0106126736335489,0.148636761461524,0.190238442105036,7.50174602845606e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42130,0.0895287428283253,0.00561736268348269,0.0785187119686992,0.100538773687951,1.19635279562068e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GH1,Somatotropin,42495,-0.277490550649192,0.0174392329478847,-0.311671447227046,-0.243309654071338,1.73955736660049e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPA2,Carboxypeptidase A2,42549,0.106771179470109,0.00671425145006675,0.0936112466279777,0.119931112312239,2.01497542013342e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUSB,Beta-glucuronidase,42592,0.0972343090819808,0.00615892467837106,0.0851628167123736,0.109305801451588,1.20214071929054e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42466,0.13846144445857,0.00878089936496176,0.121250881703245,0.155672007213895,1.63456958991547e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40187,0.0794377568650242,0.00503652823058522,0.0695661615330772,0.0893093521969713,1.95169268881803e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMBP,Protein AMBP,42584,0.0334780277058426,0.00212823028666413,0.0293066963439809,0.0376493590677043,2.92021045128874e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42518,-0.043146262534021,0.00275558949063827,-0.048547217935672,-0.03774530713237,9.04697769460121e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSO,Cathepsin O,42631,0.0487270393319838,0.00312197546642295,0.0426079674177948,0.0548461112461728,1.9363145888454e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42561,0.0582508793384224,0.00375012820550091,0.0509006280556406,0.0656011306212042,6.13416819716205e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM3B,Protein FAM3B,42466,0.0558137678546214,0.00359459098110858,0.0487683695316486,0.0628591661775942,6.76420360217231e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40125,-0.0955943330437022,0.00615900827065291,-0.107665989254182,-0.0835226768332225,9.34496264167397e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42568,0.0647628439777898,0.00418440428756699,0.0565614115741585,0.0729642763814211,1.44018334850335e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTSS1,Protein MTSS 1,40350,0.174722028572052,0.0112919310437673,0.152589843726268,0.196854213417836,1.8878756920495e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42599,0.0511727300734973,0.00332859596618005,0.0446486819797845,0.0576967781672102,6.94463844748638e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD2AP,CD2-associated protein,42518,0.0986550934288748,0.0064702218647169,0.0859734585740297,0.11133672828372,4.69767624511372e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDUA,Alpha-L-iduronidase,42599,0.0714911018894749,0.00471450418408563,0.062250673688667,0.0807315300902827,1.63508986574159e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42325,0.0745602242149439,0.00492084622768728,0.0649153656086768,0.084205082821211,2.00170328729542e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCHE,Cholinesterase,40246,0.0428505018227101,0.00283178651988729,0.0373002002437311,0.0484008034016892,3.24393391302552e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POSTN,Periostin,40428,-0.0586874084970066,0.00391249846208925,-0.0663559054827015,-0.0510189115113117,2.25455145852939e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRP1,Neuropilin-1,42584,-0.0421416100196828,0.00281795462708489,-0.0476648010887691,-0.0366184189505964,3.68626126060628e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40187,0.0574616562930137,0.00384524063981645,0.0499249846389735,0.064998327947054,5.30399916415927e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUOM,Fucose mutarotase,40187,0.0955496222318625,0.006417929186465,0.0829704810263911,0.108128763437334,1.2010673351046e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMOT,Angiomotin,40187,0.0585543998149606,0.00393472123535447,0.0508423461936659,0.0662664534362554,1.32034034207406e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42475,-0.0595701780744713,0.00401002086295507,-0.0674298189658633,-0.0517105371830794,1.60409169348239e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REN,Renin,42518,0.128938161788227,0.00870496692677742,0.111876426611743,0.14599989696471,3.01754686263556e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42631,0.0495384694560496,0.00335634873804596,0.0429600259294796,0.0561169129826197,6.44071290437443e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTGR1,Prostaglandin reductase 1,40411,0.125570680516617,0.00851204785485155,0.108887066721108,0.142254294312126,8.53547740326868e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42568,-0.0665011951963144,0.00452463289403696,-0.0753694756686269,-0.057632914724002,1.59596275735158e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40384,0.0856573693595544,0.00583304421288868,0.0742246027022926,0.0970901360168162,2.2700588688764e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40385,-0.0546660043365473,0.00374826424461121,-0.0620126022559853,-0.0473194064171094,9.67454076944245e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRP,Gastrin-releasing peptide,40125,0.0829059144637503,0.0057007189373449,0.0717325053465543,0.0940793235809463,1.791759357715e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42547,-0.0451969182109655,0.00311637231528402,-0.0513050079489222,-0.0390888284730088,2.65083057815498e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENO3,Beta-enolase,40125,0.0871214739951789,0.00600196001531031,0.0753576323651707,0.0988853156251872,2.65878312448435e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42237,0.136038771059522,0.0093957188188492,0.117623162174577,0.154454379944466,3.82597024777668e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,42377,0.0766445113467767,0.00530388636205554,0.0662488940771478,0.0870401286164055,5.67459271928842e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UMOD,Uromodulin,42643,-0.0812541078393158,0.00562827808160111,-0.0922855328792539,-0.0702226827993776,6.80765753234411e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40019,0.0816993728285643,0.00568428110102629,0.0705581818705528,0.0928405637865758,2.04640846196163e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42561,0.0326616484176487,0.00227754330832187,0.0281976635333379,0.0371256333019596,2.68444946222937e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42229,0.117911018633665,0.00827811539269054,0.101685912463991,0.134136124803338,1.07989357261015e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,42095,0.147109390781428,0.0103571227957218,0.126809430101813,0.167409351461043,1.91176035510951e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,40288,0.0454091537461856,0.00319895552554193,0.0391392009161234,0.0516791065762478,2.45177015462825e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOMO1,Nodal modulator 1,42490,0.0333858117436789,0.00235375638962156,0.0287724492200207,0.0379991742673372,2.46145825435228e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40406,-0.0709224401381342,0.00502919539931202,-0.0807796631207857,-0.0610652171554826,8.88477370354127e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42475,0.0734801396331675,0.00526525928573715,0.0631602314331227,0.0838000478332123,5.93713569048517e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCXR,L-xylulose reductase,42561,0.0737952742176736,0.00534742132988685,0.0633143284110954,0.0842762200242519,5.01431982498238e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42448,0.0358246318957651,0.00259919983077821,0.0307302002274398,0.0409190635640904,6.38087129088839e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42358,0.102908918003681,0.00747720331090912,0.0882535995142986,0.117564236493062,8.41353843419569e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42451,0.04343293371316,0.00315723102586059,0.0372447609024732,0.0496211065238468,9.13355797387206e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42123,0.0276877888470927,0.00201675322681723,0.023734952522531,0.0316406251716545,1.35573747391522e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,40187,0.103491070269844,0.00756701932448212,0.0886597123938586,0.118322428145829,3.10294311610256e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AREG,Amphiregulin,42466,0.0593639069047907,0.00434478787489271,0.050848122670001,0.0678796911395804,3.24783033784458e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFI,Complement factor I,40440,0.0271513801707189,0.00198967887179634,0.0232516095819981,0.0310511507594397,4.6020146140124e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40411,0.103017991451795,0.00755007008713145,0.0882198540810178,0.117816128822573,4.70355447245341e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42496,-0.047608680583495,0.00350406169489698,-0.0544766415054931,-0.0407407196614969,9.11946925114543e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42532,-0.061824329386424,0.00456677645579324,-0.0707752112397787,-0.0528734475330692,1.75649683074139e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42478,0.027484727856586,0.00203021850081972,0.0235054995949794,0.0314639561181927,1.76170255142426e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRP2,Neuropilin-2,42490,-0.0396273836472043,0.00293414793841559,-0.0453783136064989,-0.0338764536879098,2.71277485719141e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPB1,Carboxypeptidase B,42673,0.0834474393999035,0.00618230082939215,0.0713301297742949,0.0955647490255122,2.98575202743349e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40104,0.0606845897544192,0.00451113144864735,0.0518427721150704,0.069526407393768,6.33010165691321e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL15,C-C motif chemokine 15,42673,0.0613696309618404,0.00456607228179695,0.0524201292895184,0.0703191326341625,6.43292413762933e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42466,0.0495150839363576,0.00368826815568249,0.0422860783512199,0.0567440895214952,7.96537959276185e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40352,0.0762846909607454,0.00577883868551516,0.0649581671371357,0.0876112147843551,1.7177312650245e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42599,-0.0463005116753165,0.00352228400791545,-0.0532041883308308,-0.0393968350198022,3.17690560740531e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGF,Placenta growth factor,42631,0.0355914636863454,0.00270770249842673,0.030284366789429,0.0408985605832617,3.19348816191694e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42237,0.0742489686871539,0.00564908674977975,0.0631767586575856,0.0853211787167222,3.28943265624727e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42631,0.101918342987651,0.00779179878787388,0.0866464173634187,0.117190268611884,7.37876911220942e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PVR,Poliovirus receptor,42590,0.0490423284552796,0.00374962547978699,0.0416930625148971,0.0563915943956621,7.48246729234185e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSF,Cathepsin F,42561,0.052832006223359,0.0040457347629205,0.0449023660880348,0.0607616463586832,9.78341523444838e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPPC,C-type natriuretic peptide,42475,0.0665365391351828,0.00511206365757507,0.0565168943663357,0.07655618390403,1.71537116099023e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CES3,Carboxylesterase 3,42466,0.0931415822085818,0.0071840055567449,0.0790609313173618,0.107222233099802,3.29055487066562e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDHR2,Cadherin-related family member 2,42466,0.093177583084918,0.00719085172322939,0.0790835137073884,0.107271652462448,3.61654989658858e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42490,0.0704808386583894,0.00545821443015794,0.0597827383752799,0.081178938941499,6.44133313487675e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40019,0.0890003306855208,0.00691244578748791,0.0754519369420445,0.102548724428997,1.16976631411167e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",42191,0.0717451200476817,0.00558963010171222,0.0607894450483257,0.0827007950470376,1.75409120715838e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42599,0.0451429451994082,0.00351834964715478,0.0382469798909849,0.0520389105078316,1.83276660158644e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACAN,Aggrecan core protein,42370,-0.0363822077608401,0.00284159517960981,-0.0419517343128753,-0.0308126812088049,2.61661001690856e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42475,0.125517713009683,0.00982286459161284,0.106264898410122,0.144770527609244,3.59599871309994e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42590,-0.0614667636964488,0.00481338441479321,-0.0709009971494435,-0.0520325302434541,3.97092792950204e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40411,0.087154042210692,0.00682288837881435,0.0737811809882159,0.100526903433168,4.16475162531434e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SBSN,Suprabasin,40412,-0.0455544024884607,0.00356847419591408,-0.0525486119124523,-0.0385601930644692,4.60749591398948e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD209,CD209 antigen,42549,-0.0505521094338868,0.00396697945009654,-0.058327389156076,-0.0427768297116976,5.58235231152416e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL27,C-C motif chemokine 27,42518,0.0765416696413171,0.00600689236854122,0.0647681605989763,0.0883151786836579,5.65402763726283e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,40411,0.0724987716979206,0.00569242089313731,0.0613416267473715,0.0836559166484697,6.71437259234362e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREH,Trehalase,40428,0.0959940285490716,0.00754663505890751,0.0812026238336129,0.11078543326453,8.20035791080769e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42466,0.0570799048246561,0.00448991702951374,0.0482796674468092,0.0658801422025031,8.21710958335967e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXLNA,Alpha-taxilin,42377,0.11325344045351,0.00891724278791366,0.0957756445891988,0.13073123631782,9.64314416061476e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPA1,Carboxypeptidase A1,42673,0.0808390961637522,0.00636787561830551,0.0683580599518734,0.093320132375631,1.02475116377397e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42673,-0.0423695956114654,0.00335801643634173,-0.0489513078266952,-0.0357878833962357,2.71360345065366e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADM,Pro-adrenomedullin,42599,0.0345009666546207,0.00273764833765426,0.0291351759128183,0.039866757396423,3.28519422823659e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42572,0.0309304024075889,0.00246838905763183,0.0260923598546305,0.0357684449605473,8.06706050952649e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSN,Gelsolin,40388,-0.0248568987718502,0.00198361345229373,-0.0287447811383459,-0.0209690164053545,8.76569285419259e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS2,Trypsin-2,42568,0.0713342111812156,0.00569906433249729,0.0601640450895209,0.0825043772729103,9.57832771901879e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,40104,0.16003050517417,0.0127911980528844,0.134959756990516,0.185101253357823,1.14179219349421e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42497,-0.0393884800512447,0.00315710972913726,-0.0455764151203537,-0.0332005449821356,1.59257029101569e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEPH,Hephaestin,40411,0.0336699503425593,0.00269919448739729,0.0283795291472606,0.038960371537858,1.77715193807783e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FYB1,FYN-binding protein 1,42469,0.116209666921006,0.00934244683315176,0.0978984711280281,0.134520862713983,2.52858596811067e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BECN1,Beclin-1,40125,0.0757467661815217,0.00610414087292333,0.063782650070592,0.0877108822924515,4.02078582236272e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42673,0.0833400255888137,0.00672451619042666,0.0701599738555774,0.0965200773220499,4.40220646199664e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42518,0.0547865768773308,0.00442312373712743,0.046117254352561,0.0634558994021005,4.82703111496318e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF23,Fibroblast growth factor 23,42589,0.0688616688703356,0.00556773761219252,0.0579489031504383,0.079774434590233,6.04207137350229e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42466,0.0422693622472755,0.00342584350371304,0.035554708979998,0.0489840155145531,8.72866764701897e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42377,0.0914767946773234,0.00741783916007056,0.0769378299235851,0.106015759431062,9.46751937618935e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42599,0.0363376681617629,0.0029478308804655,0.0305599196360505,0.0421154166874753,1.00040099355836e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42475,0.0914802975258993,0.00744437662153262,0.0768893193476954,0.106071275704103,1.60774943858312e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42466,-0.0297649153249693,0.0024247031477665,-0.0345173334945917,-0.025012497155347,1.88094997807512e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42475,0.0806069568822873,0.00657137303373297,0.0677270657361707,0.0934868480284039,2.10696865254494e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLB1,Beta-galactosidase,42377,0.0515865187689152,0.00421500960271864,0.0433250999475866,0.0598479375902437,2.95983559924533e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42256,0.0863743275520794,0.00706115529554153,0.072534463172818,0.100214191931341,3.21406826250048e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42475,0.131732742158512,0.0107726846088294,0.110618280325207,0.152847203991818,3.34739531859514e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFHR4,Complement factor H-related protein 4,40410,-0.0930187190948227,0.00761190625447332,-0.10793805535359,-0.078099382836055,3.99700515838128e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,42466,0.141018819187902,0.0115497801056859,0.118381250180757,0.163656388195046,4.20605733936103e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F10,Coagulation factor X,40432,0.0353526549208047,0.00289636767405614,0.0296757742796547,0.0410295355619548,4.74978958277897e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EZR,Ezrin,42590,0.0296975705633593,0.00243460737002969,0.0249257401181011,0.0344694010086175,4.82158134230037e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEG1,Protein HEG homolog 1,40187,0.0335174461386564,0.00274622254740908,0.0281348499457346,0.0389000423315782,4.85665582308064e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYH9,Myosin-9,40428,0.141700431479582,0.0116339452074217,0.118897898873035,0.164502964086128,6.50505639842756e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ISM1,Isthmin-1,42475,0.0476714166540207,0.00392394861784276,0.0399804773630489,0.0553623559449925,8.79009730686167e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42466,0.15253204366441,0.0125729989458237,0.127888965730595,0.177175121598224,1.08143384824329e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42466,0.119615725525933,0.00988419495656526,0.100242703411065,0.138988747640801,1.55303878559009e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40352,0.0853962880152258,0.00705692825609488,0.0715647086332798,0.0992278673971717,1.68962511370851e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUMB,Protein numb homolog,40104,0.100929403999944,0.00835350435623485,0.0845565354617239,0.117302272538165,2.14019546587141e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42475,0.111894928109642,0.00926768472044685,0.0937302660575664,0.130059590161718,2.17620705167003e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRIP2,Cysteine-rich protein 2,42377,0.0449824007188194,0.00372685322071723,0.0376777684062136,0.0522870330314252,2.2862981417313e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40104,0.0842331905324095,0.00698801622550332,0.070536678730423,0.097929702334396,3.00602326410073e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD248,Endosialin,40428,-0.0500217331694372,0.00416048801338843,-0.0581762896756785,-0.0418671766631959,4.29100067165918e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM3C,Protein FAM3C,42495,0.0380685636086932,0.0031707938141778,0.0318538077329047,0.0442833194844817,4.89551685460026e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THOP1,Thimet oligopeptidase,42454,0.0376826620143537,0.00314392995676145,0.0315205592991012,0.0438447647296061,6.2362506330052e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTBS,Di-N-acetylchitobiase,40284,0.0327172972189821,0.00273617124084346,0.0273544015869289,0.0380801928510352,9.44744583915447e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40187,0.0465526341400833,0.0039010279608089,0.0389066193368978,0.0541986489432687,1.25986454142721e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42377,0.0710955716297558,0.0059769819059125,0.0593806870941673,0.0828104561653443,1.84388497489235e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42496,0.114319601996173,0.00961690748176684,0.0954704633319098,0.133168740660436,2.00933108591827e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42191,0.0621380474564283,0.00522970697808649,0.0518878217793788,0.0723882731334778,2.1663151613477e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42552,-0.0393484591821865,0.00331324592091569,-0.0458424211871812,-0.0328544971771917,2.2920007328171e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42631,0.0503017031526133,0.00423567359919211,0.0419997828981967,0.0586036234070298,2.29726614597165e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42466,0.0336157120028828,0.00283777467370238,0.0280536736424261,0.0391777503633394,3.28712502369188e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42256,0.0719700741875221,0.00608087996212969,0.0600515494617479,0.0838885989132963,3.73535235236443e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42518,0.0910106157672993,0.00769154590897473,0.0759351857857088,0.10608604574889,3.83770713390172e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,40356,0.130642056783901,0.0110429153554552,0.108997942687209,0.152286170880593,4.22665960581333e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,42229,0.0768741304791013,0.00651432788167026,0.0641060478310275,0.089642213127175,5.62458544708743e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42590,0.0800290362821334,0.00679019995207232,0.0667202443760717,0.0933378281881952,6.62780946064774e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42639,0.0231712776012368,0.00196735944791111,0.019315253083331,0.0270273021191426,7.28013138417972e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42229,0.0814574701202383,0.00691833101585989,0.0678975413291529,0.0950173989113237,7.68984079155985e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42466,0.0523083917288748,0.00444523420091706,0.0435957326950773,0.0610210507626722,8.27897069040855e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PXN,Paxillin,42191,0.0614567500052095,0.00522861392348823,0.0512086667151726,0.0717048332952465,9.75762922576271e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40385,0.102389379819279,0.00871547764307181,0.0853070436388587,0.1194717159997,1.10963326011658e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42516,-0.0410652932701569,0.00349744390588253,-0.0479202833256867,-0.0342103032146272,1.11834499170053e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42292,0.0573721134196819,0.00489175512301218,0.047784273378578,0.0669599534607857,1.31283215556877e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAN,Brevican core protein,42377,-0.0414651962221931,0.00353566863941099,-0.0483951067554386,-0.0345352856889476,1.31972635304915e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42466,0.0798561359336518,0.00681905152925751,0.0664907949363071,0.0932214769309965,1.60471012532939e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42590,0.0618396817485231,0.00528512321737543,0.0514808402424673,0.072198523254579,1.79811324162546e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,42362,0.0442293486741345,0.00378247750781969,0.0368156927588079,0.0516430045894611,1.97404484922117e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42518,0.103052501290521,0.00882802861859816,0.0857495651980688,0.120355437382974,2.47841432379679e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40384,0.0737586518372992,0.0063255783959073,0.0613605181813209,0.0861567854932775,3.07836804086502e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPY30,Protein dpy-30 homolog,42530,0.071663385305763,0.00614907128566541,0.0596112055858588,0.0837155650256672,3.08988110972635e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA11,Integrin alpha-11,42475,-0.0404464956425094,0.00347440631636367,-0.0472563320225822,-0.0336366592624366,3.60172731441281e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42561,0.108129075779733,0.00928937909684287,0.089921892749921,0.126336258809545,3.64380570506062e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42466,0.0703998316226008,0.00605215996376924,0.0585375980936131,0.0822620651515885,4.0030834882868e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXNB2,Plexin-B2,42622,0.0286487378227397,0.00246645583290881,0.0238144843902384,0.033482991255241,4.84634990463733e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40411,0.0869079462309031,0.00749856103225732,0.0722107666076788,0.101605125854127,6.94713338602059e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42357,0.104746685382276,0.00904872425873861,0.0870111858351479,0.122482184929403,7.70380682697404e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C19orf12,Protein C19orf12,42191,0.0751176393881235,0.00651303746893481,0.0623520859490112,0.0878831928272357,1.26148367927026e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSZ,Cathepsin Z,42527,0.0379892556932894,0.00329444369899187,0.0315321460432653,0.0444463653433135,1.28149982257401e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42623,0.044786053251582,0.00388454299376932,0.0371723489837941,0.0523997575193698,1.30841268752632e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40385,0.0558133522569684,0.00484440423091451,0.046318319964376,0.0653083845495609,1.53348316262385e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42475,0.0466512769055739,0.00405864261522297,0.0386963373797369,0.054606216431411,1.96266032480525e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARF6,ADP-ribosylation factor 6,40350,0.12543236616652,0.0109103606075199,0.104048059375781,0.146816672957259,2.03466103483208e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42594,0.0684479059249583,0.00597150914034617,0.0567437480098798,0.0801520638400368,2.81958665978344e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSL5,Insulin-like peptide INSL5,40350,0.115258755575024,0.0100690402954739,0.0955234365958953,0.134994074554153,3.5930072666025e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42568,0.0492356012248623,0.00431071845727311,0.040786593048607,0.0576846094011176,4.49230328247044e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AXIN1,Axin-1,42475,0.109764930551861,0.00964856301529719,0.0908537470418781,0.128676114061843,7.5432659001308e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42561,0.0355237911406369,0.00313064023503529,0.0293877362799678,0.0416598460013061,1.04784798113422e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GDF15,Growth/differentiation factor 15,42673,0.0536057808835149,0.0047252779868534,0.0443442360292822,0.0628673257377476,1.0771263560432e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAST,Gastrin,40385,0.168639188416119,0.0148592243429402,0.139515108703956,0.197763268128282,1.08827841994299e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAXX,Protein PAXX,40187,0.0525639625228504,0.004636065594731,0.0434772739571776,0.0616506510885231,1.24153505300306e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42673,0.0591716519284555,0.00522873896102193,0.0489233235648525,0.0694199802920585,1.47593056090977e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OCLN,Occludin,40384,0.0518374517545005,0.00458184232811891,0.0428570407913875,0.0608178627176136,1.62396367423396e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOC1,Apolipoprotein C-I,40417,-0.0424166185738268,0.00376403450134957,-0.0497941261964719,-0.0350391109511816,2.68375420845073e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,40019,0.0729376506598401,0.00648347977078587,0.0602300303090998,0.0856452710105804,3.37116527623243e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MBL2,Mannose-binding protein C,40280,-0.124918290567782,0.0111200829811632,-0.146713653210862,-0.103122927924702,4.00659588929342e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPE,Carboxypeptidase E,42467,-0.0442959384273673,0.00394796178477196,-0.0520339435255204,-0.0365579333292143,4.39892667207906e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42518,0.0400316802047159,0.00357409957956919,0.0330264450287603,0.0470369153806715,5.46295876634123e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH1,Cadherin-1,42069,0.0456897848929095,0.00408225959811977,0.0376885560805947,0.0536910137052242,6.05046151159205e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42631,0.0457188910892931,0.00409091594393325,0.0377006958391839,0.0537370863394023,7.18777555471527e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTN1,Dynactin subunit 1,42599,0.0736242258197293,0.00659159352088974,0.0607047025187854,0.0865437491206732,7.71634896084508e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN5,Contactin-5,42519,-0.043535863916538,0.00389987013115126,-0.0511796093735945,-0.0358921184594815,8.2645498168903e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPO,Erythropoietin,42475,0.0843126797488719,0.00756770254178016,0.0694799827669828,0.099145376730761,1.06038419882226e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGLN1,Egl nine homolog 1,42475,0.0630238039950291,0.0056661082468149,0.0519182318312719,0.0741293761587863,1.29782119313372e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42561,0.0932923418115531,0.00839487592105706,0.0768383850062813,0.109746298616825,1.44647260547293e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42475,0.0635033497692007,0.0057275989959965,0.0522772557370476,0.0747294438013538,1.92804136865358e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VASN,Vasorin,42330,-0.0311651705767291,0.00281295509967749,-0.036678562572097,-0.0256517785813612,2.11549722048755e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42561,-0.0455350941080219,0.00412047986673627,-0.053611234646825,-0.0374589535692188,2.87601965126326e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HYAL1,Hyaluronidase-1,42424,0.0261742764934199,0.00237359832680243,0.0215220237728872,0.0308265292139527,3.74433457485095e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBKS,Ribokinase,42199,0.05577847066864,0.0050656828995659,0.0458497321854908,0.0657072091517891,4.4973719450434e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK14,Kallikrein-14,42599,-0.0529936435273841,0.00482782289154423,-0.0624561763948108,-0.0435311106599574,6.50206115552085e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42229,0.0805913953789913,0.00734388786463547,0.0661973751643058,0.0949854155936768,6.7548679001704e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FETUB,Fetuin-B,42542,0.0359231084627304,0.00327768445441481,0.0294988469320774,0.0423473699933834,7.82660277200152e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MLN,Promotilin,42475,0.0989802219452877,0.00905311568440963,0.0812361152038448,0.116724328686731,1.04870664910911e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42229,0.122282622665878,0.0112014664017777,0.100327748518393,0.144237496813362,1.2636586260042e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42530,0.0649334078763197,0.00595272604421735,0.0532660648296537,0.0766007509229857,1.37758419181566e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42475,0.0948499380885032,0.00870634343921503,0.0777855049476418,0.111914371229365,1.60338914507048e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42229,0.0697153286809368,0.00640123275947637,0.0571689124723631,0.0822617448895105,1.67269454370465e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN1,Contactin-1,42673,-0.0309895805653158,0.00284580650361795,-0.036567361312407,-0.0254117998182246,1.68258883117996e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42490,-0.0327090633118484,0.00301609612080092,-0.0386206117086182,-0.0267975149150786,2.74481793868782e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A14,Protein S100-A14,40384,0.0606657845178508,0.00559959374437532,0.0496905807788752,0.0716409882568264,3.24289113668073e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42377,0.0430253217158715,0.00397398159235807,0.0352363177948497,0.0508143256368933,3.34600629201873e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42454,-0.0690816599005773,0.00638335483168356,-0.081593035370677,-0.0565702844304775,3.51134971871944e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42490,-0.0454553370109527,0.00420096947445985,-0.053689237180894,-0.0372214368410114,3.5838326238663e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40352,0.0420340408722864,0.00388838222015758,0.0344128117207776,0.0496552700237953,4.19704367519398e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40367,0.088493571778562,0.00818750144010498,0.0724460689559562,0.104541074601168,4.27704235639999e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASAH2,Neutral ceramidase,42377,0.0587705996681205,0.00544788482398683,0.0480927454131063,0.0694484539231347,5.09752374839375e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,40104,0.0492197884089716,0.0045661702835975,0.0402700946531205,0.0581694821648226,5.89757382860222e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCN1,Ficolin-1,40415,0.061359149242675,0.00569401702952555,0.0501988758648049,0.0725194226205451,6.04882153941126e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSE,Cathepsin E,40187,0.056065700297281,0.00523676601126221,0.0458016389152071,0.0663297616793549,1.28778730855953e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40104,0.091856277428035,0.00859239624312509,0.0750151807915098,0.10869737406456,1.52719389239528e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAV,Integrin alpha-V,42599,-0.0179319978411693,0.00167858592727862,-0.0212220262586354,-0.0146419694237032,1.5664983948882e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEXIM1,Protein HEXIM1,42475,0.0878013826573718,0.0082247988142429,0.0716807769814557,0.103921988333288,1.70280091165745e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42673,-0.0314982760646391,0.00296518893045442,-0.0373100463683298,-0.0256865057609485,2.96838084339493e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42490,0.0253011434547265,0.00238325268376372,0.0206299681945496,0.0299723187149034,3.18977048296461e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40019,0.0393199471150498,0.00370303127943607,0.0320620058073551,0.0465778884227445,3.29560867409115e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,40104,0.0860578778869282,0.00810949979588657,0.0701632582869905,0.101952497486866,3.51620521706912e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTYMK,Thymidylate kinase,40411,0.0734182380101818,0.00692023419172909,0.0598545789943928,0.0869818970259708,3.59216650883471e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCAN,Neurocan core protein,42590,-0.0410866972544948,0.00389009859360751,-0.0487112904979655,-0.033462104011024,5.66316482726124e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42229,0.0548959209359755,0.00520291262700011,0.0446982121870553,0.0650936296848957,6.393018294727e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42590,0.102196212352587,0.00970758015898057,0.0831693552409852,0.121223069464189,8.14100275300494e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSNL1,Visinin-like protein 1,40385,0.0410662092064893,0.00390480423822066,0.0334127928995768,0.0487196255134018,9.52582869582743e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXNA4,Plexin-A4,42475,0.0874858250845342,0.00835966446006908,0.0711008827427988,0.10387076742627,1.56824118690679e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGFR,Epidermal growth factor receptor,42673,-0.0174432740530538,0.00166737463994754,-0.0207113283473509,-0.0141752197587566,1.62495068248145e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CES2,Cocaine esterase,42466,0.0586522131995966,0.00561453126270879,0.0476477319246873,0.0696566944745058,1.90805973867181e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCR,Breakpoint cluster region protein,42475,0.0970202637084129,0.00929075766504439,0.0788103786849259,0.1152301487319,1.9858561451609e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40019,0.0786132480393651,0.00752589179835961,0.0638625001145803,0.0933639959641499,2.02469021867193e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42532,0.090583291250309,0.00867739511038306,0.0735755968339582,0.10759098566666,2.06147296006131e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH17,Cadherin-17,42518,0.0741359604404332,0.00710540715918862,0.0602093624084235,0.0880625584724429,2.17835336469307e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42531,-0.0378786888166549,0.00364719999048649,-0.0450272007980084,-0.0307301768353014,3.59299927359245e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42475,0.109633621679933,0.0105627946928001,0.0889305440820448,0.130336699277821,3.84627325169774e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42631,0.0796206399699635,0.00768233285218307,0.0645632675796847,0.0946780123602423,4.48778446422137e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40350,0.032100807501329,0.00309724841649132,0.026030200605006,0.0381714143976519,4.68199438979893e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42516,0.0558221205010721,0.00539041620850537,0.0452569047324016,0.0663873362697426,4.90105073174167e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40440,-0.0282608395992875,0.00272802948335884,-0.0336077773866708,-0.0229139018119042,4.91374474634286e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40187,0.0877985734254646,0.00848489361765817,0.0711681819348546,0.104428964916075,5.5848398657813e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42072,0.0902642381508608,0.00876753846705622,0.0730798627554307,0.107448613546291,9.23082573405717e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42423,0.0473708283334095,0.00460491141955282,0.038345201951086,0.0563964547157331,9.9918535660284e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40385,0.072188992025409,0.00703538673528601,0.0583996340242484,0.0859783500265696,1.35926310852409e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CX3CL1,Fractalkine,42377,-0.0360383001571407,0.00351833104524472,-0.0429342290058203,-0.029142371308461,1.57194504455203e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL32,Interleukin-32,42475,-0.0461823590981326,0.00451891046001471,-0.0550394235997614,-0.0373252945965037,1.99090326212775e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNC,Tenascin,42568,-0.0504952021156964,0.00495227951053011,-0.0602016699563354,-0.0407887342750574,2.52654854439592e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42443,0.0734790866327215,0.00720784889749656,0.0593517027936282,0.0876064704718147,2.58469241186557e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,42344,0.0371670361549312,0.00365952439201727,0.0299943683465773,0.044339703963285,3.81569535481601e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELL,L-selectin,40440,-0.0246964324231324,0.00243339050562947,-0.0294658778141662,-0.0199269870320987,4.25225103513034e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40404,-0.0157415429437465,0.00155108018821183,-0.0187816601126417,-0.0127014257748513,4.26495979772742e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42561,-0.024884915996423,0.00245469051840245,-0.0296961094124918,-0.0200737225803542,4.59217933428991e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EEF1D,Elongation factor 1-delta,40411,0.0944700909244242,0.00931709853003183,0.0762085778055618,0.112731604043287,4.68775317782571e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTSS2,Protein MTSS 2,40352,0.101840923837449,0.010056566431647,0.0821300536314209,0.121551794043477,5.3343709881199e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42496,0.0282983424884279,0.00279680901587148,0.0228165968173198,0.033780088159536,5.60906964012922e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42229,0.0512121692372206,0.00506161735975717,0.0412913992120965,0.0611329392623446,5.65103571675476e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40072,0.0507425840043145,0.00501358874425028,0.0409159500655839,0.060569217943045,5.69157911793809e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A4,Protein S100-A4,42561,0.058680100533033,0.00580734291000014,0.0472977084294327,0.0700624926366333,6.43244805868401e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORT1,Sortilin,42495,0.0381041755060162,0.0037785954250051,0.0306981284730062,0.0455102225390262,7.902156387608e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40125,0.0864482976303968,0.00858142230807126,0.0696287099065771,0.103267885354216,9.14999920031905e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL11,Eotaxin,42631,0.037704272290245,0.00374751061758522,0.030359151479778,0.0450493931007121,9.95393099803224e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FEN1,Flap endonuclease 1,42229,0.0654720524208146,0.00651644707642517,0.0526998161510212,0.0782442886906079,1.15240582986601e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40350,0.0531131061685184,0.00528578416810435,0.0427529691990338,0.0634732431380029,1.17829731177004e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42464,0.0194503787835975,0.0019382349579999,0.0156514382659177,0.0232493193012773,1.29710655435701e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42191,0.0296330705051032,0.00295389991534996,0.0238434266710173,0.0354227143391891,1.34565530737456e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MENT,Protein MENT,40187,-0.0237847750561913,0.00237144781683863,-0.0284328127771951,-0.0191367373351876,1.42591126065754e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANG,Angiogenin,42497,0.0343054812526125,0.00343172268558663,0.0275793047888627,0.0410316577163623,1.9085351274626e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42466,0.0544269477210615,0.00544529357746602,0.0437541723092281,0.0650997231328949,1.93537851852297e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42475,0.0429950030561078,0.00430814745165506,0.0345510340508638,0.0514389720613517,2.25539838299993e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,40440,0.0312284440345568,0.00312993248545658,0.0250937763630619,0.0373631117060517,2.39440938499885e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42449,0.106528873209911,0.0107325227965942,0.0854931285285862,0.127564617891235,3.87183167885146e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42377,0.0539812826125052,0.00544844060275592,0.0433023390311036,0.0646602261939068,4.64179118050123e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40352,0.0798453608125775,0.00806174255738731,0.0640443454000984,0.0956463762250567,4.96570521716089e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42466,-0.0253328350596745,0.00255870988306375,-0.0303479064304795,-0.0203177636888696,4.97119713747397e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42462,0.0206823141106604,0.00209516665973138,0.0165757874575869,0.0247888407637339,6.63941570695693e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42466,0.08518231595319,0.00863025337287116,0.0682670193423625,0.102097612564017,6.7211880340767e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42590,0.0358134990760012,0.00363511081358796,0.0286886818813688,0.0429383162706337,8.02452192193169e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40385,0.0637672307952694,0.00648425706185856,0.0510580869540267,0.0764763746365122,9.9182607859934e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD93,Complement component C1q receptor,42024,-0.0323310017559028,0.00329472515752077,-0.0387886630646435,-0.0258733404471621,1.18966644232774e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40352,0.0480738743863291,0.00489990792796739,0.038470054847513,0.0576776939251452,1.24421135327518e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FMNL1,Formin-like protein 1,42191,0.0621729302623575,0.00634446988155058,0.0497377692945184,0.0746080912301966,1.35419904937737e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40350,0.0594749846069728,0.00607053452160571,0.0475767369446256,0.07137323226932,1.42561849921438e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40206,0.111648604476712,0.0114156584733268,0.0892739138689911,0.134023295084432,1.68907054046035e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42466,-0.0411870664025991,0.00421334213136408,-0.0494452169800727,-0.0329289158251255,1.7102298375743e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,42229,0.0600385644370921,0.0061422196241741,0.0479998139737109,0.0720773149004734,1.72672663602998e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42493,0.0608039260026832,0.00622719045992116,0.0485986327012377,0.0730092193041287,1.90660658577449e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40125,0.0742144585848256,0.00759907515307429,0.0593202712848,0.0891086458848512,1.94118616492797e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNST,Consortin,42518,0.108156043044956,0.0110795334782655,0.0864401574275558,0.129871928662356,1.95277711990701e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42448,0.0763385963411437,0.00782623324732669,0.0609991791763834,0.0916780135059041,2.10535116115183e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFH,Complement factor H,39857,0.0228295360690823,0.00233949404692435,0.0182441277371106,0.0274149444010541,2.10868203681544e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD63,CD63 antigen,42357,0.0507973945476985,0.00521023977391454,0.0405853245908261,0.061009464504571,2.20623171558094e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARSA,Arylsulfatase A,42490,0.0443271750463634,0.00454965258316808,0.035409855983354,0.0532444941093729,2.34807885160572e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,40019,0.0677211310254497,0.00695065757522643,0.0540978421780059,0.0813444198728935,2.43817526877121e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMN,Protein amnionless,42256,0.0468068624760395,0.00480864110823055,0.0373819259039076,0.0562317990481714,2.5735880641944e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42229,0.0654202929850398,0.00672108896830403,0.0522469586071639,0.0785936273629157,2.58259768284008e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASS1,Argininosuccinate synthase,40019,0.0773527593904206,0.00795408180282708,0.0617627590568795,0.0929427597239617,2.91189850393216e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40309,0.107826341705236,0.0111026479186856,0.0860651517846126,0.12958753162586,3.29154259783057e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40125,0.0717047350120802,0.00738592458856246,0.0572283228184978,0.0861811472056626,3.41623557673385e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,40089,0.119264494830136,0.0122894623465359,0.0951771486309254,0.143351841029346,3.543105564759e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40187,0.0214571475953603,0.00221118824116031,0.0171232186426861,0.0257910765480345,3.56130516939416e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOXO1,Forkhead box protein O1,42475,0.083925143930583,0.00865964749205891,0.0669522348461476,0.100898053015019,3.87857388696382e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42191,0.0771320502486538,0.00797997358365334,0.0614913020246933,0.0927727984726144,5.00190648335405e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEPR,Leptin receptor,42518,-0.0306680884508734,0.00318237375168101,-0.0369055410041682,-0.0244306358975786,6.58633301234265e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TF,Serotransferrin,40440,0.0209729205071058,0.00217634144337432,0.0167072912780921,0.0252385497361195,6.79382758073614e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42475,-0.034667675511933,0.00359968210116112,-0.0417230524302088,-0.0276122985936572,6.99008411571105e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42229,0.0369729914759817,0.00384106781510271,0.0294444985583804,0.044501484393583,7.36258684217531e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42490,0.0444037274798591,0.00462618992464407,0.0353363952275567,0.0534710597321615,9.55606144976279e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42466,-0.0408188387907016,0.00425419037995831,-0.0491570519354198,-0.0324806256459833,9.87366546507826e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHAD,Chondroadherin,40187,-0.050802523351826,0.00531710305975711,-0.0612240453489499,-0.040381001354702,1.50485755853031e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40428,-0.032335820790854,0.00338534913430686,-0.0389711050940954,-0.0257005364876125,1.54022911709274e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42475,0.0563062548660131,0.00589826354375141,0.0447456583202603,0.0678668514117658,1.57665528782637e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42518,0.0270164894201583,0.00283130225179474,0.0214671370066406,0.032565841833676,1.6400985309985e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUS,RNA-binding protein FUS,42219,0.0387293069611051,0.00406850760113607,0.0307550320628784,0.0467035818593318,2.04686790286655e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,40385,0.0613383614856583,0.00644366641510019,0.048708775312062,0.0739679476592547,2.10347501550268e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42598,0.0786909869518965,0.00827053295460644,0.0624807423608678,0.0949012315429251,2.1306310257874e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42554,-0.0201516712212204,0.00212070526007344,-0.0243082535309644,-0.0159950889114765,2.39679754742614e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40352,0.110058723952848,0.0115842761021448,0.0873535427926438,0.132763905113051,2.50998304323338e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRPK2,SRSF protein kinase 2,42475,0.0805503751293486,0.00851514476718023,0.0638606913856753,0.0972400588730219,3.60166608092179e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42475,0.0377157288896191,0.00398735473957016,0.0299005136000616,0.0455309441791766,3.63001887039879e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R9B,Neurabin-2,42631,0.090355172802511,0.009557208811799,0.071623043531385,0.109087302073637,3.78886270768635e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40125,0.066274444225024,0.00700962139403724,0.052535586292711,0.080013302157337,3.89796357099275e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,40104,0.0333317985529481,0.003526210782852,0.0264204254185582,0.040243171687338,3.98151517776755e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBS,Cystathionine beta-synthase,40125,0.0495748030957982,0.00524485086097386,0.0392948954082894,0.0598547107833069,3.99872038254819e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH15,Cadherin-15,42571,0.060379803100749,0.00639168535754557,0.0478520997999597,0.0729075064015384,4.07195194009258e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA9,Serpin A9,42417,0.0694214907774847,0.00735113767508731,0.0550132609343136,0.0838297206206559,4.19596460948506e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42568,0.0413207643806536,0.00437627177860868,0.0327432716945806,0.0498982570667267,4.25431097812745e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42498,0.0475846060591213,0.00503979609120554,0.0377066057203585,0.0574626063978842,4.26695114415826e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP1,Interstitial collagenase,42016,0.0884166321600563,0.00936835743008337,0.0700546515970929,0.10677861272302,4.45614991150153e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40385,0.0384292052103334,0.00407318825609731,0.0304457562283827,0.0464126541922842,4.69565611752336e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELOA,Elongin-A,42466,0.0517240930669195,0.00548697005749928,0.0409696317542209,0.0624785543796181,4.92310175455537e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL23,C-C motif chemokine 23,42554,0.0403311994422471,0.00429227226319189,0.031918345806391,0.0487440530781033,6.56037614101063e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP43,Centrosomal protein 43,42136,0.0664495356458264,0.00707155496813765,0.0525892879082766,0.0803097833833762,6.560689384316e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40428,0.0223897594565279,0.0023861008064981,0.0177130018757916,0.0270665170372641,7.61279441639554e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42561,0.0226429163195103,0.00241454072452788,0.0179104164994357,0.027375416139585,7.81023892356355e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,QDPR,Dihydropteridine reductase,42464,0.0406851179487612,0.00434173335534672,0.0321753205722816,0.0491949153252408,8.35319048626465e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40350,0.131920677224254,0.0140802899888651,0.104323308846079,0.15951804560243,8.71423350947699e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40411,0.0576706812269024,0.00615840988947406,0.0456001978435333,0.0697411646102716,9.09333588369653e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH2,Cadherin-2,42518,0.0340270155836992,0.00363637097512672,0.0268997284724508,0.0411543026949475,9.46061660196772e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40352,0.0681309134984306,0.00728779740685712,0.0538468305809907,0.0824149964158706,1.0568020652209e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42561,0.0253546262155335,0.0027159099405288,0.0200314427320971,0.03067780969897,1.16062267100252e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPP1,Osteopontin,42651,-0.0450142230153314,0.00483323141714503,-0.0544873565929356,-0.0355410894377271,1.42634973782504e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GZMA,Granzyme A,42631,0.0338633070437149,0.00363773822843652,0.0267333401159793,0.0409932739714505,1.48929712948898e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42490,0.0434732018322187,0.00467274940339518,0.0343146130015641,0.0526317906628732,1.56777131032546e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42516,-0.022834348296332,0.00245680972746093,-0.0276496953621555,-0.0180190012305086,1.7088303030388e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASPN,Asporin,40411,-0.0267634808268518,0.0028835026828625,-0.0324151460852623,-0.0211118155684413,1.97591256751638e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42475,0.0658888971784292,0.0071033437497656,0.0519663434288886,0.0798114509279698,2.03261539709027e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42466,0.0561342456007714,0.00605261673503981,0.0442711168000933,0.0679973744014494,2.05915471538358e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42558,0.063974701277936,0.00690398376505484,0.0504428930984285,0.0775065094574435,2.21695388881818e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA3F,Semaphorin-3F,42518,0.0257297503009013,0.00277715373191675,0.0202865289863445,0.0311729716154581,2.25021739894488e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APLP1,Amyloid-like protein 1,42518,-0.0487960268684643,0.00527707291434243,-0.0591390897805754,-0.0384529639563531,2.66018693780956e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42490,0.0476587698049641,0.0051614393097942,0.0375423487577675,0.0577751908521607,3.00736340793292e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTD,Biotinidase,40440,0.0193322648055147,0.00209887982996191,0.0152184603387893,0.02344606927224,3.81152090852898e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42495,0.0762663548480919,0.00828857292933446,0.0600207519065963,0.0925119577895874,4.05376191885882e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKK4,Dickkopf-related protein 4,42359,0.0435116175981421,0.00473459871182879,0.0342318041229577,0.0527914310733265,4.50420363340399e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40384,0.0911123361804359,0.00991812941792926,0.0716728025212946,0.110551869839577,4.77475630317989e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40411,0.0276479969201305,0.00301367704969795,0.0217411899027226,0.0335548039375385,5.34441432472627e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42256,0.0432000280933654,0.00471463304301874,0.0339593473290486,0.0524407088576821,5.79335434828259e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH5,Cadherin-5,42673,-0.0281648245333755,0.00307633759809292,-0.0341944462256376,-0.0221352028411133,6.19031252168818e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STC1,Stanniocalcin-1,42590,0.0423299933684557,0.00462427022169687,0.0332664237339298,0.0513935630029815,6.27773746026648e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42561,-0.0410065637256277,0.00448183633110972,-0.0497909629346027,-0.0322221645166526,6.53747436898258e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40385,0.0824207388028727,0.00903491865577051,0.0647122982375625,0.100129179368183,8.5971739277609e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,42323,0.0336863698802772,0.0036977424023695,0.026438794771633,0.0409339449889215,9.41850061755477e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KAZN,Kazrin,40350,0.0966472554720134,0.0106137947825177,0.0758442176982787,0.117450293245748,1.0017492237884e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THBS2,Thrombospondin-2,42490,0.0361544788194399,0.00397328659567018,0.0283668370919263,0.0439421205469534,1.03604170733612e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42466,0.0712304189238333,0.00783613997765808,0.0558715845676235,0.0865892532800431,1.12931728644442e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPL,N-acetylneuraminate lyase,40411,0.0423232311272584,0.00465540162477694,0.0331986439426956,0.0514478183118212,1.14382015879111e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42536,0.0953260640483504,0.0105060365898908,0.0747342323321644,0.115917895764536,1.31246864084413e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42237,0.0873465488587115,0.009644273715515,0.0684437723763021,0.106249325341121,1.53176788821803e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EHBP1,EH domain-binding protein 1,40411,0.0685562907288736,0.00757501144387226,0.0537092682988839,0.0834033131588632,1.66018160055056e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,42191,0.0531265272640251,0.00587821300888832,0.041605229766604,0.0646478247614462,1.82099369785654e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIAE,Sialate O-acetylesterase,42528,0.0423870292917714,0.00469324679831986,0.0331882655670644,0.0515857930164783,1.92328002664338e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGRN,Agrin,42554,0.0335315363363831,0.00371383872483458,0.0262524124357074,0.0408106602370589,1.97029081173712e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42490,-0.0486428321409006,0.00538840941205933,-0.0592041145885369,-0.0380815496932643,1.99852195788153e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP20,Centrosomal protein 20,42229,0.068709215380459,0.00763128328590014,0.0537519001400947,0.0836665306208233,2.48354393992692e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECTIN2,Nectin-2,42495,0.0290309496733942,0.00322726665941616,0.0227055070209386,0.0353563923258499,2.66573562153988e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROC,Vitamin K-dependent protein C,42542,0.023099649987001,0.00256839418638842,0.0180655973816797,0.0281337025923223,2.70616395571258e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBIN,Erbin,42466,0.093612302301458,0.0104097279915965,0.073209235437929,0.114015369164987,2.73367069961714e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,40104,0.0501915070413321,0.00558429530043221,0.039246288252485,0.0611367258301793,2.93306533957255e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42495,0.104274565430004,0.0116189142263226,0.0815014935464117,0.127047637313596,3.22204684339984e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPA,Apolipoprotein(a),40225,-0.166988197616743,0.0186309808289664,-0.203504920041517,-0.130471475191968,3.67017652145809e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELN,Elastin,40411,0.0335857082418629,0.00374752213329504,0.0262405648606046,0.0409308516231212,3.68830621128137e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42553,0.0664760069308086,0.00742477197305711,0.0519234538636167,0.0810285599980005,3.90165817620503e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40111,0.0728255530774529,0.0081502603834592,0.0568510427258729,0.0888000634290329,4.70991519433703e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40385,0.0748210187322458,0.00837694533959055,0.0584022058666483,0.0912398315978433,4.84645552855526e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42631,0.0893010627648837,0.0100017080895108,0.0696977149094426,0.108904410620325,4.86871406329982e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40411,0.0709754804214789,0.00794743059833458,0.0553985164487432,0.0865524443942147,4.89548496754551e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42466,-0.0180193131758522,0.00201931420629113,-0.0219771690201828,-0.0140614573315216,5.10452054266229e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42631,0.0370482724345776,0.00415450780071075,0.0289054371451846,0.0451911077239707,5.37286016004038e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40350,0.0767217700456342,0.00860780899948567,0.0598504644066423,0.0935930756846261,5.73574259635334e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42191,0.055362250456642,0.00621677415058778,0.04317737312149,0.0675471277917941,6.02399810207318e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40187,0.0709976766120531,0.00797054267077691,0.0553754129773304,0.0866199402467759,6.04001776580978e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,42256,0.0770040274564815,0.00864741905175761,0.0600550861150366,0.0939529687979264,6.04437379031409e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELP,P-selectin,42568,0.0508348579490676,0.00572259116382146,0.0396185792679775,0.0620511366301576,7.31712727901712e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADD1,Alpha-adducin,40187,0.0645095362195177,0.00726407463427299,0.0502719499363426,0.0787471225026927,7.68073243353559e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLA2,Src-like-adapter 2,40384,0.0938999426406804,0.0105800311209967,0.0731630816435269,0.114636803637834,8.04119541176983e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTRB1,Chymotrypsinogen B,42490,0.0523262029885954,0.00591781323502722,0.0407272890479421,0.0639251169292488,1.05588698632762e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42612,-0.0326337927757334,0.00369271022894641,-0.0398715048244683,-0.0253960807269984,1.1007563658461e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,42191,0.076554935892537,0.00866751163432964,0.0595666130892509,0.0935432586958231,1.15465309124082e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VCAN,Versican core protein,42590,-0.0276431173681392,0.0031319280816651,-0.0337816964082028,-0.0215045383280757,1.21543100537752e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42554,0.0271781946934508,0.00308127635823777,0.0211388930313048,0.0332174963555969,1.28003807819595e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42377,0.03925315166406,0.00445110376887949,0.0305289882770562,0.0479773150510638,1.30138198828591e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40428,-0.0191139932219054,0.00216918772886041,-0.0233656011704718,-0.0148623852733391,1.41494661608984e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NIT2,Omega-amidase NIT2,40364,0.0656276893796921,0.00745353186024433,0.0510187669336132,0.080236611825771,1.50234593955189e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40352,0.0596775724395858,0.00678175631684464,0.0463853300585703,0.0729698148206012,1.57319564266289e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40187,0.0518704943103786,0.00590039187874308,0.0403057262280422,0.063435262392715,1.70246141890551e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,40440,0.0152630765934974,0.00173800537911621,0.0118565860504296,0.0186695671365651,1.83889567590445e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FSTL3,Follistatin-related protein 3,42452,0.0303929298538021,0.00346285527952504,0.023605733505933,0.0371801262016712,1.88497578039566e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRG2,Bone marrow proteoglycan,40428,-0.047435539118811,0.00540756074757506,-0.0580343581840581,-0.0368367200535639,2.00664730868594e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN8,Tetraspanin-8,40350,0.0916029039980919,0.0104626500878776,0.0710961098258518,0.112109698170332,2.33007143730916e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40411,0.0565039182392818,0.00645388867371812,0.0438542964387943,0.0691535400397693,2.33269757790895e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42256,0.0607585258377676,0.00694555866163604,0.047145230860961,0.0743718208145742,2.43903809561167e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAG1,Dystroglycan,42554,0.0410134148843189,0.00469083696862232,0.0318193744258192,0.0502074553428187,2.53163031063693e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOK2,Docking protein 2,42518,0.107297868764655,0.01228490792494,0.0832194492317725,0.131376288297537,2.74554196450753e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42358,0.0988856244666777,0.0113250043226407,0.076688615994302,0.121082632939053,2.81040257903605e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42237,0.0518806603243998,0.00594502960049179,0.0402284023074359,0.0635329183413637,2.93690217780365e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42553,-0.0216806043840598,0.00248573366866511,-0.0265526423746434,-0.0168085663934762,3.052922650849e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40350,0.0261020719662091,0.00299243216054925,0.0202369049315326,0.0319672390008856,3.10152466603133e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40195,0.0394273924346465,0.00452250251186328,0.0305632875113945,0.0482914973578985,3.23656869311893e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40411,0.0656352397580977,0.00753844731768614,0.0508598830154328,0.0804105965007625,3.56486279648246e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42475,0.0518257050035477,0.00595969893703273,0.0401446950869636,0.0635067149201319,3.83693954105784e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,40411,0.0729864247119174,0.00839339158612037,0.0565353772031214,0.0894374722207133,3.92627430195726e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRAP,BRCA1-associated protein,40244,0.0962810495833688,0.0111024044266215,0.0745203369071907,0.118041762259547,4.83523683755296e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB1,Integrin beta-1,42517,-0.0190117099973704,0.00219402873907328,-0.023312006325954,-0.0147114136687868,5.02195426889585e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL16,Pro-interleukin-16,42631,0.0365781618655593,0.00422479381455703,0.0282975659890275,0.044858757742091,5.34407648752442e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH2B3,SH2B adapter protein 3,42229,0.0860009083862123,0.00993294267860987,0.066532340736137,0.105469476036288,5.35351020361562e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCA,Calcitonin,42358,0.055672697431485,0.00643081454027083,0.0430683009325542,0.0682770939304159,5.39334270525798e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,40428,0.0344779894485062,0.00398180296511293,0.0266736556368849,0.0422823232601276,5.41356076474604e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39964,0.0470202274135174,0.00543251357645094,0.0363725008036736,0.0576679540233613,5.61441340771848e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTN2,Dynactin subunit 2,42466,0.082907041588319,0.00959326238463692,0.0641042473144307,0.101709835862207,6.13887052436034e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42568,0.0501402178938545,0.00581838935224588,0.0387361747634526,0.0615442610242564,7.60146665532362e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL15,Interleukin-15,42475,0.0292848954628183,0.00340052640259688,0.0226198637137284,0.0359499272119082,7.99087655509427e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOA4,Apolipoprotein A-IV,40440,0.0316797426756078,0.0036808884557164,0.0244652013024037,0.038894284048812,8.52934405541256e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40187,0.0580999060721659,0.00675723826845516,0.0448557190659938,0.0713440930783381,9.1969395654601e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40019,0.054370367262166,0.00634342712579271,0.0419372500956123,0.0668034844287197,1.16398158195142e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMMT,MICOS complex subunit MIC60,40352,0.03936118187731,0.00460543642399965,0.0303345264862707,0.0483878372683493,1.43158419672054e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,40359,0.0503319356252429,0.00590601549873392,0.0387561452477244,0.0619077260027614,1.76735205773586e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNMBP,Dynamin-binding protein,42377,0.0521629807498246,0.00612333445848342,0.0401612452111971,0.0641647162884521,1.78688962651053e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42466,0.119116225711093,0.0139911267334619,0.0916936173135081,0.146538834108679,1.86435377804356e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGN,Secretagogin,42256,0.0394097822126162,0.00463285592252766,0.0303293846044619,0.0484901798207704,1.984854217e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUCB2,Nucleobindin-2,42561,0.0320251205742524,0.00377551233230127,0.0246251164029419,0.0394251247455629,2.43744942255122e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42377,0.0621096663841327,0.00735079803913316,0.0477021022274317,0.0765172305408337,3.23334464183546e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40104,-0.0283787931547913,0.00335813039636163,-0.0349607287316601,-0.0217968575779225,3.26149939429051e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNCG,Gamma-synuclein,42377,0.0593883725244923,0.0070413252565253,0.0455873750217027,0.0731893700272819,3.67729471950151e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42568,-0.0261493618811888,0.00310274321629017,-0.0322307385851175,-0.0200679851772601,3.87882015380638e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42377,0.0813732445783061,0.00966457750350363,0.062430672671439,0.100315816485173,4.16011491937159e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40385,0.0551875775250425,0.00655445226901717,0.0423408510777688,0.0680343039723161,4.22844560980559e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40350,0.0933143684358039,0.0110887258688679,0.0715804657328228,0.115048271138785,4.39873433948777e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42518,0.054302760183864,0.00646965550070722,0.0416222354024779,0.0669832849652502,5.19324079885802e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,40384,0.0471995245781077,0.00562321458474814,0.0361780239920013,0.058221025164214,5.27765817146483e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATRN,"Attractin, Isoform 2",40440,0.0143511173219688,0.00171033930872656,0.0109988522768647,0.0177033823670728,5.40514242656797e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDHD2,Phospholipase DDHD2,40384,0.056156006753228,0.00669321407998003,0.0430373071564671,0.0692747063499888,5.44534888764492e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMMD1,COMM domain-containing protein 1,40125,0.0516310496209273,0.00617395915840308,0.0395300896704572,0.0637320095713973,6.87311687157994e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD36,Platelet glycoprotein 4,40104,0.038254614973309,0.00457564358083992,0.0292863535548627,0.0472228763917552,7.00468334703582e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,42320,-0.0325847411241811,0.00390342392649096,-0.0402354520201034,-0.0249340302282589,7.65044734969345e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TADA3,Transcriptional adapter 3,40352,0.0337705918716919,0.0040456215039458,0.0258411737239581,0.0417000100194257,7.797949393344e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42516,0.0271676640392095,0.00325685417882644,0.0207842298487097,0.0335510982297094,8.03856898885602e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKK1,Dickkopf-related protein 1,42590,0.0499771692739922,0.00599442515038089,0.0382280959792457,0.0617262425687388,8.33840319810127e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42584,0.0565847246870881,0.00678944036805634,0.0432774215656977,0.0698920278084785,8.55534582195354e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS8,Galectin-8,42590,0.0508822573799429,0.0061156076832274,0.0388956663208172,0.0628688484390686,9.63557546025525e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD207,C-type lectin domain family 4 member K,42246,0.033921695279881,0.00407929056443172,0.0259262857735949,0.0419171047861672,1.0028667906428e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42673,-0.0213333186957408,0.00256668438269154,-0.0263640200858162,-0.0163026173056654,1.03368233552726e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGA,Protein O-GlcNAcase,40350,0.059364985337804,0.0071430980414987,0.0453645131764666,0.0733654574991415,1.06047068521577e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42466,-0.0225851787349449,0.00272213813189995,-0.0279205694734688,-0.017249787996421,1.17151922386184e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40104,0.0451268902910122,0.00544168596565461,0.0344611857983292,0.0557925947836953,1.23589110550165e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPL14,60S ribosomal protein L14,40125,0.0339147410269763,0.00409664663411511,0.0258853136241107,0.041944168429842,1.39066730711705e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLO1,Lactoylglutathione lyase,42237,0.049148963557241,0.00594225494299577,0.0375021438689693,0.0607957832455127,1.45522058406166e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JAM3,Junctional adhesion molecule C,40187,0.0429349298391648,0.00519192049305512,0.0327587656727767,0.0531110940055528,1.49930008250412e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39937,0.0280835404327855,0.0033962030839368,0.0214269823882694,0.0347400984773017,1.50895134952834e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDT,D-dopachrome decarboxylase,40428,0.0349986213584938,0.0042427969801358,0.0266827392774277,0.04331450343956,1.77593328920388e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFF3,Trefoil factor 3,42492,0.0364098514972582,0.00441613028107421,0.0277542361463528,0.0450654668481637,1.80943700163083e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6AP2,Renin receptor,42229,0.0338772120093626,0.00411867117776626,0.0258046165009407,0.0419498075177844,2.13091401363658e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42554,0.0874356418806666,0.0106436247276521,0.0665741374144684,0.108297146346865,2.31864604691684e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42631,0.0560361826978332,0.00682915816053817,0.0426510327031784,0.069421332692488,2.50536679793073e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NIT1,Deaminated glutathione amidase,40125,0.0397226990999001,0.00484738830611936,0.0302218180199062,0.0492235801798941,2.79335373385212e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42237,0.0776410903431539,0.00947872741024915,0.0590627846190656,0.0962193960672423,2.82840585771713e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42518,0.0313614521396622,0.00383326423262425,0.0238482542437186,0.0388746500356057,3.05855444838011e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD5,Programmed cell death protein 5,42590,0.0481399916435017,0.00588486015430781,0.0366056657410584,0.059674317545945,3.08463063893205e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALM2,Paralemmin-2,40385,0.0313694271476856,0.00383996436895297,0.0238430969845378,0.0388957573108334,3.43802250088719e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL3,C-C motif chemokine 3,42475,0.0481026452977291,0.00589028744696527,0.0365576819016771,0.059647608693781,3.46140152093166e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BOC,Brother of CDO,42237,-0.0195983618850548,0.00240059104801168,-0.0243035203391577,-0.0148932034309519,3.5378443923423e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42590,0.0542696143398459,0.00665503888486041,0.0412257381255195,0.0673134905541723,3.8110304464534e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40191,0.0540039727439357,0.00663713295886597,0.0409951921445584,0.067012753343313,4.50134644152193e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD69,Early activation antigen CD69,42467,0.0727511406596247,0.00894412814758777,0.0552206494903527,0.0902816318288968,4.52206367296032e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42490,-0.0373780185131336,0.00460185661512278,-0.0463976574787743,-0.028358379547493,4.97208500996838e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XCL1,Lymphotactin,42599,0.0467775572083489,0.00575939585544239,0.0354891413316818,0.0580659730850159,4.98594071227239e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST3,Cystatin-C,42538,0.0250702301927066,0.00308779308570311,0.0190181557447286,0.0311223046406847,5.1042471701599e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42237,-0.0178393042405896,0.00219723511273443,-0.0221458850615491,-0.0135327234196301,5.12093235696332e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42191,0.0552889345222952,0.00681922797879151,0.0419232476838638,0.0686546213607265,5.61369697698416e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,40139,-0.0288911095703546,0.00356548440040954,-0.0358794589951573,-0.0219027601455519,5.93231520083714e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTDH,Protein LYRIC,40104,0.0776018338337389,0.00958335224622554,0.0588184634311369,0.096385204236341,6.203473286802e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,42229,0.0470996786911893,0.00582299256636917,0.0356866132611058,0.0585127441212729,6.56799662292234e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE4,Ribonuclease 4,40072,0.0243391970723173,0.0030085301825819,0.0184424779144568,0.0302359162301779,6.59739623029436e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POF1B,Protein POF1B,40104,0.0387231091570347,0.00478732437673446,0.0293399533786352,0.0481062649354342,6.67057034828311e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42631,0.0469136887999652,0.00580866844501245,0.0355286986477408,0.0582986789521896,7.23005887970468e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VNN1,Pantetheinase,40432,0.0600828409973844,0.00745054168249695,0.0454797792996904,0.0746859026950784,8.11758109822086e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,40019,0.0357876008912223,0.00443787497119498,0.0270893659476802,0.0444858358347645,8.153695696019e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100P,Protein S100-P,42237,0.0450013739705249,0.0056000724429848,0.0340252319822747,0.0559775159587751,1.00881017943018e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42475,0.0646672124147289,0.00806048476700447,0.0488686622714002,0.0804657625580577,1.12035449833419e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40125,-0.0290548590718307,0.00362158484243095,-0.0361531653629954,-0.0219565527806661,1.14023549410533e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CETN2,Centrin-2,42191,0.0551697531156297,0.00689412434743596,0.0416572693946552,0.0686822368366042,1.32287510592089e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42561,-0.0230205216708081,0.00287771581486409,-0.0286608446679417,-0.0173801986736744,1.35067563146938e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42191,0.0421974426851546,0.00527917774638855,0.031850254302233,0.0525446310680761,1.42548334358859e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40206,0.043112549208097,0.0053934952687896,0.0325412984812693,0.0536837999349246,1.44338224257094e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42377,0.0468615505453175,0.00586443010369245,0.0353672675420803,0.0583558335485547,1.45142338586865e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42466,0.0684628177244663,0.00857804548820618,0.0516498485675822,0.0852757868813504,1.56803304143388e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFC1,Cryptic protein,42229,0.0386381230706439,0.00484822719023002,0.0291355977777931,0.0481406483634948,1.72454984830984e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42490,-0.0235324286074645,0.00295305098058098,-0.0293204085294032,-0.0177444486855258,1.73137243411084e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RFC4,Replication factor C subunit 4,40352,0.0172508137761358,0.00216492252790237,0.0130075656214472,0.0214940619308245,1.76475605375232e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42518,0.0596311700656424,0.00749020152000012,0.0449503750864422,0.0743119650448427,1.84071543932618e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFHR5,Complement factor H-related protein 5,40283,-0.0345120101436718,0.00434019647549175,-0.0430187952356356,-0.0260052250517079,2.01795609608034e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42599,-0.0477049091811798,0.00600117325133756,-0.0594672087538014,-0.0359426096085581,2.02554123205178e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASET2,Ribonuclease T2,42630,0.0224514787712478,0.00283193571864914,0.0169008847626955,0.0280020727798002,2.40264357073909e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAMBP,STAM-binding protein,42358,0.0510655420739917,0.00644534861925219,0.0384326587802574,0.063698425367726,2.50692577525891e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAB2,Stabilin-2,40428,0.0226618954060562,0.002860298670417,0.0170557100120389,0.0282680808000735,2.53893807294374e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN4,CCN family member 4,42599,0.03248802141162,0.00410229882798656,0.0244475157087664,0.0405285271144737,2.57223477487141e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40042,0.0660420876812728,0.00834320261041348,0.0496894105648624,0.0823947647976832,2.69878001725001e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40878,-0.0257023692875389,0.00324796463688416,-0.0320683799758318,-0.0193363585992459,2.73066750109416e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40350,0.0378166830724105,0.0047846694311141,0.0284387309874269,0.0471946351573941,2.96165327927296e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TALDO1,Transaldolase,40400,0.035558135857007,0.00449912455696831,0.0267398517253491,0.0443764199886649,2.96931054123765e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40385,0.0863791726827376,0.0109332163997233,0.06495006853928,0.107808276826195,3.03499790229875e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFNA4,Ephrin-A4,42357,0.0274133062195152,0.00347414287881467,0.0206039861770385,0.0342226262619919,3.24223998557144e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40125,0.0472609331981379,0.00599254780577836,0.0355155394988124,0.0590063268974635,3.40053781121365e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,42191,0.0463860266851623,0.00588304931577372,0.0348552500262458,0.0579168033440788,3.4037413742054e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CMIP,C-Maf-inducing protein,40352,0.0665973435750155,0.00846085031982094,0.0500140769481665,0.0831806102018645,3.83626366449651e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40125,0.0613434837013943,0.00779965798856853,0.0460561540438,0.0766308133589887,4.04191304974034e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLIN1,Perilipin-1,42191,0.0281889634361194,0.0035857584762025,0.0211608768227625,0.0352170500494763,4.09798218889605e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42590,0.0504470935727463,0.00642167844128715,0.0378606038278235,0.0630335833176692,4.27544307889145e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42482,-0.0459984691877679,0.00585653436568615,-0.0574772765445127,-0.034519661831023,4.33047380909487e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GMPR,GMP reductase 1,42631,0.0396083041853144,0.00504633396453872,0.0297174896148185,0.0494991187558103,4.51241123817617e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40384,0.0637199813243272,0.00811969396452125,0.0478053811538655,0.0796345814947888,4.6274831315565e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42554,0.0316608409774272,0.00403848745616317,0.0237454055633474,0.0395762763915071,4.85407135097909e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPT1,Angiopoietin-1,42432,0.0672023360720784,0.00857755761554266,0.0503903231456148,0.0840143489985421,5.05790465175521e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN2,CCN family member 2,42502,0.0441624429845868,0.00564101178482687,0.0331060598863261,0.0552188260828474,5.29588133637129e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,42321,-0.0226578534547828,0.00289679296840679,-0.0283355676728601,-0.0169801392367055,5.60808558261826e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINH1,Serpin H1,40206,0.10311654436675,0.0131935122798348,0.0772572602982738,0.128975828435226,5.96350132796019e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42554,0.0835212464308541,0.0106946047462624,0.0625598211281799,0.104482671733528,6.1601435124255e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPEP2,Dipeptidase 2,42466,-0.0236871405716137,0.00303314556806293,-0.029632105885017,-0.0177421752582103,6.17431456681533e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPEP1,Dipeptidase 1,42358,-0.039902283609004,0.00511442993028238,-0.0499265662723574,-0.0298780009456505,6.55620296854305e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCTN3,Tectonic-3,40411,0.0239380797455208,0.00306998430755334,0.0179209105027163,0.0299552489883253,6.87541987693345e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OPLAH,5-oxoprolinase,40125,0.0539560210959197,0.00691964334546025,0.0403935201388176,0.0675185220530218,6.88765786286347e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12A_IL12B,Interleukin-12,42466,0.0654411865357643,0.00840071105832528,0.0489757928614468,0.0819065802100818,7.19938875587763e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLK1,Protein delta homolog 1,42673,0.043843232648666,0.00563060245287017,0.0328072518410404,0.0548792134562915,7.38445918359431e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,P4HB,Protein disulfide-isomerase,42448,0.0304220243825417,0.0039124781158328,0.0227535672755094,0.038090481489574,8.05899739742475e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINE2,Glia-derived nexin,40411,0.0508430681265503,0.00655859871276734,0.0379882146495263,0.0636979216035743,9.8174874603083e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,40104,0.0388078798420817,0.0050097190465685,0.0289888305108075,0.048626929173356,1.02819079460896e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42554,0.0978439442025344,0.0126376651950802,0.0730741204201772,0.122613767984892,1.04678252536372e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40350,0.0315415084242397,0.00407991802336828,0.0235448690984378,0.0395381477500415,1.15947176014847e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDS,Iduronate 2-sulfatase,42631,-0.00692069596222887,0.000897699426147923,-0.0086801868374788,-0.00516120508697894,1.35300656330686e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42475,0.0546991099786945,0.00710114265228699,0.040780870380212,0.068617349577177,1.42456820636476e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NADK,NAD kinase,42518,0.043210089114565,0.00561097943582549,0.0322125694203471,0.054207608808783,1.44518124426227e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM13A,Protein FAM13A,40350,0.0528657424488466,0.00686917516722401,0.0394021591210875,0.0663293257766056,1.52132872668329e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40432,0.051438650073675,0.00668602732092502,0.038334036524662,0.0645432636226881,1.55183928257749e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL25,C-C motif chemokine 25,42631,0.0377044019848639,0.00490837489249504,0.0280839871955737,0.0473248167741542,1.67900715291828e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OPTC,Opticin,42466,-0.0365712685610766,0.0047672062929761,-0.0459149928953097,-0.0272275442268434,1.81926018771332e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42590,0.0507949081116885,0.0066263739864309,0.0378072150982839,0.0637826011250931,1.90271746469852e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN2L,Ataxin-2-like protein,40384,0.0378285042896752,0.00493653584029684,0.0281528940426934,0.047504114536657,1.96695456485348e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42554,0.0316624981328941,0.00413593475662534,0.0235560660099084,0.0397689302558798,2.05810373223337e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADA,Adenosine deaminase,42631,0.0272174330072495,0.00355593376553638,0.0202478028267982,0.0341870631877008,2.07935459453578e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40187,-0.0340070738885007,0.00444347829740134,-0.0427162913514073,-0.025297856425594,2.12355757003445e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EREG,Proepiregulin,42358,0.0628597230949571,0.00822318159040299,0.0467422871777672,0.078977159012147,2.24767844701959e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40104,0.0352916721848063,0.00461886518464994,0.0262386964228924,0.0443446479467202,2.34026670689926e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AAMDC,Mth938 domain-containing protein,40125,0.0415013677702594,0.00543858333409591,0.0308417444354314,0.0521609911050874,2.52484785417536e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42561,-0.0228573335958348,0.00300161659499605,-0.0287405021220271,-0.0169741650696425,2.81343784462727e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN3,Ataxin-3,40385,0.0484029539787767,0.00635741548441731,0.0359424196293187,0.0608634883282346,2.87960412456437e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,40125,0.0254828078804443,0.00335032966388455,0.0189161617392306,0.032049454021658,3.05775748677511e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42175,0.0448685741737385,0.0059004720454438,0.0333036489646686,0.0564334993828083,3.06273762984273e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GMPR2,GMP reductase 2,40187,0.0523226384336315,0.00687950565068748,0.038838807358284,0.0658064695089789,3.06767748544468e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F12,Coagulation factor XII,40440,0.0322878835026094,0.00424678683294274,0.0239641813100416,0.0406115856951771,3.12616632774651e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42561,0.0741259198510192,0.00976814668200052,0.0549803523542981,0.0932714873477402,3.44918962000828e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42623,0.0409544366095021,0.00539852025501752,0.0303733369096678,0.0515355363093365,3.50966453941344e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42502,0.0583580972861907,0.00770753267513923,0.0432513332429179,0.0734648613294636,3.9300211770386e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40411,-0.024914030545106,0.00329441722486667,-0.0313710883058446,-0.0184569727843673,4.26264868156527e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,40384,0.0605087725116701,0.00800153307106196,0.0448257676923887,0.0761917773309516,4.27493953219826e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,40432,0.0362701403627487,0.00479903245618087,0.0268640367486342,0.0456762439768632,4.41797854007863e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPA33,Cell surface A33 antigen,42466,0.107646649597081,0.0142612801792133,0.0796945404458231,0.135598758748339,4.70145380388399e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPARCL1,SPARC-like protein 1,42523,-0.02144308383842,0.00284161815746429,-0.02701265542705,-0.01587351224979,4.7760038342811e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COCH,Cochlin,40411,0.0362122789776471,0.00479873563508343,0.0268067571328836,0.0456178008224106,4.82777336647752e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40125,0.0788136094480894,0.010459785952994,0.0583124289802212,0.0993147899159575,5.27253633195411e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCOF1,Treacle protein,40411,0.0248245510221884,0.00330332137536609,0.0183500411264708,0.0312990609179059,6.12287778190125e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40171,0.0651766101407374,0.0086736082336827,0.0481763380027193,0.0821768822787555,6.16390372959692e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42673,-0.0207241157379973,0.00275901041380378,-0.0261317761490527,-0.0153164553269419,6.21602102537647e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40350,-0.0233496197260583,0.00310891367793446,-0.0294430905348098,-0.0172561489173067,6.33793299788806e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42459,0.0637775763153914,0.00849568769198874,0.0471260284390935,0.0804291241916893,6.43278756101303e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40384,0.0474204726963703,0.00632526160895018,0.035022959942828,0.0598179854499127,7.02287686653934e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40104,0.0336014039886318,0.00448328107036754,0.0248141730907114,0.0423886348865522,7.15294226085175e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40125,0.028446443871631,0.00379621876791348,0.0210058550865206,0.0358870326567415,7.2316453137491e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,40104,0.0739822444299269,0.00988635674743585,0.0546049852049527,0.0933595036549012,7.80778385258826e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGA,Fibrinogen alpha chain,40185,-0.0237134565256914,0.0031690697198671,-0.0299248331766309,-0.0175020798747519,7.8322575943116e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARSB,Arylsulfatase B,42466,0.0419958985733501,0.00562966191506615,0.0309617612198204,0.0530300359268797,9.20662238978438e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42561,0.0528907879177535,0.00711576437615644,0.0389438897404868,0.0668376860950201,1.12693733612783e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL5,C-C motif chemokine 5,42568,0.0756158191241862,0.010187367082699,0.0556485796420961,0.0955830586062763,1.21861056188661e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,40187,0.052317816712729,0.00704719578856184,0.0385053129671478,0.0661303204583102,1.22110918340207e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,42229,0.0431876174201033,0.00582153392064343,0.0317774109356422,0.0545978239045644,1.2568873656967e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMPACT,Protein IMPACT,40385,0.0423803337503994,0.00572228463695266,0.0311646558619722,0.0535960116388267,1.3932199897852e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40385,0.0679230302005284,0.00917124564428143,0.0499473887377367,0.08589867166332,1.39432327001113e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,42256,-0.0305105219077182,0.00412171830750936,-0.0385890897904365,-0.0224319540249998,1.41949838457724e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42229,0.0437667924280803,0.00591613712749115,0.0321711636581976,0.0553624211979629,1.46853926928817e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLR2,Folate receptor beta,42590,-0.0224439396399453,0.00303588802773775,-0.0283942801743113,-0.0164935991055793,1.52209628505414e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,40019,0.0497511206088743,0.00672846456255789,0.0365633300662609,0.0629389111514878,1.52860008318453e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42237,0.0288634864410719,0.00390584845686122,0.0212080234656239,0.0365189494165199,1.559840624683e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MITD1,MIT domain-containing protein 1,42377,0.072075969476851,0.00976929035330155,0.05292816038438,0.091223778569322,1.7053623978676e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42475,0.0836866248260305,0.0113576663842247,0.0614255987129502,0.105947650939111,1.8302804539996e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42466,0.0761415173691186,0.010357392967786,0.0558410271522582,0.0964420075859791,2.0759510273237e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42493,0.073289876206378,0.00997074985805975,0.0537472064845809,0.0928325459281752,2.0901373748231e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARB2,Lysosome membrane protein 2,42185,0.026268211405913,0.00357448591937556,0.0192622190039369,0.0332742038078891,2.11929885798223e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATG4A,Cysteine protease ATG4A,42229,0.0441736749132212,0.00602307063028212,0.0323684564778682,0.0559788933485741,2.36436398140992e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42536,0.0525102877693721,0.00717022209137421,0.0384566524702787,0.0665639230684656,2.55656174237054e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40384,0.0493224720012721,0.0067356109368785,0.0361206745649902,0.0625242694375539,2.59827507489864e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42518,0.0300916316543974,0.00411116183624451,0.0220337544553581,0.0381495088534366,2.63162234810933e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42381,0.0219159703262554,0.00299843414704442,0.0160390393980484,0.0277929012544625,2.84336998980908e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42532,0.0565114720312937,0.00774861827726374,0.0413241802078567,0.0716987638547306,3.19977329932638e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNXB,Tenascin-X,42490,-0.0193215199741056,0.00265029073400171,-0.0245160898127489,-0.0141269501354622,3.26639301468595e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASHC3,WASH complex subunit 3,40385,0.0557031354243362,0.00763964851761537,0.0407294243298101,0.0706768465188623,3.27636734754136e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42256,0.0447485150961681,0.00614198753295555,0.0327102195315752,0.056786810660761,3.38432578558894e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42475,0.0748045290478048,0.0102693816716567,0.0546765409713577,0.0949325171242519,3.4174929761821e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42465,0.0481148661438921,0.00661088468827011,0.0351575321548827,0.0610722001329015,3.57512213526218e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42475,0.0771422342666784,0.0106133327307118,0.0563401021144832,0.0979443664188736,3.84018269129196e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42187,0.0580776586289,0.00799199880538343,0.0424133409703484,0.0737419762874515,3.88615806429773e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40089,0.0516248645389831,0.0071056939254461,0.0376977044451088,0.0655520246328575,3.97710424855671e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40104,0.0658347399594263,0.00908479425811499,0.0480285432135209,0.0836409367053317,4.55912848960446e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42475,-0.0203961646199048,0.00281520088045596,-0.0259139583455984,-0.0148783708942111,4.56247599794178e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40350,0.0565231309008626,0.00780291357613414,0.0412294202916397,0.0718168415100855,4.64874674701755e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40350,0.0758666099897209,0.0104789449440313,0.0553278778994197,0.0964053420800222,4.78516808225542e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42475,0.0379263591712089,0.00524548436576637,0.0276452098143068,0.0482075085281109,5.08337419219378e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,42237,0.0536066116781626,0.00741621063064111,0.039070838842106,0.0681423845142191,5.16291915131583e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM3D,Protein FAM3D,40350,0.0633559641076698,0.00878514147550335,0.0461370868156832,0.0805748413996563,5.88273669849273e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP10,Caspase-10,42191,0.0527886832154801,0.00733085937581093,0.0384201988388906,0.0671571675920695,6.31136455462891e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42631,0.0403138459658309,0.00561947702728756,0.0292996709923472,0.0513280209393145,7.66806487224484e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40384,0.0566319359084874,0.00790463358944018,0.0411388540731846,0.0721250177437901,8.30396522582702e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFC,Platelet-derived growth factor C,42229,0.0208986440874054,0.00292010938309575,0.0151752296965377,0.026622058478273,8.69999754433704e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNRD2,Protein ZNRD2,40350,0.0509914766369359,0.00712594607166336,0.0370246223364757,0.0649583309373961,8.84384771661953e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRG3,Proteoglycan 3,40428,-0.0365468762152085,0.00510868300857505,-0.0465598949120156,-0.0265338575184014,8.96115812431049e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42377,0.0420796050584816,0.00589017730928011,0.0305348575322926,0.0536243525846706,9.53932978376361e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOLM2,Protein GOLM2,42590,0.0168768567035811,0.00236431108390344,0.0122428069791304,0.0215109064280319,9.94512787412978e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42598,-0.0184534669986558,0.0025880748001991,-0.023526093607046,-0.0133808403902655,1.05364842822617e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42554,0.0622022114903048,0.00873789008289983,0.0450759469278211,0.0793284760527884,1.14533588334795e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40104,0.041410867326441,0.00581830373283389,0.0300069920100866,0.0528147426427954,1.16937679412449e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OPHN1,Oligophrenin-1,40385,0.0776047185737394,0.0109054673091662,0.0562300026477736,0.0989794344997052,1.17787397091059e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LARP1,La-related protein 1,40352,0.0446092078853104,0.00627019641697255,0.0323196229080442,0.0568987928625766,1.19216238562098e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40384,0.0522537630969368,0.00735631907535297,0.037835377709245,0.0666721484846286,1.29255720061196e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42590,0.0378603197289318,0.0053363497765848,0.0274010741668256,0.048319565291038,1.3605042805899e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL2,C-C motif chemokine 2,42357,0.0386190971386585,0.00545075262231058,0.0279356219989298,0.0493025722783873,1.46018820023475e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPP,Lipoma-preferred partner,40019,0.0476905220223955,0.00674298737023154,0.0344742667767417,0.0609067772680493,1.61431069443375e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGFR,Opioid growth factor receptor,42466,0.0235321378616642,0.00333232375376821,0.0170007833042785,0.0300634924190499,1.72566903809385e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40322,0.0217798493974423,0.00308646132649789,0.0157303851975065,0.0278293135973782,1.80801149691264e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40350,0.0595329714262372,0.00844256853414424,0.0429855370993145,0.0760804057531599,1.87433229689718e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42494,0.0714239636077986,0.0101319661362835,0.0515653099806828,0.0912826172349143,1.88597597966709e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA4C,Semaphorin-4C,42466,-0.0200843960572959,0.00285051053279716,-0.0256713967015783,-0.0144973954130134,1.93365795258614e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,40187,0.016740429868115,0.00237693734304755,0.0120816326757418,0.0213992270604882,1.99587252692553e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN4,Contactin-4,42490,-0.0173551637311328,0.00246630594054783,-0.0221891233746066,-0.0125212040876591,2.06185308591292e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APP,Amyloid-beta precursor protein,42471,0.0478306663353935,0.00679823580816603,0.0345061241513881,0.0611552085193989,2.07914983375823e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB8,Serpin B8,42631,0.041633442162647,0.00592019515968483,0.0300298596496648,0.0532370246756293,2.12758382173255e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40428,-0.0194981409631295,0.00277623849660945,-0.024939568416484,-0.014056713509775,2.29332163040009e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,40125,0.0448259238332217,0.00639090235519874,0.0322997552170322,0.0573520924494113,2.45248601498709e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40352,0.0206537053545277,0.00294501143542212,0.0148814829411003,0.026425927767955,2.46547569629056e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42502,0.0406697017328673,0.00580231889146618,0.0292971567055936,0.052042246760141,2.51205890311048e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40187,0.0508337238166236,0.00725338868092913,0.0366170820020025,0.0650503656312447,2.55407605294923e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRKL,Crk-like protein,42514,0.0749637864531215,0.0107002235880527,0.0539913482205382,0.0959362246857048,2.57349665733375e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42475,0.0446894859949092,0.00637992899821436,0.0321848251584091,0.0571941468314093,2.59436151106846e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42377,0.0558241903916022,0.00797526440650386,0.0401926721548546,0.0714557086283497,2.68986565851417e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42229,0.0648509380076394,0.00926520119074676,0.0466911436737757,0.083010732341503,2.69622470084979e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSTB,Cystatin-B,42320,0.0304912783236969,0.0043579492644819,0.0219496977653123,0.0390328588820814,2.74769069817561e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLF4,Krueppel-like factor 4,40042,0.0287613870178035,0.00411446351384539,0.0206970385306665,0.0368257355049404,2.9038786047184e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42532,-0.0622615596225047,0.00892008861969907,-0.0797449333171149,-0.0447781859278946,3.09296152971032e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42229,0.0429745442998644,0.0061569507869435,0.0309069207574552,0.0550421678422737,3.09812142413523e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42584,0.0257937916633326,0.00369593833889013,0.018549752519108,0.0330378308075573,3.11375264924632e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40093,0.0198096619757195,0.00284192432074329,0.0142394903070627,0.0253798336443764,3.34048351553305e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OLFM4,Olfactomedin-4,39777,0.088235828832265,0.0126738061381107,0.0633951688015679,0.113076488862962,3.55206897309601e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40411,0.0346433993568027,0.004979075637066,0.0248844111081534,0.0444023876054521,3.64890757110807e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40019,0.0477986438925569,0.00688903297227132,0.0342961392669051,0.0613011485182087,4.19319741178458e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42443,0.0480054923745454,0.00692398609634742,0.0344344796257044,0.0615765051233863,4.30438701200667e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40384,0.034380684761889,0.0049608689298473,0.0246573816593883,0.0441039878643897,4.42798089223322e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42584,-0.0143699993489653,0.00207420937775149,-0.0184354497293583,-0.0103045489685724,4.46522998581036e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40350,0.0536760660737482,0.00775201163983485,0.0384821232596719,0.0688700088878245,4.62710522466003e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42229,0.0443586080066531,0.00640818661059495,0.031798562249887,0.0569186537634192,4.65570153644904e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42518,-0.0234497686147421,0.00339101616706949,-0.0300961603021983,-0.0168033769272859,4.88286414226356e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40384,0.0374609891071012,0.00542262233861008,0.0268326493234254,0.0480893288907769,5.17191388638175e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42518,0.0556169779516442,0.00805359081375143,0.0398319399566914,0.071402015946597,5.21624363052131e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40385,0.0305840842806148,0.00443061454576588,0.0219000797709137,0.0392680887903159,5.37082056573516e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42229,0.037051988276169,0.00537549627476625,0.0265160155776272,0.0475879609747109,5.72394847758122e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDA,Cytidine deaminase,40394,0.0331685458997974,0.0048113831122003,0.0237382349998848,0.04259885679971,5.7255949642407e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42229,0.0458255747517787,0.00665571495297534,0.032780373443947,0.0588707760596104,6.03726706367195e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BID,BH3-interacting domain death agonist,42475,0.0471990818651218,0.00687028736373194,0.0337333186322072,0.0606648450980364,6.70481732252217e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPARC,SPARC,42561,0.0491442004103773,0.00716159727104262,0.0351074697591337,0.0631809310616208,7.08034588191719e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACHE,Acetylcholinesterase,40187,0.0234313782379162,0.00341763164405611,0.0167328202155662,0.0301299362602661,7.45968995615769e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40073,0.0275892594599364,0.00402870401697824,0.019692999586659,0.0354855193332137,7.88335108480846e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMP10,Bone morphogenetic protein 10,40187,-0.0201916159999826,0.00295161479509511,-0.025976780998369,-0.0144064510015962,8.28952856364071e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMT,Catechol O-methyltransferase,42095,0.058233767202713,0.00851770113014458,0.0415390729876297,0.0749284614177964,8.46303338268943e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPPK1,Epiplakin,40125,0.0509111100785439,0.00745196399953743,0.0363052606394506,0.0655169595176373,8.82487923859444e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNM3,Dynamin-3,40384,0.0383320023521273,0.0056222395843537,0.027312412766794,0.0493515919374605,9.71200770774504e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL8,Interleukin-8,42374,0.0487546836434747,0.00715459544810358,0.0347316765651917,0.0627776907217577,9.87333004172082e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42475,-0.0368650505681443,0.00541085651174269,-0.04747032933116,-0.0262597718051286,9.95902376093062e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40270,0.0238521396022688,0.00350600964186905,0.0169803607042054,0.0307239185003321,1.0758533666054e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40187,0.0374597381529275,0.00550742346597675,0.0266651881596131,0.0482542881462419,1.08774128862223e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOXJ3,Forkhead box protein J3,40104,0.0304517286145103,0.00447717540977847,0.0216764648113445,0.0392269924176761,1.08915224169726e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG1B,Lithostathine-1-beta,42673,0.040811745882831,0.00601192591501199,0.0290283710894075,0.0525951206762545,1.18075235701611e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40352,0.0238187157824085,0.0035093773882408,0.0169403361014565,0.0306970954633605,1.20158057024606e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPT2,Angiopoietin-2,42599,0.0262884902058212,0.00387400711667605,0.0186954362571362,0.0338815441545063,1.20240736796423e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42496,0.027875654746822,0.00410796563533881,0.0198240421015579,0.035927267392086,1.20369243519117e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBCC,Tubulin-specific chaperone C,42377,0.0555021165263479,0.00818406319741089,0.0394613526594225,0.0715428803932733,1.2380622596643e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USO1,General vesicular transport factor p115,42466,0.0622670969308066,0.00919895271824399,0.0442371496030483,0.0802970442585648,1.35186799310511e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESYT2,Extended synaptotagmin-2,40385,0.0568226166602324,0.00840171575235611,0.0403552537856144,0.0732899795348504,1.41687817348806e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBI,Acyl-CoA-binding protein,42441,0.0527020533149953,0.0078088665869039,0.0373966748046637,0.068007431825327,1.55059844968952e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX4,Syntaxin-4,42466,0.0410998299407115,0.00609183856976291,0.0291598263439762,0.0530398335374468,1.5751383542394e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WDR46,WD repeat-containing protein 46,40352,0.0248531578535779,0.00368565121255586,0.0176292814769684,0.0320770342301874,1.62566246035949e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40125,0.030071392969477,0.00446010184300491,0.0213295933571873,0.0388131925817666,1.63746511965794e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C8B,Complement component C8 beta chain,40440,-0.0209829320794701,0.00311293301567269,-0.0270842807901886,-0.0148815833687517,1.65488997902706e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYDGF,Myeloid-derived growth factor,40411,0.0675002623070685,0.0100298256250575,0.0478418040819557,0.0871587205321813,1.77989838217899e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42229,0.0674818299122895,0.0100326031476065,0.0478179277429808,0.0871457320815982,1.81352120854624e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42673,0.0493134089102892,0.00733514889769332,0.0349365170708103,0.0636903007497681,1.85324303956324e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42475,0.0489977955522303,0.00729041133340894,0.0347085893387487,0.0632870017657118,1.88034863842841e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEZ6L,Seizure 6-like protein,42561,-0.0193532800440758,0.00288144005377564,-0.025000902549476,-0.0137056575386755,1.93628546791326e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRAS,Ras-related protein R-Ras,40089,0.0889032378818071,0.0132351396271923,0.0629623642125102,0.114844111551104,1.94465960494077e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXNB3,Plexin-B3,42479,0.0321945539633401,0.00479621486889003,0.0227939728203156,0.0415951351063646,1.99095771077527e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOXO3,Forkhead box protein O3,42229,0.0650255745576662,0.00969183411257393,0.0460295796970213,0.0840215694183111,2.0361740866478e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42466,0.0234255675065711,0.00349627728417864,0.016572864029581,0.0302782709835612,2.16611125154869e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42673,0.0259995302397754,0.00388499116080177,0.0183849475646039,0.0336141129149469,2.28371648307181e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40411,0.0728896043853674,0.0108936531335937,0.0515380442435237,0.0942411645272112,2.32181861506499e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFAP,Glial fibrillary acidic protein,42209,-0.0335422122269942,0.00502009783325859,-0.0433816039801811,-0.0237028204738074,2.45990995875573e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPQ,Carboxypeptidase Q,40417,0.0244194107481236,0.00365802956694475,0.0172496727969119,0.0315891486993354,2.5789794463102e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLRX,Glutaredoxin-1,42429,0.0383153764284246,0.0057413497291093,0.0270623309593704,0.0495684218974788,2.59571769990461e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42590,0.0314948081808874,0.00472221873331208,0.0222392594635958,0.0407503568981791,2.66758938673997e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40187,0.0204873614807079,0.00307130995834251,0.0144675939623566,0.0265071289990593,2.67064612723433e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42466,0.0235141925460471,0.0035294890743688,0.0165963939602843,0.03043199113181,2.80380707390512e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBPL,FK506-binding protein-like,40350,0.0398199478718632,0.00597999130906066,0.0280991649061043,0.0515407308376221,2.88915786117658e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CREG1,Protein CREG1,42329,0.0262268736365916,0.00394115292599451,0.0185022139016423,0.0339515333715408,2.95302736877485e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40382,0.027059842326999,0.00406741614927337,0.0190877066744232,0.0350319779795748,3.00921270676357e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42490,0.0181773473876197,0.00274023184926839,0.0128064929630537,0.0235482018121857,3.40487056611056e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40350,0.0536143707651479,0.00809395200069053,0.0377502248437945,0.0694785166865014,3.6567901300445e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GTPBP2,GTP-binding protein 2,40089,0.0546600612792788,0.00825189808600884,0.0384863410307015,0.0708337815278561,3.66235191784658e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40385,0.0220924412765788,0.00333926314859471,0.0155474855053332,0.0286373970478245,3.8598550841152e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42532,-0.0334361649292836,0.00505574168383531,-0.0433454186296008,-0.0235269112289664,3.89632452998189e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40384,0.0508838772671903,0.00769399477915427,0.0358036475000479,0.0659641070343327,3.92564245978811e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40089,0.0564929451157879,0.00854425951773765,0.0397461964610221,0.0732396937705536,3.97432515353381e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNMT,Histamine N-methyltransferase,42321,0.0324596309498561,0.00491092000729494,0.022834227735558,0.0420850341641541,4.00023052979923e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSM,Oncostatin-M,42415,0.0474366858169478,0.00717911680110935,0.0333656168867735,0.0615077547471222,4.05583649650579e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ING1,Inhibitor of growth protein 1,42172,0.0319687683149683,0.00483881713244293,0.0224846867353801,0.0414528498945564,4.08228460929957e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40385,0.028257813197837,0.00427741219164986,0.0198740853022032,0.0366415410934707,4.11955938092746e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INHBB,Inhibin beta B chain,40187,-0.0370209354554886,0.00560503056926976,-0.0480067953712574,-0.0260350755397199,4.16013583508199e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42490,0.026307555266034,0.00399032036488419,0.0184865273508609,0.034128583181207,4.47774685882611e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDC,Nuclear migration protein nudC,42631,0.0417743116608471,0.00633774703711612,0.0293523274680995,0.0541962958535947,4.52109828722605e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NBN,Nibrin,42256,0.0361735626483542,0.00549042098807727,0.0254123375117227,0.0469347877849856,4.61371124143328e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA4,Carbonic anhydrase 4,42673,-0.0162756482390399,0.00247305831656253,-0.0211228425395024,-0.0114284539385773,4.83978008384073e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBNL,Drebrin-like protein,42554,0.0615875690770856,0.0093721567341614,0.0432181418781293,0.079956996276042,5.17160064658589e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40384,0.0289253674361882,0.0044045250497286,0.0202924983387202,0.0375582365336563,5.35442044281941e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42568,-0.0186704861994226,0.0028440188625135,-0.0242447631699491,-0.0130962092288961,5.40163902106475e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGF,Pro-epidermal growth factor,42476,0.06882294256586,0.0105119139386427,0.0482195912461202,0.0894262938855998,6.08067868961452e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42599,0.0358963640596341,0.00548508314728241,0.0251456010909605,0.0466471270283076,6.192291131431e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40352,0.0452955636977771,0.00692063576768724,0.0317311175931101,0.0588600098024441,6.21035154844182e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42325,0.07683181465447,0.0117741861867762,0.0537544097283887,0.0999092195805514,7.0288253833155e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42673,0.0274183049464993,0.00420850225347814,0.0191696405296821,0.0356669693633164,7.52817781613315e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,40187,0.0268581995904038,0.00412606368336684,0.0187711147710048,0.0349452844098028,7.87375716301187e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42475,0.0553214328887149,0.0085027172188967,0.0386561071396774,0.0719867586377524,7.97740672889036e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD226,CD226 antigen,40104,0.0281167075301889,0.00433381405541354,0.0196224319815784,0.0366109830787994,9.09004805109075e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40078,0.0181897169269705,0.00280385202268487,0.0126941669625082,0.0236852668914329,9.11193911266116e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42490,0.0199582629407455,0.00308137325516406,0.0139187713606239,0.025997754520867,9.68131125139431e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3GLB2,Endophilin-B2,40385,0.0441450427974976,0.00681587194884607,0.0307859337777593,0.0575041518172359,9.76153121061167e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42478,-0.0117608410998249,0.00181685110266111,-0.0153218692610407,-0.00819981293860917,9.93199110093855e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40432,0.0180015792565729,0.00278193681884562,0.0125489830916355,0.0234541754215103,1.0148602061644e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42229,0.051122270443643,0.00790465917035042,0.0356291384697562,0.0666154024175298,1.03289718212971e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42532,0.0342947278756537,0.00530705986635691,0.0238928905375941,0.0446965652137132,1.06851668636841e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40384,-0.0177047630349511,0.0027465207515984,-0.023087943708084,-0.0123215823618183,1.19367326849731e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA2,Annexin A2,39957,0.0477081334326125,0.0074018654118917,0.0332004772253048,0.0622157896399202,1.20212380420884e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42561,0.0365879315488079,0.00567921497771406,0.0254566701924883,0.0477191929051275,1.21605644813877e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DENR,Density-regulated protein,40104,0.0376119196626059,0.00583960907617336,0.0261662858733061,0.0490575534519057,1.23822665316031e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42490,0.0502400065501903,0.0078116527987617,0.0349291670646174,0.0655508460357632,1.30743866686423e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPBP,Platelet basic protein,40372,0.0552944582523642,0.00860083929709327,0.0384368132300614,0.072152103274667,1.33714529633594e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42561,-0.0186566639462941,0.00290372242278297,-0.0243479598949487,-0.0129653679976395,1.36262944872372e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42229,0.0554177821583903,0.00863869376729738,0.0384859423744874,0.0723496219422931,1.45627086611002e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40350,0.0414840961541295,0.00647207009494023,0.0287988387680467,0.0541693535402124,1.51678255820281e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS9,Galectin-9,42498,0.0211078220155006,0.00330391203195519,0.0146321544328684,0.0275834895981327,1.7283224074164e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,40019,0.0506127736155166,0.00792960504218825,0.0350707477328276,0.0661547994982055,1.81038174531171e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MGLL,Monoglyceride lipase,42532,0.0560106051438953,0.0087788307094594,0.0388040969533548,0.0732171133344357,1.82712108658142e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFA,Protransforming growth factor alpha,42475,0.0310195182481042,0.0048647571490054,0.0214845942360536,0.0405544422601548,1.87330518441746e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,42229,0.0299778256483101,0.0047065731027092,0.0207529423670001,0.0392027089296201,1.96203425198823e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40350,0.041646705037032,0.00653885559237411,0.0288305480759788,0.0544628619980853,1.97604482210439e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RALY,RNA-binding protein Raly,40352,0.0309657358898686,0.00486190231260839,0.0214364073571561,0.040495064422581,1.97673229871896e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42191,0.0415436348226721,0.00653714289288056,0.0287308347526262,0.054356434892718,2.15366157071189e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42490,0.0368852224531041,0.00580857335362912,0.025500418679991,0.0482700262262172,2.22124405748473e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOK1,Docking protein 1,40385,0.088005077330306,0.0138575543399739,0.0608442708239572,0.115165883836655,2.22655418060444e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42377,0.0604899104494409,0.00953488361938494,0.0418015385554465,0.0791782823434354,2.31096786633875e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YJU2,Splicing factor YJU2,40352,0.0211085400768782,0.00332767827489566,0.0145862906580827,0.0276307894956737,2.33562634560635e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40019,0.0185823040590659,0.00292969311478368,0.0128401055540899,0.0243245025640419,2.34707878566784e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42673,-0.0194664264872776,0.00306997027596309,-0.0254835682281653,-0.01344928474639,2.35686897465381e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNR,Tenascin-R,42377,-0.0275339901994459,0.00434544744590098,-0.0360510671934119,-0.01901691320548,2.43028664309326e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40206,0.0426209274213836,0.00672756208561212,0.0294349057335838,0.0558069491091833,2.46170705047507e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42590,-0.0196707400045827,0.00310566419149126,-0.0257578418199056,-0.0135836381892598,2.46795621684445e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMB1,Laminin subunit beta-1,40125,0.0197749854406829,0.00312173956423694,0.0136563758947785,0.0258935949865873,2.47302861665339e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSNAX,Translin-associated protein X,40019,0.0256957300773215,0.0040597360013992,0.0177386475145791,0.0336528126400639,2.55838621738819e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL4,C-C motif chemokine 4,42520,0.0443841051949444,0.00702027885138898,0.030624358646222,0.0581438517436668,2.6596727198777e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,40104,0.0491356686740746,0.00777146815871563,0.033903591082992,0.0643677462651573,2.67298483818005e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42518,0.0821404022870948,0.0130008799754769,0.05665867753516,0.10762212703903,2.73285189061922e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DHPS,Deoxyhypusine synthase,40352,0.0261681344928112,0.00414210112357989,0.0180496162905946,0.0342866526950277,2.75774327082937e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE6,Ribonuclease K6,40369,0.0220854362721884,0.00349935128684304,0.015226707749976,0.0289441647944007,2.8719044161816e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,40187,-0.0179776224459179,0.00284876969508749,-0.0235612110482893,-0.0123940338435464,2.88539547953935e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42377,-0.0772280341727653,0.0122462380656247,-0.10123066078139,-0.0532254075641409,2.94972431454595e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40384,0.0692654281752626,0.0109886753539562,0.0477276244815085,0.0908032318690166,3.02247895989048e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HRG,Histidine-rich glycoprotein,40380,0.0199294736164865,0.00316428890083092,0.0137274673708579,0.0261314798621151,3.12325798662347e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40384,0.0431382027956148,0.00685541289170501,0.029701593527873,0.0565748120633566,3.23911636160738e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLG4,Disks large homolog 4,40385,0.0449980845780154,0.00715379154641128,0.0309766531470493,0.0590195160089815,3.29093687514631e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42496,-0.0245168335406745,0.00389853853974716,-0.032157969078579,-0.0168756980027701,3.3009948312132e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42494,0.028474350936252,0.00452818077281662,0.0195991166215314,0.0373495852509726,3.31099073060297e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICA1,Islet cell autoantigen 1,42256,0.0505438382433738,0.0080388342040552,0.0347877232034257,0.066299953283322,3.3298043739187e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,40384,0.0419612288244547,0.00667516649504159,0.0288779024941732,0.0550445551547362,3.37507045808899e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42475,0.0613749683075206,0.00976896337652855,0.0422278000895247,0.0805221365255166,3.43242020344192e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40089,0.0461282460415748,0.00734469301699727,0.0317326477282601,0.0605238443548894,3.5037825911276e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40385,0.0198705692151778,0.00317195795622545,0.0136535316209759,0.0260876068093797,3.87881676260102e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42590,0.0401217766189368,0.00642860637469052,0.0275217081245434,0.0527218451133303,4.4751151149907e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40125,0.061895123802152,0.00992140320373431,0.0424491735228328,0.0813410740814713,4.57994019015785e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPR,Nucleoprotein TPR,40019,0.0311901193464987,0.00500001645499456,0.0213900870947093,0.040990151598288,4.59740684826694e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40089,0.0514288964498464,0.0082453798505358,0.0352679519427962,0.0675898409568965,4.61699892244475e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACYP1,Acylphosphatase-1,40154,0.041804954447663,0.00670274139389067,0.0286675813156373,0.0549423275796887,4.62498187284447e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FST,Follistatin,42532,-0.0313930426667745,0.00503768036357356,-0.0412668961793787,-0.0215191891541704,4.75448074500218e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40187,0.0659861568339208,0.0105889686027467,0.0452317783725373,0.0867405352953043,4.78616108430977e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HPSE,Heparanase,40311,0.0597300350488177,0.00958530986722637,0.040942827709054,0.0785172423885814,4.78973584211959e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42561,0.0385478566573076,0.00619894915983558,0.0263979163040299,0.0506977970105854,5.17039464500938e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40019,0.0425046874315956,0.00683726495483095,0.0291036481201269,0.0559057267430642,5.26685227205022e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP2,Caspase-2,42475,0.0427887339112415,0.00689558731345434,0.029273382776871,0.056304085045612,5.62386995743225e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSS,Cathepsin S,39780,0.0154803016641098,0.00250048386141448,0.0105793532957374,0.0203812500324822,6.20301962510307e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX15,Sorting nexin-15,40187,0.0343298961598877,0.00555572197488002,0.0234406810891228,0.0452191112306525,6.67099416115999e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEC31A,Protein transport protein Sec31A,40125,0.0484724611075612,0.00784488535796848,0.033096485805943,0.0638484364091794,6.68641207184023e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100G,Protein S100-G,40384,-0.0304672480737246,0.00494685002872233,-0.0401630741300204,-0.0207714220174289,7.57571636385709e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42466,0.0134225127637804,0.00218049794053745,0.00914873680032698,0.0176962887272338,7.68954467765215e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAM,Basal cell adhesion molecule,42490,-0.0155586514151454,0.00253057236769817,-0.0205185732558338,-0.010598729574457,8.05728661364095e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40384,0.0382829856109436,0.00623461256523678,0.0260631449830795,0.0505028262388077,8.5108215078762e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,42390,-0.0212030973764333,0.0034574636008724,-0.0279797260341432,-0.0144264687187234,8.89460696440362e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40350,0.0910753661534974,0.0148677555986307,0.0619345651801811,0.120216167126814,9.33300922836792e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST13,Hsc70-interacting protein,40187,0.0353217018126101,0.00576938809414881,0.0240137011480784,0.0466297024771417,9.54052721158771e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40384,0.0583106866785535,0.00952611617464209,0.039639498976255,0.076981874380852,9.6020585783812e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42466,0.07219742901021,0.0118129268273806,0.049044092428544,0.0953507655918759,1.01316657031073e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDHR5,Cadherin-related family member 5,42518,0.0241263592501433,0.00395520372265736,0.0163741599537349,0.0318785585465518,1.09071046972801e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCN2,Ficolin-2,42476,0.0256191954237034,0.00420538435440933,0.0173766420890611,0.0338617487583457,1.14590831349771e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42475,-0.0373876738834647,0.0061685959284958,-0.0494781219033164,-0.0252972258636129,1.38967445531437e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BIN2,Bridging integrator 2,42490,0.0560074328879306,0.00924334839205545,0.037890470039502,0.0741243957363593,1.40483661285525e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,40125,0.0548589816299289,0.00905585349311371,0.037109508783426,0.0726084544764317,1.42496174240304e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42434,0.0202809842827022,0.00334844385499927,0.0137180343269036,0.0268439342385008,1.42583871835064e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40384,0.0517979429237454,0.00855103385610121,0.035037916565787,0.0685579692817037,1.42690948308262e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,40206,0.021358147288517,0.0035267281117823,0.0144457601894237,0.0282705343876103,1.44030681125415e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YWHAQ,14-3-3 protein theta,40187,0.0455011083484005,0.00751577506238058,0.0307701892261346,0.0602320274706664,1.45832741202361e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42466,0.0340791573987781,0.00563057645658879,0.0230432275438641,0.0451150872536921,1.46443588431462e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,42237,0.030530886306116,0.0050478250349588,0.0206371492375968,0.0404246233746353,1.50363189578035e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKK3,Dickkopf-related protein 3,42673,-0.0186687211334185,0.00308841939788065,-0.0247220231532646,-0.0126154191135725,1.53592828144067e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL21,C-C motif chemokine 21,42554,0.0261103177022244,0.00432189710622808,0.0176393993740174,0.0345812360304315,1.56841484168475e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18,Interleukin-18,42445,0.028722020605198,0.00475617422485916,0.019399919124474,0.0380441220859219,1.59328271814362e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42377,-0.0321314815382529,0.00533531576786602,-0.0425887004432703,-0.0216742626332355,1.76406407916687e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CENPF,Centromere protein F,40206,0.0336761369477057,0.00560066892508091,0.0226988258545471,0.0446534480408642,1.88040623061759e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAB2,Disabled homolog 2,42599,0.0669245486691177,0.0111514307892386,0.0450677443222101,0.0887813530160254,2.00632187643994e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTNB,Dystrobrevin beta,40331,0.0263019834565822,0.00438303231040266,0.017711240128193,0.0348927267849714,2.02376814114939e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42518,-0.0245328324847939,0.00408956410208094,-0.0325483781248725,-0.0165172868447152,2.03824090938094e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40384,0.0380403300800436,0.0063434789578067,0.0256071113227425,0.0504735488373447,2.07508003892574e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42592,0.0193225557273075,0.00323224317501312,0.0129873591042818,0.0256577523503333,2.31546077016017e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40284,0.0364969168467967,0.00610450763368003,0.0245320818847839,0.0484617518088096,2.31876156221688e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42553,0.0363921743697096,0.00609183459388283,0.0244521785656992,0.0483321701737199,2.37499194807536e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40125,0.0331364940714313,0.00554854198034968,0.0222613517899459,0.0440116363529166,2.41494045987254e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42448,0.0541875687300881,0.00907608391201999,0.0363984442625289,0.0719766931976473,2.42771201467973e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40411,-0.0226332550806018,0.00379433946798934,-0.0300701604378609,-0.0151963497233427,2.52006131981846e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,40125,0.0495096503472135,0.00830083522284878,0.0332400133104299,0.0657792873839971,2.53107666140689e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPART,Spartin,40187,0.0466821584110041,0.00783178983725846,0.0313318503299775,0.0620324664920306,2.59030843410509e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42518,0.0407976182319373,0.00684620600424179,0.0273790544636234,0.0542161820002512,2.59943628891994e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PF4,Platelet factor 4,40365,0.0595336172464134,0.0100248514101228,0.0398849084825728,0.079182326010254,2.96017474581508e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42256,0.0323070947803213,0.00544384995088804,0.0216371488765807,0.0429770406840619,3.0202070368418e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40206,0.0298374382207808,0.00502803786610936,0.0199824840032065,0.0396923924383552,3.04153705372791e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OBP2B,Odorant-binding protein 2b,42344,-0.0372888587463269,0.00629256996805762,-0.0496222958837199,-0.024955421608934,3.18451670503761e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF2,Fibroblast growth factor 2,42475,0.0415856799413149,0.00702291045402459,0.0278207754514267,0.0553505844312031,3.27036919404367e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40206,0.0276645022463673,0.00467292479604741,0.0185055696461144,0.0368234348466202,3.31207300019778e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAG6,Large proline-rich protein BAG6,42237,0.0215967488250465,0.0036517924049838,0.0144392357112783,0.0287542619388148,3.42230086301576e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42518,-0.0479887421017323,0.00811816474927252,-0.0639003450103065,-0.0320771391931582,3.47763005135674e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40104,0.0327916196099953,0.0055483092790273,0.0219169334231018,0.0436663057968888,3.51914598605744e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53,Cellular tumor antigen p53,42229,0.0259945951497234,0.00440542693414011,0.0173599583588088,0.034629231940638,3.71208990910643e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,42358,0.0141228463941599,0.00239359492670852,0.0094314003378112,0.0188142924505086,3.71836188165385e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40411,0.0242663725887076,0.00411798909384088,0.0161951139647795,0.0323376312126358,3.90688479859252e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40384,0.070222078829086,0.0119284230281737,0.0468423696938655,0.0936017879643064,4.04671936566475e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB10,Ras-related protein Rab-10,40411,0.0322221439880795,0.00547782255285183,0.0214856117844899,0.0429586761916691,4.1617967819568e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42590,-0.0171549264666014,0.00292002129420924,-0.0228781682032515,-0.0114316847299512,4.33060592160808e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA5,Integrin alpha-5,42490,0.0150403657169446,0.00256256425104178,0.0100177397849027,0.0200629916489865,4.4816661004217e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RLN2,Prorelaxin H2,40162,0.0299860846132724,0.0051103452939132,0.0199698078372026,0.0400023613893423,4.54602533818229e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40187,0.0506252088422766,0.00862785964161968,0.033714603944702,0.0675358137398512,4.54785808379205e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PARK7,Parkinson disease protein 7,42490,0.0310684424108309,0.00530137527875586,0.0206777468644695,0.0414591379571924,4.72552289282276e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42475,-0.0275954190836825,0.00471427167392786,-0.0368353915645811,-0.0183554466027838,4.92428331804709e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TWF2,Twinfilin-2,40428,0.0495753989061259,0.00846841055123195,0.0329773142257112,0.0661734835865405,4.92849156846994e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD5L,CD5 antigen-like,40380,-0.0286646030208933,0.00489729911243686,-0.0382633092812695,-0.019065896760517,4.95905244854528e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42561,0.041704004403402,0.00712738771209723,0.0277343244876914,0.0556736843191126,4.99370118706338e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40385,0.031436473014091,0.00537957684381125,0.0208925024002209,0.041980443627961,5.24869366048441e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42466,0.0265637664464385,0.004550536690319,0.0176447145334133,0.0354828183594637,5.4227746328155e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42465,0.040400041439127,0.00692307175038262,0.0268308208083771,0.053969262069877,5.48596777712476e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40206,0.0337975873034221,0.0057971486059258,0.0224351760358075,0.0451599985710366,5.69715440552286e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINI2,Serpin I2,40350,0.0334997966210315,0.00574911038248184,0.0222315402713671,0.0447680529706959,5.80097720453774e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42480,0.0207981929149703,0.00357671625838013,0.0137878290485453,0.0278085567813954,6.20707863387309e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40125,-0.0125340225147488,0.00215573783207262,-0.0167592686656112,-0.00830877636388651,6.26071801373951e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42237,0.0322321640908659,0.0055599457371725,0.0213346704460079,0.043129657735724,6.89886342723298e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX8,Syntaxin-8,42475,0.0283844497746097,0.00489754611258659,0.01878525939394,0.0379836401552795,6.9603374154056e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40411,0.0536269483780497,0.00925457250163418,0.0354879862748467,0.0717659104812527,7.03089583372442e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACYBP,Calcyclin-binding protein,40171,0.0603205996545969,0.0104229198374903,0.0398916767731158,0.0807495225360779,7.34829017037111e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TG,Thyroglobulin,40352,-0.0685196117741863,0.0118515374765644,-0.0917486252282526,-0.0452905983201201,7.60247075970108e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40104,0.0296205106718879,0.00512446491124129,0.019576559445855,0.0396644618979209,7.66497437249417e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42377,0.0465338718785951,0.00806032815236086,0.0307356286999679,0.0623321150572224,7.95331353203736e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40352,0.0517342294980334,0.00896126918771343,0.0341701418901151,0.0692983171059517,7.99050326978858e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40125,0.0540987487018955,0.00937249422321436,0.0357286600243953,0.0724688373793956,8.04307332997992e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40187,0.024759064961024,0.00429143475694112,0.0163478528374194,0.0331702770846286,8.16951337774346e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA2,Carbonic anhydrase 2,42452,0.04103745622396,0.00712270451293563,0.0270769553786062,0.0549979570693139,8.52227051769548e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40111,0.0328632498369068,0.00570569551654421,0.0216800866244801,0.0440464130493334,8.65254431267494e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBCB,Tubulin-folding cofactor B,42377,0.058548419105955,0.0101670526555963,0.0386209959009864,0.0784758423109237,8.66845818005537e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP2B1,AP-2 complex subunit beta,40089,0.0284800428898562,0.00495066832719762,0.0187767329685489,0.0381833528111635,9.01590518164511e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42631,0.0204435859849208,0.00355536877964343,0.0134750631768197,0.0274121087930219,9.1152045668909e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASC3,Protein CASC3,40089,0.0246473958431631,0.00429425869689173,0.0162306487972553,0.0330641428890709,9.74244813202113e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42561,0.0210887834842357,0.00368153229357908,0.0138729801888207,0.0283045867796507,1.03650401981938e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39896,0.0288217065886989,0.00503124850536986,0.0189604595181739,0.0386829536592238,1.04031382129045e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42229,0.0347152906966344,0.00607381461524574,0.0228106140507527,0.046619967342516,1.1173440973226e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42631,-0.016428697175069,0.00288199121093505,-0.0220773999485017,-0.0107799944016363,1.21991428721731e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBC1D23,TBC1 domain family member 23,42466,0.052143023340948,0.00915981128769472,0.0341897932170663,0.0700962534648296,1.27778212525798e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROS1,Vitamin K-dependent protein S,40440,0.0151716647624862,0.00267266644740868,0.00993323852556521,0.0204100909994072,1.4079735646364e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE1,Ribonuclease pancreatic,40432,0.0154047992791673,0.00271411916492371,0.0100851257159168,0.0207244728424177,1.41459038359362e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42568,0.0172534434676601,0.00304190197779241,0.011291315591187,0.0232155713441332,1.44125575122774e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42191,0.0387602010514972,0.0068569929458597,0.0253204948776122,0.0521999072253822,1.61313766265919e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42229,0.0251890362303179,0.00446608272844586,0.016435514082564,0.0339425583780718,1.73511546718237e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPOCK1,Testican-1,42377,-0.0148659316116125,0.00264093135604277,-0.0200421570694563,-0.00968970615376867,1.84902685746673e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHRDL2,Chordin-like protein 2,42518,0.0272272399374467,0.00484887897412398,0.0177234371481637,0.0367310427267297,2.0030359982636e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42237,0.0433680240805677,0.00772615375429601,0.0282247627221476,0.0585112854389879,2.02733366610381e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PENK,Proenkephalin-A,40187,0.0188541347167095,0.00336332946518841,0.0122620089649403,0.0254462604684788,2.12299657734742e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFF2,Trefoil factor 2,42532,0.0334683361616183,0.00597117926648354,0.0217648247993106,0.0451718475239261,2.12409055691673e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42489,0.0649177068144516,0.0115849547906514,0.0422111954247749,0.0876242182041284,2.14089606023799e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40019,0.0211659129514831,0.00377909254330458,0.0137588915666061,0.0285729343363601,2.18581063600374e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,40104,0.0323774641333901,0.00578395532794519,0.0210409116906176,0.0437140165761627,2.22325271543267e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CETN3,Centrin-3,40350,0.0432673105146459,0.00773928461527325,0.0280983126687103,0.0584363083605815,2.31593431105466e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOA1,Apolipoprotein A-I,40440,-0.0157794393968143,0.00282796800667719,-0.0213222566899016,-0.010236622103727,2.46394807245786e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40339,-0.0156235709857431,0.00280434547556068,-0.0211200881178421,-0.0101270538536442,2.58861311627997e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40385,-0.0178591545384725,0.0032128792062528,-0.024156397782728,-0.011561911294217,2.78154852307335e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42229,0.0188012796915057,0.00338323290702818,0.0121701431937305,0.025432416189281,2.79525863241882e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42599,-0.0338755020037986,0.00610210358552563,-0.0458356250314289,-0.0219153789761684,2.88697672750631e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40019,0.0393341651646591,0.00708974021677294,0.0254382743397841,0.0532300559895341,2.9568189472081e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42554,0.0739449584082164,0.0133405385255014,0.0477975028982337,0.100092413918199,3.03180249254945e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,42191,0.0349502140582083,0.00630639352792104,0.0225896827434831,0.0473107453729335,3.04808279270704e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AZU1,Azurocidin,42103,0.043414323627454,0.00783399069841485,0.0280597018585609,0.0587689453963471,3.05264980259649e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42490,0.0183234822530105,0.00331387558814884,0.0118282861002388,0.0248186784057822,3.27534651825392e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NGRN,Neugrin,40385,0.0131399686504816,0.00237701960252584,0.00848101022953098,0.0177989270714323,3.31317911312584e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42554,0.0383596968298119,0.00694049953187809,0.0247563177473309,0.051963075912293,3.31976941116666e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA6,Carbonic anhydrase 6,42460,-0.0354206144529829,0.00641085333978356,-0.0479858869989587,-0.0228553419070071,3.35500798528513e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,40187,0.0234232639860932,0.00423998700210522,0.0151128894619669,0.0317336385102194,3.38194749723373e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLG,Plasminogen,40186,0.0121255064749526,0.00219735984306237,0.00781868118255039,0.0164323317673549,3.50221192977427e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42377,0.01335865513999,0.00242126326967267,0.00861297913143157,0.0181043311485485,3.50888346628613e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD164,Sialomucin core protein 24,42490,0.0155041509454488,0.00281044009817968,0.00999568835301667,0.021012613537881,3.52025189930247e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLIN3,Perilipin-3,42518,0.0238435713174808,0.00432378750731258,0.0153689478031482,0.0323181948318135,3.56264999388153e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42673,-0.00901728201904266,0.0016359515105981,-0.0122237469798149,-0.00581081705827039,3.61400778264876e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FBLN2,Fibulin-2,40428,-0.0184190005354578,0.00334482739286962,-0.0249748622254822,-0.0118631388454333,3.73639401639528e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOBR,Apolipoprotein B receptor,40125,-0.0240887845073264,0.00437956369164705,-0.0326727293429546,-0.0155048396716982,3.87744182900615e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CIAPIN1,Anamorsin,42561,0.034903280216346,0.00634836449575517,0.0224604858046658,0.0473460746280261,3.91179159623848e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42673,-0.017837354443921,0.00324667073730977,-0.0242008290890481,-0.0114738797987938,3.99956666905537e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHRDL1,Chordin-like protein 1,42532,-0.0181947560753983,0.00331317709281706,-0.0246885831773197,-0.0117009289734769,4.0552020741501e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42673,0.0132367771887671,0.00241799323719434,0.00849751044386618,0.017976043933668,4.47145829279079e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD302,CD302 antigen,42466,0.0180104960523129,0.00329052410144614,0.0115610688134785,0.0244599232911474,4.49388628196359e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42475,0.021515977145674,0.00393249453842321,0.0138082878503645,0.0292236664409835,4.54761586052159e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40384,0.0633175530839791,0.0115772223965035,0.0406261971868322,0.086008908981126,4.61923343408572e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40352,0.0457332310454248,0.00839924400919258,0.0292707127874073,0.0621957493034422,5.29261915012394e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40350,0.0267012319350972,0.00490567593228629,0.0170861071078161,0.0363163567623783,5.35215515468623e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42237,0.0273140182780201,0.00503514522856004,0.0174451336300424,0.0371829029259978,5.90965387475022e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,40125,0.0132399090762976,0.00244173593662487,0.00845410664051286,0.0180257115120824,6.00777035114225e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40350,0.0171906084142131,0.00317157751490669,0.010974316484996,0.0234069003434303,6.07692327248187e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40104,0.018605539510884,0.00343431512639655,0.0118742818631468,0.0253367971586213,6.17087598190886e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40411,0.0168655929366812,0.00311478837469751,0.0107606077222741,0.0229705781510884,6.26633997652461e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42561,0.0397901598481093,0.00735127225567463,0.025381666226987,0.0541986534692315,6.31562181431552e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40385,-0.0391397233971446,0.00723681548147713,-0.0533238817408398,-0.0249555650534494,6.48922596630212e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42546,0.0657239437729235,0.0121579704733764,0.0418943216451057,0.0895535659007413,6.56172705240111e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FN1,Fibronectin,40440,0.0147382922665969,0.00272639441353626,0.00939455921606587,0.020082025317128,6.58451652553264e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYAP1,Synapse-associated protein 1,40187,0.0317061580070108,0.00586701898966801,0.0202068007872615,0.0432055152267601,6.64823369120892e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,40012,-0.0348092939015105,0.00644594729237576,-0.047443350594567,-0.022175237208454,6.79821318857034e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMSB10,Thymosin beta-10,42490,0.0408667707642733,0.00757860992178041,0.0260126953175837,0.0557208462109629,7.07179304791744e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40104,0.020169922483082,0.00374353661404317,0.0128325907195574,0.0275072542466066,7.27553579873275e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40104,0.050185306256984,0.00931708093726022,0.031923827619954,0.0684467848940141,7.33860038427624e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,40104,0.0484505089380175,0.00899584581576642,0.0308186511391153,0.0660823667369197,7.35900607613182e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40232,0.0314868145885831,0.00585126470337215,0.0200183357699737,0.0429552934071925,7.55053820279084e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42466,0.0483353455262134,0.00898632086866565,0.0307221566236287,0.065948534428798,7.62687317438753e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAS2,Growth arrest-specific protein 2,40206,0.0291257605033291,0.00541489565862992,0.0185125650124145,0.0397389559942438,7.6509528276814e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD70,CD70 antigen,42475,-0.0239175702564208,0.00445110129552944,-0.0326417287956585,-0.0151934117171831,7.85678861253044e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42358,0.0524283033112225,0.0097589161945711,0.0333008275698631,0.0715557790525818,7.90403066864328e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CIT,Citron Rho-interacting kinase,40089,0.0250231875087394,0.00466018307958772,0.0158892286727474,0.0341571463447313,8.05459938186851e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRR3,Small proline-rich protein 3,40385,0.0384851215679492,0.0071755868369277,0.0244209713675709,0.0525492717683275,8.33233889008533e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR3,Toll-like receptor 3,42631,0.0335411258242086,0.00626260072232002,0.0212664284084614,0.0458158232399559,8.65902970565189e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,42229,0.0218118935036731,0.00408160207921709,0.0138119534284076,0.0298118335789386,9.24719667072157e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40089,0.0352556928945921,0.00659718509081229,0.0223252101166,0.0481861756725842,9.27257253469193e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40432,-0.0150347309625251,0.00281431155463252,-0.0205507816096048,-0.00951868031544534,9.35971649614454e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMPD3,AMP deaminase 3,40385,0.0387730661331203,0.00725825858158807,0.0245468793132077,0.052999252953033,9.37682557008907e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MATN3,Matrilin-3,42357,-0.0179372331389528,0.00335821467416389,-0.024519333900314,-0.0113551323775916,9.38179005251144e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS3,Galectin-3,42550,0.0163866080137792,0.0030690014431969,0.0103713651851132,0.0224018508424451,9.47849609219988e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42489,-0.0122223691598121,0.00228975865152028,-0.0167102961167918,-0.00773444220283231,9.56052327531107e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BGN,Biglycan,42211,-0.0656691583362374,0.0123207377312994,-0.0898178042895842,-0.0415205123828906,9.98686368570713e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40187,0.0448742463045251,0.00842096868816805,0.0283691476757157,0.0613793449333345,1.00779769767078e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAP3,Cytosol aminopeptidase,42256,0.0263743994986025,0.00495020524494114,0.0166719972185179,0.0360768017786872,1.00982273662435e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DXO,Decapping and exoribonuclease protein,40385,0.024884170331118,0.00467248295841016,0.0157261037326341,0.034042236929602,1.02522076543336e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB9,Serpin B9,42377,0.0178844231046701,0.00335968438089609,0.0112994417181137,0.0244694044912264,1.03603756605398e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOST,Sclerostin,42495,0.0212272304456339,0.00398995648857005,0.0134069157280366,0.0290475451632312,1.05353681689367e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40350,0.0488770487690215,0.00921677950600778,0.0308121609372463,0.0669419366007968,1.16060170641782e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MICALL2,MICAL-like protein 2,40089,0.0372950792832149,0.00705265117455676,0.0234718829810837,0.0511182755853462,1.25990845379587e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL22,C-C motif chemokine 22,42387,0.0287407622695777,0.0054395078059952,0.0180793269698271,0.0394021975693283,1.28610950286788e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS22,Brain-specific serine protease 4,40104,0.0198257045723723,0.00375618014040359,0.0124635914971813,0.0271878176475634,1.32994974047353e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F2R,Proteinase-activated receptor 1,42532,0.0301881119559027,0.00573458490623278,0.0189483255396864,0.0414278983721189,1.42970927535305e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40350,-0.0275394415115828,0.0052418191175837,-0.0378134069820468,-0.0172654760411187,1.51743196524307e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED8,Protein TMED8,40350,0.0547416530721637,0.0104264482973592,0.0343058144093397,0.0751774917349877,1.54669680312055e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGT,Angiotensinogen,40432,0.0128939871849054,0.00245645720836798,0.00807933105650419,0.0177086433133067,1.55700226292988e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,40125,0.0300147985176045,0.00571814446878753,0.018807235358781,0.0412223616764281,1.55755905295134e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40104,0.0188954651910975,0.0036035532598879,0.0118325008017172,0.0259584295804778,1.60449919608971e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THTPA,Thiamine-triphosphatase,40337,0.0471618914085134,0.00899921033453333,0.0295234391528281,0.0648003436641987,1.62918383809915e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40385,0.0204831106154187,0.00391197808688621,0.0128156335651218,0.0281505876657157,1.67070828444675e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40104,0.0426514244562061,0.00815274887571842,0.026672036659798,0.0586308122526142,1.71221261082798e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMMD9,COMM domain-containing protein 9,40352,0.0213486942707251,0.00408544311385103,0.0133412257675771,0.0293561627738731,1.76769834986945e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42673,0.0224132895807316,0.00429014886193172,0.0140045978113454,0.0308219813501177,1.77361693958038e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42460,0.0364455885689013,0.00697762254299376,0.0227694483846335,0.050121728753169,1.78508839964136e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP7,Caspase-7,40385,0.0446055119624241,0.00854136853208761,0.0278644296395323,0.0613465942853158,1.79894719332658e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42466,0.0300421727019784,0.00575631109158544,0.018759802962471,0.0413245424414859,1.82606909625186e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40104,0.0461538929255261,0.00884245799916965,0.0288226752471536,0.0634851106038987,1.82627378929786e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42475,0.0227725662915215,0.00436523563242592,0.0142167044519667,0.0313284281310763,1.84778117678478e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40350,0.031173246775272,0.00597927729476839,0.0194538632775259,0.042892630273018,1.88576782588927e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL20,C-C motif chemokine 20,42631,0.0490756990360154,0.00941619734107193,0.0306199522475144,0.0675314458245163,1.89748164155858e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLIT2,Slit homolog 2 protein,42191,0.0282041879883287,0.00541215019573073,0.0175963736046965,0.038812002371961,1.90421692878793e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40089,0.0258063102869175,0.00495269560232685,0.0160990269063569,0.0355135936674782,1.91714210182139e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42590,0.0356465605991969,0.00684561183381251,0.0222291614049243,0.0490639597934694,1.94536368710725e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39987,0.0281319724903439,0.00540461969661206,0.0175389178849843,0.0387250270957035,1.97379424282841e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40385,0.051620962483804,0.00992270791043233,0.0321724549793567,0.0710694699882514,2.00311071726109e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42469,0.0444142735968811,0.00854151089025409,0.027672912251983,0.0611556349417791,2.02451939924132e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40019,0.0366683080159206,0.00707018917631479,0.0228107372303436,0.0505258788014976,2.18357691193511e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,40384,0.0399386393134872,0.00770469047563435,0.0248374459812439,0.0550398326457305,2.21345253730059e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42561,-0.0133985017542709,0.00258543114704779,-0.0184659468024846,-0.00833105670605722,2.22348551658945e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40104,0.047740216654194,0.00922330493578291,0.0296625389800595,0.0658178943283285,2.30673114400625e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42590,-0.0247703327720019,0.0047863129774152,-0.0341515062077357,-0.0153891593362681,2.30905197493869e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40040,0.0225753526291052,0.00436315712964339,0.0140235646550041,0.0311271406032062,2.33120319435068e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42561,0.0149115613554069,0.00288623716210048,0.00925453651768996,0.0205685861931238,2.42033239900508e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40125,0.0259180346454057,0.00501607524110509,0.0160865271728397,0.0357495421179717,2.42082084567781e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TTF2,Transcription termination factor 2,40089,0.0259183662306978,0.00501664713544698,0.0160857378452218,0.0357509946161739,2.42772380556981e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40206,0.0555916281299531,0.0107632652607748,0.0344956282188346,0.0766876280410716,2.44717592445868e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40352,0.0569073908383609,0.0110184792331384,0.0353111715414096,0.0785036101353122,2.44946881575686e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42237,0.0224022006732394,0.00434231199717383,0.0138912691587787,0.0309131321877001,2.51848677000362e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40352,0.0273039770041474,0.00529419073488574,0.0169273631637713,0.0376805908445234,2.54768057527435e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBXN1,UBX domain-containing protein 1,40187,0.0360831093364294,0.00700016059165097,0.0223627945767935,0.0498034240960653,2.58571242310982e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40384,0.0453925074586784,0.00882001237409953,0.0281052832054433,0.0626797317119134,2.69840315128999e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,42434,0.0318039746497195,0.00618073020240308,0.0196897434530095,0.0439182058464296,2.70386651651133e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL13,C-C motif chemokine 13,42612,0.0363902198246461,0.00707853778222605,0.0225162857714831,0.0502641538778092,2.77236823995026e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40350,0.0403121207487892,0.00784488324847003,0.024936149581788,0.0556880919157905,2.81395552208443e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC3B,Tetranectin,40171,-0.0110736516087199,0.00215525895492133,-0.0152979591603657,-0.0068493440570741,2.82495229288472e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40089,0.0226055860376021,0.00440260922521621,0.0139764719561784,0.0312347001190259,2.87643163327232e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNCA,Alpha-synuclein,40187,0.0604143676891584,0.01177315192273,0.0373389899206077,0.0834897454577092,2.92290164174723e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42191,0.0201566188538999,0.00393143852722426,0.0124509993405404,0.0278622383672595,2.98572443932316e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDK,Midkine,42521,0.0268349230051369,0.00523566912036159,0.0165730115292282,0.0370968344810456,3.01054715226766e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42475,0.0198564848482999,0.0038772503608042,0.0122570741411237,0.0274558955554761,3.0771738552187e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G1B,Phospholipase A2,42661,-0.0238986997453481,0.00466689714721604,-0.0330458181538915,-0.0147515813368046,3.08282743672168e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42578,0.0487980405098779,0.00953932589919872,0.0301009617474484,0.0674951192723074,3.17306030701972e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42518,0.0340896571019968,0.00666876242453684,0.0210188827499046,0.047160431454089,3.23453722609837e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42229,0.0304144922855847,0.00595468914499931,0.018743301561386,0.0420856830097833,3.30788662213145e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPD52L2,Tumor protein D54,40187,0.0559034843240385,0.010949466281152,0.0344425304129807,0.0773644382350963,3.35282384298666e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEXN,Nexilin,40432,0.0360535171483702,0.00706481601221216,0.0222064777644343,0.049900556532306,3.39325342106941e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40125,0.0382820541009653,0.00750170588330252,0.0235787105696923,0.0529853976322382,3.3972332216226e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGA4,Pepsin A-4,40432,0.0422189205920472,0.00827506429377299,0.0259997945762522,0.0584380466078423,3.41667814815161e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42518,0.0355630061428571,0.00697635433586472,0.0218893516445622,0.049236660641152,3.4861133198689e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALB2,Calretinin,42191,0.0167968462648598,0.00330116573582177,0.0103265614226492,0.0232671311070705,3.66606485096239e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRGN,Neurogranin,40432,0.0472045551470453,0.00930059237904791,0.0289753940841114,0.0654337162099792,3.92793229815285e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA11,Serpin A11,42673,-0.0212506553703403,0.00419658843644706,-0.0294759687057765,-0.013025342034904,4.16421872709781e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42561,0.043235640882425,0.00854606114738476,0.0264853610335509,0.0599859207312991,4.26759222056544e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MINK1,Misshapen-like kinase 1,40385,0.0477852801638542,0.00945614358055951,0.0292512387459576,0.0663193215817508,4.40964076326023e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GET3,ATPase GET3,40411,0.0279990986891689,0.00554088871406693,0.0171389568095977,0.03885924056874,4.41362687346234e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40351,0.0231320308806706,0.00457989731999469,0.014155432133481,0.0321086296278602,4.46977278894287e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMOD1,Leiomodin-1,40384,-0.0184983367372635,0.00366517148073585,-0.0256820728395058,-0.0113146006350213,4.55714331399543e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMBS,Porphobilinogen deaminase,42599,0.0223720619549592,0.00443526165421312,0.0136789491127015,0.0310651747972169,4.61533142527086e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYO9B,Unconventional myosin-IXb,42256,0.0340517763021825,0.00675752188690899,0.0208070334038408,0.0472965192005241,4.73998645834675e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42256,-0.020475256796918,0.0040653929065781,-0.028443426893811,-0.0125070867000249,4.80505656457746e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42554,0.0142825360532725,0.00283756631896076,0.00872090606810942,0.0198441660384356,4.88189523834629e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40350,0.0237685147160576,0.0047252394714656,0.014507045351985,0.0330299840801302,4.97804000620319e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40094,0.0181243078759054,0.00360404097327191,0.0110603875682925,0.0251882281835184,5.01190460908223e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB6,Serpin B6,42559,0.0297626890110211,0.00592495957251857,0.0181497682488847,0.0413756097731575,5.14539172718243e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40125,0.0167239744042472,0.00333054702506824,0.0101961022351134,0.0232518465733809,5.21082581201407e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42490,0.0154655591535545,0.0030816034267307,0.00942561643716231,0.0215055018699467,5.27023359282252e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40132,0.0290421047750737,0.00579999960199834,0.017674105555157,0.0404101039949905,5.60713488557012e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40125,0.0214285496490194,0.00428026453331311,0.0130392311637257,0.0298178681343131,5.63336121550231e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42536,0.0263012168615681,0.00526281510899575,0.0159860992479364,0.0366163344751997,5.87971590640581e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOD3,Extracellular superoxide dismutase,40432,-0.0300097642108778,0.0060061554197711,-0.0417818288336292,-0.0182376995881265,5.92583072525794e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42631,0.0241315299031425,0.00483272847389371,0.0146593820943108,0.0336036777119742,6.00835848850718e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPAG1,Sperm-associated antigen 1,40384,0.0292823407574819,0.00586631888348808,0.0177843557458453,0.0407803257691186,6.07815238514037e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40350,0.0442955563729807,0.00888337858043392,0.0268841343553302,0.0617069783906312,6.24589815979171e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CR1,Complement receptor type 1,40409,-0.0184703523595339,0.00370478543495193,-0.0257317318120397,-0.0112089729070281,6.27131945699539e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42518,-0.0174099554233112,0.00349427835106573,-0.0242587409914,-0.0105611698552224,6.35822377118447e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,40019,0.0358151783491558,0.00721151545480725,0.0216806080577336,0.049949748640578,6.9252905216075e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL7,C-C motif chemokine 7,42475,0.0299824789524167,0.00606021397729686,0.0181044595569148,0.0418604983479185,7.61209033605125e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42229,0.0256941024738362,0.00520142280393482,0.015499313778124,0.0358888911695485,7.9163784198557e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42245,0.0242924802244398,0.00492465535292617,0.0146401557327045,0.033944804716175,8.20458159451975e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP2,Microtubule-associated protein 2,40385,0.0234286803239544,0.0047593957081904,0.0141002647359012,0.0327570959120075,8.66127445153124e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX5,Sorting nexin-5,40125,0.0147096674981774,0.0029882590046182,0.00885267984912575,0.0205666551472291,8.66989687505664e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42466,0.0300652916090774,0.00612137968624765,0.0180673874240321,0.0420631957941228,9.14486541953563e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF6,SLAM family member 6,42229,0.0195693190803414,0.00398452065448047,0.0117596585975597,0.0273789795631231,9.15551071300762e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40411,0.016464392837527,0.00335744734343786,0.00988379604438877,0.0230449896306652,9.52976442287407e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40411,0.045161720933025,0.00923739067407009,0.0270564352118477,0.0632670066542024,1.02747364048096e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42475,0.0307011179687178,0.0062845143580136,0.0183834698270111,0.0430187661104244,1.04527895654017e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLKB1,Plasma kallikrein,40195,0.0122741669821721,0.00251722360016582,0.00734040872584704,0.0172079252384971,1.09732082474926e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIFBP,KIF-binding protein,42466,0.0406280448247194,0.00835920934222546,0.0242439945139575,0.0570120951354813,1.18564490108053e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBCA,Tubulin-specific chaperone A,40187,0.0420766297958776,0.00867107780400928,0.0250813173000194,0.0590719422917358,1.23573482188e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NXPH3,Neurexophilin-3,40104,-0.0152506495886956,0.00314408608785227,-0.0214130583208861,-0.00908824085650518,1.24800716337073e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCRIB,Protein scribble homolog,40125,0.0450864757000554,0.00933044058005873,0.0267988121631403,0.0633741392369705,1.36873910002865e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40350,0.0516236651625357,0.0106882442411947,0.0306747064497942,0.0725726238752773,1.38384176181032e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD6,Programmed cell death protein 6,42518,-0.0349374916183102,0.00724557523135177,-0.0491388190717597,-0.0207361641648608,1.43763299547095e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42072,0.0597241060850842,0.0123919625039679,0.0354358595773072,0.0840123525928613,1.45499636014188e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA3,Annexin A3,42560,0.0342647156499493,0.00711292969166056,0.0203233734542946,0.048206057845604,1.47152208011453e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42358,0.0358274807686777,0.00744928187042022,0.0212268883026541,0.0504280732347013,1.52967532918757e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42470,0.0216019863713537,0.00449321315805128,0.0127952885815732,0.0304086841611343,1.54356578671241e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40384,0.0329426554999484,0.00685502761500984,0.0195068013745291,0.0463785096253677,1.56278027039613e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL4,Myosin light chain 4,40125,0.0257549317421027,0.00536310172727215,0.0152432523566493,0.0362666111275562,1.5897817208232e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB44,Ras-related protein Rab-44,40352,0.0207035581567849,0.00431788894621221,0.012240495822209,0.0291666204913609,1.64913870828216e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAT,Catalase,40266,0.0266485242776247,0.00556400206059243,0.0157430802388635,0.0375539683163858,1.69405308021338e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRADD,Death domain-containing protein CRADD,42358,0.036594740708802,0.00764340044437785,0.0216136758378214,0.0515758055797826,1.70491353034224e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42475,0.0384210739320181,0.00803312962830351,0.0226761398605432,0.054166008003493,1.74703246299288e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOA2,Apolipoprotein A-II,40432,-0.0241008033229805,0.00503895901909149,-0.0339771630003998,-0.0142244436455611,1.74985372862603e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANPEP,Aminopeptidase N,42545,-0.0136214409380822,0.00284878381578419,-0.0192050572170192,-0.00803782465914516,1.75855129474624e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40384,0.0415270967912934,0.00868805923222025,0.0244985006961417,0.0585556928864451,1.77712252900356e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSPN,Persephin,42475,0.0455782392948933,0.00955681708992595,0.0268468777986385,0.0643096007911482,1.86937047340014e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,42296,-0.0204203894965256,0.00428762671420533,-0.0288241378563681,-0.0120166411366832,1.93131063145457e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40071,0.027267158301801,0.00573580941979898,0.016024971838995,0.038509344764607,2.02142035296933e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39987,0.0175311448739443,0.00369551707316918,0.0102879314105327,0.0247743583373559,2.12335412812193e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42568,-0.0175133738020339,0.00369314233845638,-0.0247519327854084,-0.0102748148186594,2.13662070079497e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40411,0.0352719157759071,0.0074453816975384,0.0206789676487319,0.0498648639030824,2.19109682776705e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,40125,0.0254551611707769,0.0053776794839807,0.0149149093821747,0.035995412959379,2.23468104906038e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42545,0.0537929215512936,0.011376184284947,0.0314956003527974,0.0760902427497897,2.28434835451777e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPB1,Heat shock protein beta-1,42331,0.0327244782154945,0.00692786847877275,0.0191458559970999,0.0463031004338891,2.34104580150555e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40187,0.057145520142118,0.0121068756705052,0.0334160438279278,0.0808749964563083,2.38652534925315e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP3,Caspase-3,42673,0.0418820837449901,0.00887903440636405,0.0244791763085166,0.0592849911814636,2.41792060495007e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40385,0.0327336614791608,0.00694210951391403,0.0191271268318893,0.0463401961264323,2.44350444090828e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40384,0.0388393975945082,0.00823702417260191,0.0226948302162084,0.0549839649728079,2.44363468752922e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRY2,Protein sprouty homolog 2,42256,0.0443018002848506,0.00940711317556932,0.0258638584607347,0.0627397421089664,2.51011386437649e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UNC5D,Netrin receptor UNC5D,40104,-0.0126192679613907,0.0026856399181222,-0.0178831222009102,-0.00735541372187115,2.64901507002749e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42256,0.0208201408633169,0.00443453478829673,0.0121284526782553,0.0295118290483785,2.69318052668635e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42237,0.0526635773354645,0.0112213459554057,0.0306697392628693,0.0746574154080597,2.71752003149436e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BOLA1,BolA-like protein 1,40042,0.0260390002624219,0.00554929323259757,0.0151623855265306,0.0369156149983131,2.73441605995193e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAM,Integrin alpha-M,42490,-0.0151943145823509,0.00324276415885912,-0.0215501323337148,-0.00883849683098703,2.81900173007135e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,40385,0.0273788928233561,0.00585233163765253,0.0159083228135571,0.0388494628331551,2.92669168737325e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42568,0.0221665687056748,0.00474066400451546,0.0128748672568245,0.0314582701545251,2.95620209406522e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFF1,Trefoil factor 1,42435,0.0398058874390459,0.00851753719312593,0.023111514540519,0.0565002603375727,2.9916861100553e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42554,0.0524372206477845,0.0112233477382662,0.0304394590807828,0.0744349822147863,3.00963949694305e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40384,0.027827842514599,0.00595691667678982,0.016152285828091,0.0395033992011071,3.02465707161379e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40187,0.0286761330515515,0.00614011499997311,0.0166415076516042,0.0407107584514988,3.0433506197765e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42466,-0.0317456257523425,0.00679895185456155,-0.0450715713872831,-0.0184196801174019,3.05346339437238e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UNC79,Protein unc-79 homolog,39987,0.0266761157978736,0.00571625630726834,0.0154722534356276,0.0378799781601195,3.09742604829584e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42673,0.0155376728546599,0.00332989626277616,0.00901107617961858,0.0220642695297011,3.09904257334949e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42490,0.0147550286811471,0.00316283159470091,0.00855587875553337,0.0209541786067609,3.1142441692562e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP7,Matrilysin,42213,0.0241697656623277,0.00519109332791359,0.013995222739617,0.0343443085850383,3.25586920806798e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,42229,0.0246127892557651,0.00529200487672219,0.0142404596973897,0.0349851188141406,3.33675066552487e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NID2,Nidogen-2,42490,0.0352699059907445,0.00758400024220951,0.0204052655160139,0.0501345464654752,3.34210660560274e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42229,0.0358885813899182,0.00772973618988191,0.0207382984577497,0.0510388643220868,3.46865377848187e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42518,0.0394367722690785,0.0084962441693794,0.0227841336970948,0.0560894108410621,3.48899395917283e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40125,0.0248831946064542,0.00536430237831069,0.0143691619449652,0.0353972272679432,3.54739933542845e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42517,-0.017917268621135,0.00386663500786618,-0.0254958732365527,-0.0103386640057172,3.62391700621292e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PI16,Peptidase inhibitor 16,40432,-0.0119393732233196,0.0025773772557643,-0.0169910326446177,-0.00688771380202162,3.65557868837674e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST7,Cystatin-F,42520,0.044628337809812,0.00963503769536189,0.0257436639269027,0.0635130116927213,3.65788608105833e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42561,0.0117034862178,0.0025291497848147,0.00674635263956322,0.0166606197960368,3.73694310427542e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42229,0.0398862238480069,0.00863790152174942,0.022955936865378,0.0568165108306357,3.91947167598956e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40187,0.0407001708100789,0.00881755494813505,0.0234177631117342,0.0579825785084236,3.95996935530393e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40350,0.0418345750407501,0.00907853616191671,0.0240406441633934,0.0596285059181069,4.10920178630817e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42590,0.0271646579808926,0.00589654904480824,0.0156074218530684,0.0387218941087168,4.12535470926055e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40385,0.0152326334778358,0.00330934810693524,0.00874631118824268,0.0217189557674288,4.21211980739693e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSAP,Prosaposin,40342,0.0136393141467602,0.00296690735562639,0.00782417572973251,0.0194544525637879,4.33021008629602e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,40428,0.0393914914924877,0.00857738340648335,0.0225798200157804,0.0562031629691951,4.42762053859412e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42474,0.0152385010286568,0.00332007700173882,0.0087311501052487,0.0217458519520649,4.47730261765938e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP2,Retinol-binding protein 2,42466,-0.0363408544145969,0.0079272077689819,-0.0518781816418014,-0.0208035271873924,4.59625330076669e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMTN,Smoothelin,40362,0.0431767064605527,0.00943576227991754,0.0246826123919144,0.0616708005291911,4.79385320446605e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42518,-0.0133317225187158,0.00291514447025646,-0.0190454056804185,-0.00761803935701312,4.8451312176804e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C3,Complement C3,39892,0.0219307066372703,0.00482533475768278,0.012473050512212,0.0313883627623285,5.55616917091493e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42475,0.0702825379937782,0.0155007735033008,0.0399010219273086,0.100664054060248,5.83469714155947e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39987,0.0195153379700708,0.00430573019878483,0.0110761067804526,0.0279545691596891,5.89414320367953e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40440,-0.0118828331012896,0.00262276556479992,-0.0170234536082975,-0.0067422125942818,5.94083494614423e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SWAP70,Switch-associated protein 70,40350,0.0165695248987879,0.00366147531660464,0.00939303327824282,0.023746016519333,6.09138277587736e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,40125,0.0144052147882711,0.00319117510297188,0.00815051158644617,0.020659917990096,6.42574528099127e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AOC3,Membrane primary amine oxidase,42568,-0.0139971259036849,0.00310352607588485,-0.0200800370124192,-0.00791421479495062,6.53570642596467e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,42172,0.0334162569710836,0.0074105633872908,0.0188915527319937,0.0479409612101736,6.56200683727513e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOC,Myocilin,42490,-0.0206911079370509,0.00459191226197992,-0.0296912559705315,-0.0116909599035702,6.66278667175608e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX9,Sorting nexin-9,42518,0.0309542217047068,0.00687226062488637,0.0174845908799295,0.0444238525294841,6.71811041978731e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40384,0.0220069207809718,0.00489886924741528,0.0124051370560379,0.0316087045059058,7.11826242343851e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKD2,Polycystin-2,40019,0.0269370219165705,0.00599772523028819,0.0151814804652056,0.0386925633679353,7.15540460991577e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIF1,Allograft inflammatory factor 1,42229,0.023978550775433,0.00534064500352146,0.0135108865685309,0.0344462149823351,7.18940787645648e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40400,0.0219165748174303,0.00488159612684748,0.0123486464088092,0.0314845032260513,7.20584421973259e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42561,-0.0126691908884659,0.00283258706906358,-0.0182210615438306,-0.00711732023310131,7.7890563814584e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40350,-0.032238511255982,0.00722544914753802,-0.0464003915851565,-0.0180766309268075,8.20699323753406e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,40007,0.0249047172403483,0.00558294334804465,0.0139621482781808,0.0358472862025158,8.24564710500629e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL17,C-C motif chemokine 17,42482,0.0418028062277079,0.00938590764179075,0.0234064272497981,0.0601991852056178,8.50584934356526e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42191,0.0287012803002066,0.00646074293008234,0.0160382241572452,0.041364336443168,8.96911661106175e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42475,-0.022091243950877,0.00498842959908033,-0.0318685659650744,-0.0123139219366795,9.5650276845873e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAX,Protein max,42191,0.0475999204370987,0.0107488152034233,0.0265322426383891,0.0686675982358083,9.57151895259955e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAL,Integrin alpha-L,40104,0.0202475475802596,0.00457493131126178,0.0112806822101865,0.0292144129503327,9.70363975209451e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX16,Syntaxin-16,42229,0.0262557208075222,0.00594087233940588,0.0146116110222867,0.0378998305927577,9.97258313326186e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL14,C-C motif chemokine 14,42497,0.0183120775200851,0.00414459252508256,0.0101886761709233,0.026435478869247,1.00264009852803e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42495,0.0214970600410006,0.00486662486825297,0.0119584752992248,0.0310356447827764,1.00757968091536e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTN6,Dynactin subunit 6,42191,0.0325292274901297,0.00736442136411322,0.0180949616164678,0.0469634933637916,1.00852624017788e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40206,0.0310667331452705,0.00704197841234371,0.0172644554570768,0.0448690108334641,1.03561284721014e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40089,0.0309900494628479,0.00704505587270676,0.0171817399523426,0.0447983589733531,1.09866341833185e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42466,0.0178958643576897,0.00407267739021268,0.00991341667287286,0.0258783120425066,1.12081432609411e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42490,-0.0160406631544315,0.00365150720942709,-0.0231976172849086,-0.00888370902395441,1.12720037004594e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX7,Syntaxin-7,40104,0.0224751179712881,0.00512120086698941,0.0124375642719888,0.0325126716705873,1.15132751769659e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEPACAM2,HEPACAM family member 2,40385,-0.0189653411022459,0.00432375813942596,-0.0274399070555208,-0.010490775148971,1.16344362288415e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42191,0.023488780206245,0.0053607966421337,0.012981618787663,0.0339959416248271,1.18743100545232e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,40385,0.0443579962749603,0.0101278785429268,0.0245073543308239,0.0642086382190968,1.19873060424958e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASAH1,Acid ceramidase,40321,0.0204975814866463,0.00468377387945843,0.0113173846829078,0.0296777782903848,1.21813553299101e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40206,0.0331215731279301,0.00757005519151516,0.0182842649525604,0.0479588813032998,1.22358813033307e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42542,-0.0125551428948932,0.00287037019259488,-0.0181810684723792,-0.00692921731740723,1.22886981684572e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,42237,0.0157105590025162,0.00359201183602755,0.00867021580390217,0.0227509022011302,1.23077992022303e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40385,0.010216359698062,0.00233648503992411,0.00563684901981075,0.0147958703763132,1.23922441470173e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42191,0.0326515879094137,0.0074773495319436,0.0179959828268042,0.0473071929920231,1.27094537966006e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A16,Protein S100-A16,42172,0.0272483843092757,0.00625014248092846,0.014998105046656,0.0394986635718955,1.31278427502131e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42377,0.0479246363952235,0.0110065217525124,0.0263518537602991,0.0694974190301478,1.345590143502e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42466,0.0150289374750148,0.00345528577417226,0.00825657735763718,0.0218012975923925,1.37435298350718e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42568,-0.0262644272695769,0.00603952864869915,-0.0381019034210273,-0.0144269511181266,1.37926041793654e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42229,0.0295152422561563,0.00681129931689193,0.0161650955950482,0.0428653889172645,1.48006860948721e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GMFG,Glia maturation factor gamma,40411,0.031656979970092,0.00731221287394026,0.017325042737169,0.0459889172030149,1.50861788765376e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ULBP2,UL16-binding protein 2,42377,0.0176857576301407,0.00409674358983809,0.00965614019405808,0.0257153750662234,1.59298433702059e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPB6,Heat shock protein beta-6,42599,0.0174424431415702,0.00404797487740714,0.00950841238185222,0.0253764739012882,1.65215023255051e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAX,Apoptosis regulator BAX,42172,0.0393206931355507,0.00913420858151127,0.0214176443157887,0.0572237419553128,1.68383359069496e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,40125,0.0340824085453061,0.00791736726882366,0.0185643686984117,0.0496004483922005,1.6861940747239e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMCN2,Hemicentin-2,40173,0.0258726803223329,0.00601339828595518,0.0140864196818607,0.0376589409628051,1.70339491884369e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42438,-0.00955918807611079,0.00222196873215747,-0.0139142467911394,-0.00520412936108214,1.70380637444264e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,40089,0.0299248545255872,0.00696378682058425,0.0162758323572421,0.0435738766939324,1.7446330990394e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40385,0.0170803473693113,0.00398186221922587,0.00927589741962855,0.024884797318994,1.80548850573993e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42518,0.0152335548734867,0.00355450570873773,0.00826672368436074,0.0222003860626126,1.83442013844731e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42237,0.0273309795127118,0.00639067099459377,0.014805264363308,0.0398566946621156,1.91034875731981e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40411,0.0391446410992629,0.00915397380129373,0.0212028524487272,0.0570864297497986,1.9164481289248e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42639,0.0146403079138706,0.00342691720176513,0.0079235501984109,0.0213570656293302,1.94927787437289e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,40206,0.0327780816278149,0.00767219252728604,0.0177405842743342,0.0478155789812955,1.95072930638537e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42473,0.0262920543714592,0.00616962447506221,0.0141995904003373,0.0383845183425811,2.04430373063195e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42657,0.0124691661742947,0.00293516396455779,0.00671624480376141,0.018222087544828,2.16942717355438e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40042,0.0430022062746863,0.01013418341916,0.0231392067731327,0.0628652057762399,2.22104208673224e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40352,0.0189083935183325,0.00445998660887823,0.0101668197649312,0.0276499672717339,2.25758829105919e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42561,-0.0195088015927766,0.00460703266484,-0.028538585615863,-0.0104790175696902,2.30521111119677e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42191,0.0480221419420551,0.0113660659355294,0.0257446527084174,0.0702996311756928,2.40522135534826e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,42466,-0.00925666228923777,0.0021911562958522,-0.0135513286291081,-0.00496199594936746,2.41010603849497e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIF22,Kinesin-like protein KIF22,40019,0.0542935526979925,0.0128578212130599,0.0290922231203951,0.0794948822755899,2.43464550498739e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,42362,0.0204051811864007,0.00483872854748907,0.0109212732333222,0.0298890891394793,2.49168463202408e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PODXL,Podocalyxin,42466,-0.00659277530195112,0.0015676553220324,-0.00966537973313461,-0.00352017087076762,2.62214236820409e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40411,0.0302031841312807,0.0071928927284915,0.0161051143834373,0.044301253879124,2.70128653017093e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,40019,0.0503574904806216,0.0119965145261501,0.0268443220093673,0.0738706589518758,2.71822304305469e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMS,Spermine synthase,40042,0.0274838754359323,0.00655382128230416,0.0146383857226162,0.0403293651492485,2.76786149912894e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MILR1,Allergin-1,42256,-0.0221271018004783,0.0052784735791094,-0.0324729100155327,-0.0117812935854238,2.78387268691823e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40159,-0.0208473239377085,0.00497491135370924,-0.0305981501909787,-0.0110964976844384,2.80532571242708e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COLEC12,Collectin-12,42496,0.0120198216372782,0.00286987391353937,0.00639486876674103,0.0176447745078154,2.82894134520847e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40384,0.0205806357113373,0.00491751464992662,0.0109423069974811,0.0302189644251935,2.87130433959826e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40411,0.0114883779165655,0.002747172094958,0.00610392061044778,0.0168728352226831,2.91290514848476e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,40206,0.0299745213642234,0.00716950546842931,0.0159222906461019,0.0440267520823448,2.92687153775595e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40019,0.0295068371177087,0.00705809793484495,0.0156729651654126,0.0433407090700048,2.93073703535182e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42475,0.0156253538771807,0.00373802150809144,0.00829883172132152,0.02295187603304,2.93230584397158e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42475,-0.0209383404902496,0.00501954665304347,-0.0307766519302148,-0.0111000290502844,3.04710508341072e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42237,0.01437358699766,0.00344617499294432,0.00761908401148912,0.0211280899838308,3.05386899138053e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42471,-0.0209876306910954,0.00503244054888267,-0.0308512141669054,-0.0111240472152853,3.05906324931493e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRUNE2,Protein prune homolog 2,40206,0.0129090456586734,0.003098028739093,0.00683690933005112,0.0189811819872957,3.11185680214114e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42237,0.0375097264065602,0.00900556209964181,0.0198588246912622,0.0551606281218581,3.13118571177781e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40428,-0.0157638824300781,0.00378799946495918,-0.0231883613813981,-0.00833940347875815,3.18474377256174e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMEM106A,Transmembrane protein 106A,40352,0.0298509299492537,0.00717619962606246,0.0157855786821713,0.0439162812163361,3.21034208126732e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40089,0.0265806005338114,0.00642167968875629,0.0139941083438491,0.0391670927237737,3.51146119366106e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40384,0.0201002801676851,0.00485737511499212,0.0105798249423006,0.0296207353930697,3.52764881028738e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLC,Galectin-10,42493,-0.0279594243184785,0.00677301408360439,-0.0412345319223431,-0.0146843167146139,3.68064682526293e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42525,0.020845102274404,0.0050575319258462,0.0109323396997454,0.0307578648490625,3.78533139225468e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTF1,Cardiotrophin-1,42237,0.0355175673987186,0.00862034789351051,0.018621685527438,0.0524134492699992,3.80879416041042e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40384,0.0169773387234031,0.00412473557679657,0.00889285699288182,0.0250618204539244,3.88299166545378e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH6,Cadherin-6,42518,-0.0163649025665501,0.00397822026531937,-0.024162214286576,-0.00856759084652409,3.91835774467189e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42475,0.0416498623398782,0.0101406098721714,0.0217742669904223,0.0615254576893341,4.02824143355842e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42518,-0.048584888971148,0.0118347706665468,-0.0717810394775796,-0.0253887384647164,4.06256555429896e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42325,-0.012916700652705,0.00314867444171342,-0.0190881025584633,-0.00674529874694665,4.1159146625501e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNG,Interferon gamma,42256,0.0475577645632195,0.0115990515195907,0.0248236235848216,0.0702919055416173,4.15394999858663e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBC1D17,TBC1 domain family member 17,42191,0.0191193240709143,0.00466344259309506,0.00997897658844802,0.0282596715533806,4.15967324294323e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40206,0.0318086499197374,0.00779441999288795,0.016531586733677,0.0470857131057978,4.51681740676683e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42554,0.0118376646893332,0.00290301314373598,0.0061477589276107,0.0175275704510558,4.57437506363933e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN8,Septin-8,40372,0.0135856645551632,0.00333272532161268,0.00705352292480235,0.0201178061855241,4.60463915783663e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40411,0.0405769364305789,0.00995747253354717,0.0210602902648264,0.0600935825963314,4.63265882504261e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLVRB,Flavin reductase,42490,0.0275094119945092,0.00675277101452124,0.0142739808060476,0.0407448431829708,4.65213586544569e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40125,0.0424448176445837,0.0104371761883169,0.0219879523154826,0.0629016829736848,4.80189443469701e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42590,0.0128389538302206,0.00316513650705802,0.00663528627638687,0.0190426213840543,5.01244146750862e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40428,-0.0164522680522104,0.00406040265629327,-0.0244106572585452,-0.00849387884587559,5.11494815178461e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42191,0.0303317535746859,0.00750341849330971,0.0156250533277988,0.0450384538215729,5.32138119120378e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42465,-0.0250872087736545,0.00622187967601207,-0.0372820929386382,-0.0128923246086709,5.55909205425074e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42554,0.0280757976664303,0.00697059958858919,0.0144134224727954,0.0417381728600651,5.66258101483104e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SATB1,DNA-binding protein SATB1,40384,0.0120851197151622,0.00300051182405369,0.00620411654001697,0.0179661228903074,5.67005302615194e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CERT,Ceramide transfer protein,42191,0.0252672759034065,0.00627804276131297,0.012962312091233,0.0375722397155799,5.73699458618743e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMOX2,Heme oxygenase 2,42191,0.0187489929921124,0.0046649963906298,0.00960560006647796,0.0278923859177468,5.8755323184276e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMNB2,Lamin-B2,40385,0.0118347231865331,0.00294523828757976,0.00606205614287682,0.0176073902301895,5.90141159306802e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTD,Deoxycytidylate deaminase,40187,0.0386249066937043,0.00962484142646677,0.0197602174978294,0.0574895958895791,6.03383627629915e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42673,-0.00936612774910907,0.00233695727961732,-0.013946564017159,-0.00478569148105911,6.16088130007453e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDN1,Endothelin-1,40125,0.012527827590908,0.00312641319082138,0.00640005773689815,0.0186555974449179,6.18783749903468e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42229,0.0302875157792956,0.0075688902630544,0.0154524908637089,0.0451225406948822,6.32690140433277e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42229,0.0232440747480453,0.00581131084028729,0.0118539055010822,0.0346342439950084,6.37463221503132e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,40321,0.0211555632884583,0.00530514249748368,0.0107574839933903,0.0315536425835263,6.71305197757941e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42475,0.0332902223378693,0.00834887871591519,0.0169264200546755,0.0496540246210631,6.71623275130761e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYTL1,Cytokine-like protein 1,40428,-0.0104324228712636,0.00262057122750152,-0.0155687424771666,-0.00529610326536063,6.90657809504981e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",40206,0.0185971200251855,0.00467615276670835,0.00943186060243715,0.0277623794479339,7.02328001821645e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40428,0.0257964412294797,0.00648848391680396,0.013079012752544,0.0385138697064155,7.06039747520588e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40352,0.0383221010113328,0.00963925573859769,0.0194291597636814,0.0572150422589843,7.06361539371661e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPO,Lactoperoxidase,42019,0.0246932308949263,0.00621440691435193,0.0125129933427965,0.0368734684470561,7.11980529445379e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42466,-0.016014394962515,0.00403120689281006,-0.0239155604724228,-0.00811322945260733,7.14663173374453e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAFB2,Scaffold attachment factor B2,40384,0.0112211182133894,0.00282491213367501,0.00568429043138639,0.0167579459953924,7.16578846903639e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,40305,0.0196672437652995,0.00495309681619875,0.00995917400554991,0.029375313525049,7.21144569971788e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA11,Annexin A11,42451,0.0270657311131348,0.00682613753150854,0.0136865015513781,0.0404449606748915,7.37770266803987e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42256,0.0175321651322737,0.00442251198845459,0.00886404163490275,0.0262002886296447,7.40036392255978e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,40019,0.0246500143859905,0.0062201328908343,0.0124585539199553,0.0368414748520257,7.45077029332691e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFB,Complement factor B,40245,0.0131414074312247,0.00331835215136792,0.00663743721454359,0.0196453776479058,7.53501995638916e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA1,Annexin A1,40139,0.0168885434820332,0.00427002554883741,0.0085192934063119,0.0252577935577545,7.6972376898154e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40187,0.0148419547275665,0.0037531187786385,0.00748584192143502,0.0221980675336979,7.71547119448854e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DMD,Dystrophin,40125,0.0209601266812913,0.00530035344103797,0.0105714339368569,0.0313488194257257,7.71859722139199e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40019,0.0222928932681139,0.00565619262489797,0.0112067557233139,0.033379030812914,8.15423837817982e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD84,SLAM family member 5,42475,0.0126593857822786,0.00321571625757711,0.00635658191742751,0.0189621896471298,8.30230757620277e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXN,Thioredoxin,40289,0.0179418119952753,0.00456233560313321,0.0089996342131342,0.0268839897774164,8.45455322995336e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,40104,0.0161000029810866,0.00410179494093043,0.0080604848968629,0.0241395210653102,8.72221018035988e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBN1,Drebrin,40104,0.0200290889871025,0.00511332020467849,0.0100069813859326,0.0300511965882723,9.01886438569996e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG1A,Lithostathine-1-alpha,42454,0.0209611291471551,0.00536188522449877,0.0104518341071376,0.0314704241871727,9.30309309370875e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMVK,Phosphomevalonate kinase,42183,0.0432963564214087,0.011082083085557,0.021575473573717,0.0650172392691003,9.39698474297379e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IST1,IST1 homolog,40276,0.0393499087681392,0.0100839486587857,0.0195853693969193,0.0591144481393591,9.58734787369175e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40125,0.012778503263428,0.00327545428252743,0.00635861286967424,0.0191983936571817,9.62540023606287e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40104,0.0138745710854606,0.00357285078467121,0.00687178354750503,0.0208773586234162,0.00010364195782591
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PARD3,Partitioning defective 3 homolog,40206,0.0296360027488734,0.00763585404384458,0.014669728822938,0.0446022766748087,0.000104563983647855
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRLB,Fc receptor-like B,42229,0.0258774320050141,0.0066830334228879,0.0127786864961538,0.0389761775138744,0.000108424604733073
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,40350,0.0172650906155856,0.00446700118450857,0.00850976829394879,0.0260204129372224,0.000111705322664537
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42561,0.0130791684660198,0.00338487150693142,0.00644482031243426,0.0197135166196054,0.000112068711920364
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL19,C-C motif chemokine 19,42590,0.0518542548293209,0.0134262961818364,0.0255387143129214,0.0781697953457203,0.000112926244838809
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39987,0.0146316945699569,0.00379013078664744,0.00720303822812794,0.0220603509117859,0.000113828106057358
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP6,Platelet glycoprotein VI,42469,0.0343592618326286,0.0089096323956228,0.0168963823372079,0.0518221413280493,0.000115604134908252
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSL,Cathepsin L1,42518,0.00981661770763506,0.00254734391574099,0.00482382363278272,0.0148094117824874,0.00011690720829679
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40125,0.025437795268877,0.00661353900007192,0.012475258828736,0.038400331709018,0.000120585475394335
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITM2A,Integral membrane protein 2A,42475,-0.0243615199755722,0.00633760975394028,-0.0367832350932952,-0.0119398048578493,0.000121628973932684
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42377,-0.0143401202103437,0.00373382971777332,-0.0216584264571794,-0.00702181396350804,0.00012331197535471
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBM17,Splicing factor 45,40384,0.0299891513039919,0.00781488360947422,0.0146719794294225,0.0453063231785614,0.000125006959898124
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40428,0.0234987749328941,0.00612535820773118,0.011493072845741,0.0355044770200473,0.000125579914519935
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42466,0.0078720210395685,0.00205418093438209,0.00384582640817961,0.0118982156709574,0.000127590850394689
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40319,0.0170816872286562,0.00446393344543074,0.00833237767561198,0.0258309967817005,0.000130636435451695
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK4,Kallikrein-4,42599,-0.0249421528230736,0.0065211539661977,-0.0377236145968211,-0.0121606910493261,0.000131467911982741
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40384,-0.0177280146379725,0.00463966273362975,-0.0268217535958868,-0.00863427568005818,0.000133646711058968
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42377,0.0118998822445937,0.00311674195306521,0.00579106801658589,0.0180086964726015,0.000135125453659262
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRSF1,G-rich sequence factor 1,39921,0.031612036130915,0.00828765364592405,0.0153682349849039,0.0478558372769261,0.000137305856762542
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROCR,Endothelial protein C receptor,40019,-0.0137479565594013,0.00360497007836065,-0.0208136979129882,-0.00668221520581446,0.000137710933540722
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42256,0.0257316534154009,0.00675293586825277,0.0124958991136254,0.0389674077171763,0.000139356099257429
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40385,0.0183602461968244,0.00482134104328623,0.00891041775198335,0.0278100746416654,0.000140775164457734
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN10,Ataxin-10,42191,0.0282714654290629,0.00744064319356999,0.0136878047696657,0.0428551260884601,0.000145590810235408
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42518,0.0333001125298561,0.00879178121389831,0.0160682213506154,0.0505320037090967,0.000152752651545733
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40428,0.0198990566899682,0.00526454902579933,0.00958054059940154,0.0302175727805349,0.000157752611994363
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42191,0.0163166674694257,0.00431713169361289,0.00785508934994447,0.024778245588907,0.000157835880939195
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40089,0.0235740041455448,0.00623702379990277,0.0113494374977354,0.0357985707933543,0.000157862542192638
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTBDN,Retbindin,42466,0.0115774726128123,0.00306660894987524,0.00556691907105684,0.0175880261545678,0.000160489915035148
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF7,SLAM family member 7,42475,-0.0230456111151342,0.00610583212647521,-0.0350130420830256,-0.0110781801472428,0.000161116683886064
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTRC,Chymotrypsin-C,42504,-0.0255891664558172,0.00678925614685349,-0.03889610850365,-0.0122822244079844,0.000164566051949757
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMP6,Bone morphogenetic protein 6,42222,0.0156857123961044,0.00416209611073875,0.00752800401905645,0.0238434207731523,0.000164820466902972
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40384,0.0258799568280194,0.00686964166763543,0.012415459159454,0.0393444544965849,0.000165873353756151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD40LG,CD40 ligand,42631,0.0299160323553762,0.00794687251922783,0.0143401622176896,0.0454919024930627,0.000167590708386291
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCG3,Secretogranin-3,42516,-0.0131949201620703,0.00350878897010063,-0.0200721465434675,-0.00631769378067306,0.000170276389237247
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLB,Beta-klotho,42191,-0.0287290919675199,0.00766995280519221,-0.0437621994656966,-0.0136959844693432,0.000180692128421396
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX6,Syntaxin-6,42229,0.0253873851376693,0.00677988126967477,0.0120988178491068,0.0386759524262319,0.000181518334456885
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42377,0.0225817448732443,0.00603311776180622,0.0107568340601041,0.0344066556863845,0.000182634507047462
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QL2,Complement C1q-like protein 2,40104,-0.0169256632492746,0.00452531301421102,-0.0257952767571282,-0.008056049741421,0.000184801102965891
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40350,0.0188545834020241,0.00504420313367316,0.00896794526002472,0.0287412215440235,0.000186511721214325
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40206,0.0146204722994997,0.00392284729694735,0.00693169159748294,0.0223092530015165,0.000194738334448788
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUGT1,Protein SGT1 homolog,42229,0.0305459091265045,0.00819978035571133,0.0144743396293103,0.0466174786236987,0.000195975683209997
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP8,Neutrophil collagenase,42560,0.0279318395072722,0.00750051144828739,0.013230837068629,0.0426328419459155,0.000196903645409845
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,40187,0.0473693356754858,0.0127304685854837,0.0224176172479377,0.0723210541030338,0.000199470101890493
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40384,-0.0138064671949923,0.0037105787541256,-0.0210792015530785,-0.0065337328369061,0.00019953373630467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MESD,LRP chaperone MESD,42490,0.045612613459962,0.0123138065491336,0.0214775526236602,0.0697476742962637,0.000212930547741261
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42554,-0.00832320285099299,0.00224784704823747,-0.0127289830655384,-0.00391742263644755,0.000214138129260725
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40384,0.0251669243826582,0.00680103484588851,0.0118368960847167,0.0384969526805997,0.000216245036154915
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42466,0.0352377657433677,0.00954196328465847,0.0165355177054371,0.0539400137812983,0.000222577572531436
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP1,Guanylate-binding protein 1,40369,0.0248150195156728,0.00672502305765265,0.0116339743226736,0.037996064708672,0.000225360884084338
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PXDNL,Peroxidasin-like protein,40352,-0.0211569380398727,0.00574452129313496,-0.0324161997744172,-0.00989767630532819,0.000231615200228909
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42673,-0.0155678182243054,0.00423158094649215,-0.02386171687943,-0.00727391956918076,0.000235098500050705
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40187,0.0266015003426306,0.00723418325456974,0.0124225011636739,0.0407804995215873,0.000236937068090344
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMM2,Phosphomannomutase 2,40019,0.0227181918016142,0.00617896568011001,0.0106074190685986,0.0348289645346298,0.000237415457977612
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42229,-0.0144800856579092,0.00394002222456749,-0.0222025292180615,-0.00675764209775689,0.000238683668784868
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42460,0.00924851885721842,0.00251729092628129,0.0043146286417071,0.0141824090727297,0.000239725544414769
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNPY4,Protein canopy homolog 4,42466,0.0277894150594683,0.00757944333601957,0.0129337061208699,0.0426451239980666,0.000246930987072495
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APCS,Serum amyloid P-component,40320,0.0127702117613869,0.00348508805692126,0.0059394391698212,0.0196009843529525,0.000249223464679413
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40384,0.0122623856042105,0.003349058546702,0.00569823085267461,0.0188265403557464,0.000251954648306663
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42229,0.0163947705102272,0.0044823173925334,0.00760942842086175,0.0251801125995927,0.000255536031146797
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,40206,0.0130822040737146,0.00358051458868742,0.0060643954798873,0.020100012667542,0.000259666985694891
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40125,0.0228158693040125,0.00624465556894342,0.0105763443888834,0.0350553942191416,0.000259734916163509
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40104,0.0145482997370874,0.00398946680781338,0.00672894479377313,0.0223676546804016,0.000266889342535525
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40350,0.0196271675839285,0.00538664952009115,0.0090693345245499,0.0301850006433072,0.000269998803722014
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40350,0.0152709762516664,0.00419576447019277,0.00704727789008858,0.0234946746132442,0.000274277620498748
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EHD3,EH domain-containing protein 3,40125,0.043736058526446,0.0120237738516106,0.0201694617772891,0.0673026552756028,0.000276601509393715
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA1,Carbonic anhydrase 1,42243,0.0224083395642706,0.00618095733478008,0.0102936631881016,0.0345230159404395,0.000289631405974645
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,40104,0.0232376611631217,0.00643242927298849,0.0106300997880643,0.0358452225381792,0.000304528613443133
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42496,0.0193857786810592,0.00536800891771267,0.00886448120234235,0.029907076159776,0.000305723857715791
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42554,0.0320648734707214,0.00888438593407555,0.0146514770399333,0.0494782699015095,0.000308352742698988
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40019,0.0139142016003433,0.00385911080318183,0.00635034442610689,0.0214780587745797,0.000312897775101298
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RSPO1,R-spondin-1,42377,-0.0125413570351773,0.00347975563131061,-0.0193616780725461,-0.00572103599780852,0.000314401326328767
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40329,0.015274721774134,0.00424308991357604,0.00695826554352499,0.0235911780047431,0.000319716306029446
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40411,0.0224357945889805,0.00623279303953228,0.0102195202314973,0.0346520689464638,0.000320035379596423
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40019,0.0247775444181626,0.00689703677115894,0.011259352346691,0.0382957364896341,0.000328984324580843
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,40187,-0.0117659062545792,0.00327689036381241,-0.0181886113676516,-0.00534320114150691,0.000331392983355609
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40187,0.0119931109093934,0.00334585328854211,0.00543523846385085,0.0185509833549359,0.000339226166674778
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,40089,-0.0116634918422165,0.00325433831358057,-0.0180419949368344,-0.00528498874759858,0.000339872690222377
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL19,Interleukin-19,42148,0.0266385474666619,0.00744393631387746,0.012048432291462,0.0412286626418617,0.000346758774165413
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42602,0.0307502423196114,0.00862650024974359,0.013842301830114,0.0476581828091089,0.000365643078308518
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42599,-0.00971904941479917,0.00273534519064453,-0.0150803259884625,-0.0043577728411359,0.000381977736369986
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,40411,-0.013326673652339,0.00375201558264118,-0.0206806241943157,-0.00597272311036224,0.000384071886214412
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40352,0.0201263339156605,0.00566700628372438,0.00901900159956069,0.0312336662317603,0.000384630822504836
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RCOR1,REST corepressor 1,42237,0.0161358083344649,0.00455003814468798,0.0072177335708765,0.0250538830980534,0.000392048316918514
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GDF2,Growth/differentiation factor 2,42518,-0.013056336576121,0.00368170470580145,-0.0202724777994919,-0.00584019535275018,0.000392059505261841
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42229,0.0208985293006812,0.00589898253480173,0.00933652353246985,0.0324605350688926,0.000397385146527133
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKAP12,A-kinase anchor protein 12,40187,-0.00803900210883517,0.00226985033040342,-0.0124879087564259,-0.00359009546124447,0.000399287955672942
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSTN,Growth/differentiation factor 8,42237,0.0193331897791412,0.00547524436223984,0.00860171082915108,0.0300646687291313,0.000415390769254637
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EBI3_IL27,Interleukin-27,42568,-0.011175028726912,0.00316564008879536,-0.0173796833009509,-0.00497037415287304,0.000416797570305349
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42490,-0.0124891653334718,0.00353976561445981,-0.019427105937813,-0.00555122472913055,0.000419734106000357
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C2,Complement C2,42542,0.0083030909981156,0.00235399834712407,0.00368925423775243,0.0129169277584788,0.000421343504218257
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA10,Annexin A10,42191,0.031352276884545,0.00889493598543239,0.0139182023530975,0.0487863514159924,0.000425367298397432
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,42256,0.0125906076586732,0.0035795288433265,0.00557473112575325,0.0196064841915931,0.000437288751979628
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD55,Complement decay-accelerating factor,42084,-0.00983041983820176,0.00280147047437504,-0.0153213019679768,-0.00433953770842668,0.000451292574299251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HLA_E,,42475,0.0110610218953102,0.00316235763909798,0.00486280092267812,0.0172592428679422,0.000470799051920388
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40352,0.0211239663038567,0.00604658323531095,0.0092726631626472,0.0329752694450661,0.00047851323262873
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40352,0.0133719417029513,0.00385344551999335,0.00581918848376433,0.0209246949221382,0.000522180479146955
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAPK2,Death-associated protein kinase 2,40104,0.0192693036827893,0.0055559236626778,0.00837969330394082,0.0301589140616378,0.000525890830878118
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENO2,Gamma-enolase,42590,0.0228865356624119,0.00660587015327193,0.00993903016199891,0.0358340411628249,0.000532730823938198
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHISA5,Protein shisa-5,40428,0.00988218644140466,0.00285650007882143,0.00428344628691466,0.0154809265958947,0.000543100130189959
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEZ6,Seizure protein 6 homolog,40089,-0.0111488975526595,0.00322656327359513,-0.017472961568906,-0.00482483353641306,0.000551677802839778
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK13,Kallikrein-13,42264,0.0163875011345086,0.00474336810741968,0.00709049964396603,0.0256845026250512,0.000552400061288044
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",40125,0.0307197508292789,0.00889215358324656,0.0132911298061157,0.0481483718524422,0.00055298962885357
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLL1,Delta-like protein 1,42561,-0.0111528451170509,0.00323379985363042,-0.0174910928301665,-0.00481459740393526,0.000564744445801047
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XRCC4,DNA repair protein XRCC4,42191,0.0130549453511875,0.0037971386492061,0.00561255359874355,0.0204973371036315,0.00058764570273724
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP4,Guanylate-binding protein 4,42191,0.0174927924622653,0.0050916013241845,0.00751325386686369,0.027472331057667,0.00059305395513007
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,42229,0.0170551200896314,0.00496428190610808,0.00732512755365957,0.0267851126256032,0.000593159405150254
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40125,-0.0139960590012188,0.00407880633118621,-0.0219905194103438,-0.00600159859209385,0.000602673049840689
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40019,-0.0138148258116046,0.00402614702363734,-0.0217060739779338,-0.00592357764527544,0.000602991209000764
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP13,Collagenase 3,42191,-0.0117741382073406,0.00343425939405502,-0.0185052866196884,-0.00504298979499274,0.000608952729337302
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42590,0.0179565438124385,0.00524608401583071,0.00767421914141027,0.0282388684834667,0.000621542495987893
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,40104,-0.0152681867662801,0.00447305918305423,-0.0240353827650663,-0.00650099076749377,0.000643990461321486
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACE,Angiotensin-converting enzyme,40432,0.00943320680844797,0.00276399583752923,0.00401577496689067,0.0148506386500053,0.000645052073022027
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40385,0.02479519445896,0.00726569328333396,0.0105544356236255,0.0390359532942946,0.000645647373925765
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42599,-0.0211156646874621,0.00619581066063393,-0.0332594535823046,-0.00897187579261962,0.000656200869344174
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LXN,Latexin,42344,-0.0236928059392631,0.00695223430620152,-0.0373191851794181,-0.0100664266991082,0.000656512099537068
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP9,Caspase-9,40104,0.0218378596398859,0.00641229969636049,0.00926975223501934,0.0344059670447525,0.000662518282304308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40125,0.0169738193232288,0.00498657490012907,0.00720013251897582,0.0267475061274818,0.000666687984765765
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40231,0.019493107769303,0.00572902349232953,0.00826422172433706,0.0307219938142688,0.000670049700749134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42466,0.0190431032295916,0.00560901624990882,0.00804943137977028,0.0300367750794129,0.000688074999096171
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F3,Tissue factor,42515,-0.00949502934581282,0.00279843761300083,-0.0149799670672944,-0.0040100916243312,0.000693391790842793
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA12,Serpin A12,42137,0.0359195068730007,0.0106019583195184,0.0151396685667446,0.0566993451792568,0.000706123206700219
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP3,Stromelysin-1,42490,-0.0175438820463859,0.00517899869338542,-0.0276947194854213,-0.00739304460735046,0.000707360151099644
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A12,Protein S100-A12,42315,0.0261318497299048,0.0077280037037622,0.0109849624705309,0.0412787369892787,0.000723150741985759
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40019,0.0136261709722553,0.0040308670692703,0.00572567151648554,0.0215266704280251,0.000726212778591665
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLU,Clusterin,40440,-0.010896811862056,0.00322901856917274,-0.0172256882576346,-0.00456793546647745,0.000741590901526515
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX2,Sorting nexin-2,40352,0.0284598619771853,0.00843629122294009,0.0119247311802228,0.0449949927741479,0.000744705066641493
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROBO2,Roundabout homolog 2,42590,-0.00811065317907573,0.00240590521155689,-0.0128262273937272,-0.00339507896442423,0.000750682541596246
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42229,0.0161308626174844,0.00478579194482262,0.00675071040563208,0.0255110148293367,0.000752296865886662
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40125,0.0182141983848015,0.00541270423016599,0.00760529809367617,0.0288230986759268,0.000767839902395753
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLGN,Calmegin,40089,0.0159431551169206,0.00474779026490237,0.00663748619771198,0.0252488240361293,0.000787730353879331
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40352,0.00996366277715621,0.00296834366649596,0.00414570919082413,0.0157816163634883,0.00079159099916035
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FSHB,Follitropin subunit beta,40125,-0.0186317354302197,0.00556110854218321,-0.0295315081728988,-0.00773196268754058,0.000809787952367459
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX3,Syntaxin-3,40385,0.0133387798438352,0.00399090978056342,0.00551659667393086,0.0211609630137395,0.000833623709199247
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42237,-0.0108708675946247,0.00326103452582045,-0.0172624952652328,-0.00447923992401666,0.000859796609166423
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42475,0.0409035245530165,0.0122733035078452,0.0168478496776398,0.0649591994283931,0.000862353799739709
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST5,Cystatin-D,42240,0.0194581430277603,0.0058549241852695,0.00798249162463204,0.0309337944308885,0.000891781840033368
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TST,Thiosulfate sulfurtransferase,42157,0.0254235113926757,0.00766478633085945,0.0104005301841912,0.0404464926011602,0.000912647767319411
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSTN2,Calsyntenin-2,42631,-0.0134794588875503,0.00407960831771008,-0.021475491190262,-0.00548342658483852,0.000955289366272067
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAPG,Macrophage-capping protein,42341,0.0198724881968186,0.00601574102214097,0.00808163579342229,0.0316633406002149,0.000957700899767567
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17C,Interleukin-17C,42256,0.0253124111368387,0.00767823667932782,0.0102630672453562,0.0403617550283212,0.000981085765078064
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB7,Integrin beta-7,42599,-0.0155503462980053,0.00472116673475029,-0.0248038330981158,-0.00629685949789471,0.000991163032484051
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40385,0.0354858208976754,0.0107820757871906,0.0143529523547818,0.056618689440569,0.00100074609216962
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,42172,0.0224400559541237,0.00682438752937071,0.00906425639655711,0.0358158555116903,0.00101092865730256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB37,Ras-related protein Rab-37,42256,0.0272371653489661,0.00829460037786879,0.0109797486083432,0.0434945820895889,0.00102715144187961
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,40019,0.0154355337068516,0.00471447801531279,0.00619515679683857,0.0246759106168647,0.00106342898449614
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPO,Myeloperoxidase,42490,0.0156277474464681,0.00477362282365541,0.00627144671210353,0.0249840481808327,0.00106393687233018
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42599,0.0117047958774897,0.00357659365747264,0.00469467230884336,0.0187149194461361,0.00106829047113267
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42485,0.0364380423661622,0.0111495679313731,0.014584889220671,0.0582911955116534,0.00108542207417354
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLGAP5,Disks large-associated protein 5,40384,-0.0171015651560636,0.00523351963403222,-0.0273592636387667,-0.00684386667336043,0.00108752607892742
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,42229,0.0119099436524846,0.00364564919796416,0.00476447122447487,0.0190554160804944,0.0010901611297084
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELENOP,Selenoprotein P,40440,-0.00770084501056337,0.00235717307059036,-0.0123209042289205,-0.00308078579220627,0.00109025900216388
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP10,Stromelysin-2,42486,-0.0196541275498153,0.00602332514824529,-0.0314598448403761,-0.00784841025925453,0.00110516639875434
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42475,0.0302684715623909,0.00927694720182695,0.0120856550468101,0.0484512880779718,0.00110610750693899
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42599,-0.0203685931134817,0.00625899528160099,-0.0326362238654196,-0.00810096236154375,0.00113957413272422
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,40089,0.0203564139762682,0.00626955156987863,0.00806809289930612,0.0326447350532304,0.00117034844738295
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39987,0.0187740748712883,0.00578233071252311,0.00744070667474304,0.0301074430678336,0.00117066369118285
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHNAK2,Protein AHNAK2,40125,0.0100488981424659,0.00309820430058711,0.00397641771331514,0.0161213785716166,0.00118442412990288
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KEL,Kell blood group glycoprotein,42191,0.0120822713361317,0.00373002102745848,0.00477143012231305,0.0193931125499503,0.00120168098157274
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40350,0.0169733724718323,0.00524666046196842,0.0066899179663742,0.0272568269772904,0.00121962493856226
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40206,0.0225177715436622,0.00696301819059821,0.00887025589008975,0.0361652871972347,0.00122468060641612
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CORO1A,Coronin-1A,42236,0.0295379896780348,0.00913577165745472,0.0116318772294235,0.047444102126646,0.00122706244686596
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5E,5'-nucleotidase,42561,0.018729646927606,0.00580197560737685,0.00735777473714734,0.0301015191180646,0.00124894226931985
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,42229,0.018040396578358,0.00559124626908044,0.00708155389096036,0.0289992392657557,0.00125604782720916
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEFTY2,Left-right determination factor 2,42568,0.0165284765394362,0.00512331734191104,0.00648677454929054,0.0265701785295818,0.00125779143011722
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,40042,0.0249830060139214,0.00775596376401633,0.00978131703644941,0.0401846949913934,0.00128060565817748
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOM3,Myomesin-3,40187,-0.0306679955557812,0.00952496015964546,-0.0493369174686863,-0.0119990736428761,0.00128674990264958
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40411,0.00936633488310821,0.00291075391585244,0.00366125720803742,0.015071412558179,0.00129527679124708
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MARCO,Macrophage receptor MARCO,42518,-0.00868051136282218,0.00269816830973895,-0.0139689212499105,-0.00339210147573383,0.00129763681412421
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,40187,0.0365104865879017,0.0113538216600701,0.0142569961341644,0.058763977041639,0.00130503038789481
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42554,0.0388255720422183,0.0120817410771441,0.0151453595310158,0.0625057845534208,0.00131405059011513
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42447,0.0142530493039681,0.00444453090773307,0.00554176872481125,0.0229643298831249,0.00134504502150327
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42673,-0.00906422298002154,0.00282971541540256,-0.0146104651942106,-0.00351798076583252,0.00136212386697391
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACTN2,Alpha-actinin-2,40019,-0.0196735337748232,0.00614292731430123,-0.0317136713108536,-0.0076333962387928,0.00136572011608413
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,42229,0.0238354855054841,0.00745980355125036,0.00921427054503341,0.0384567004659348,0.00140071923670671
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42673,-0.00899971906680453,0.00281702691856268,-0.0145210918271874,-0.00347834630642169,0.00140270360659075
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,42377,0.0114846670227459,0.00359525009493234,0.00443797683667848,0.0185313572088132,0.00140451503812431
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40352,0.015971424679114,0.00500609544851726,0.0061594776000202,0.0257833717582079,0.00142471383356713
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40384,0.0134813449012988,0.00422908867345698,0.00519233110132307,0.0217703587012744,0.00143770991524108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA6,Integrin alpha-6,42475,0.0166203936214096,0.00521423033932428,0.00640050215633401,0.0268402850864852,0.00143837691084889
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RELB,Transcription factor RelB,40104,0.0161930045621681,0.00508634090846331,0.00622377638157997,0.0261622327427562,0.00145851511874372
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42496,-0.00840662064111405,0.00264169393755731,-0.0135843407587264,-0.00322890052350172,0.00146454397553775
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42466,-0.00766009228783834,0.00241213162420804,-0.0123878702712861,-0.00293231430439058,0.00149841726659003
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42516,0.00842872872737472,0.00265508442389615,0.00322476325653826,0.0136326941982112,0.00150404572652671
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,40411,0.00929534518275419,0.00293518122873838,0.00354238997442697,0.0150483003910814,0.00154500555260651
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42256,0.0126437846582209,0.00399443179033864,0.00481469834915719,0.0204728709672846,0.00155250836475286
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB2,Integrin beta-2,42452,-0.00928409556779971,0.00293405354362378,-0.0150348405133023,-0.0035333506222971,0.00155831422721637
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGMN,Legumain,42554,0.0115647624361912,0.00366044832161326,0.00439028372582921,0.0187392411465532,0.00158455408326276
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40104,0.0130629785697582,0.00413723781797741,0.00495399244652248,0.0211719646929939,0.00159608005904292
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42590,0.0258556981669246,0.0081923165298155,0.00979875776848623,0.041912638565363,0.00160253003730069
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,40019,0.016705291624079,0.00529570244093685,0.00632571483984277,0.0270848684083152,0.0016121346897427
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40019,0.014832268671621,0.00471693145043053,0.00558708302877722,0.0240774543144649,0.00166835616462852
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDCP1,CUB domain-containing protein 1,42377,0.0175141486099452,0.00557459946563999,0.00658793365729078,0.0284403635625995,0.00168297533163895
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40440,-0.0050574774003356,0.00161123698911778,-0.00821550189900645,-0.00189945290166475,0.00170034239849287
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42599,0.0197408279669862,0.00629041731786403,0.00741161002397269,0.0320700459099997,0.00170335115864171
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42554,0.00811030076501575,0.00258595690166479,0.00304182523775275,0.0131787762922787,0.00171473469912562
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCT,Secretin,40089,0.0160916304797059,0.00513304679486601,0.00603085876176847,0.0261524021976432,0.00172364660931603
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSHB,Thyrotropin subunit beta,42518,-0.0255113092317083,0.00815602549395492,-0.04149711919986,-0.00952549926355666,0.00176433730257055
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39972,0.0282058800113227,0.0090383441941258,0.0104907253908362,0.0459210346318093,0.00180903781393309
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYGD,Gamma-crystallin D,40385,0.0311354414045997,0.00998071263721105,0.011573244635666,0.0506976381735334,0.00181580910874986
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42537,0.0296432491209206,0.00953303766256983,0.0109584953022838,0.0483280029395575,0.00187780941839037
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42377,-0.0220042609220037,0.00708741307939885,-0.0358955905576255,-0.008112931286382,0.00190878459930246
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40384,0.0315177395938066,0.0101580332186621,0.0116079944852289,0.0514274847023843,0.00192215342744507
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40019,-0.0153484062154678,0.00494750051626542,-0.025045507227348,-0.0056513052035876,0.00192546912124551
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP1,Caspase-1,42191,0.0220818103632162,0.00713041319299818,0.00810620050493973,0.0360574202214926,0.0019600618784548
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42490,0.0136782930003316,0.00442213706385297,0.00501090435517979,0.0223456816454835,0.00198460494505114
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42490,0.00765074977999004,0.00248465784679537,0.00278082040027112,0.012520679159709,0.00207982770719316
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40125,0.0106021792296241,0.0034533542364098,0.0038336049262609,0.0173707535329873,0.00214504401640244
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39987,0.0252582163439179,0.00822789659760496,0.00913153901261217,0.0413848936752236,0.00214714920697382
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALB1,Calbindin,42466,0.0143866471787152,0.00469152278528268,0.00519126251956116,0.0235820318378693,0.00217002084646297
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39987,0.00911111422367859,0.00298004772514586,0.0032702206823927,0.0149520077649645,0.00223833334371774
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JAM2,Junctional adhesion molecule B,42590,0.00891465830962133,0.00291785502947062,0.00319566245185892,0.0146336541673837,0.00225345507062071
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",40019,0.0195493646662211,0.00640104979132928,0.00700330707521574,0.0320954222572265,0.0022629491229673
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLNS1A,Methylosome subunit pICln,40089,0.0104745647419149,0.00343074508570304,0.00375030437393697,0.0171988251098929,0.00227002007065652
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40385,-0.0188431597916381,0.00617296673416415,-0.0309421745905998,-0.00674414499267631,0.00227454151157622
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40384,0.0119015266225428,0.00390172385427316,0.00425414786816736,0.0195489053769182,0.00229128576092853
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,40104,0.0121301745381736,0.00398043443101866,0.00432852305337706,0.0199318260229702,0.00231343971135215
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,40230,-0.0025547125294187,0.000839905554982968,-0.00420092741718532,-0.000908497641652084,0.00235824876292654
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42466,0.0214383191755548,0.00705044812762759,0.00761944084540468,0.0352571975057048,0.00236486714687876
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42490,-0.00740514783526491,0.00244052708341729,-0.0121885809187628,-0.00262171475176702,0.0024160726898454
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40089,-0.0197969285472023,0.00652647991309979,-0.0325888291768779,-0.00700502791752675,0.00242445226741834
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40042,-0.0200914307191449,0.00663856194262833,-0.0331030121266964,-0.00707984931159333,0.0024800493255191
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAA4,Serum amyloid A-4 protein,40440,0.00999977871747173,0.0033044609851269,0.003523035186623,0.0164765222483205,0.00248253461279495
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTN,Pleiotrophin,42237,0.0153477256488782,0.00508117987866052,0.00538861308670354,0.0253068382110528,0.00252842786619598
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD46,Membrane cofactor protein,42459,0.00895406520861048,0.00297057394939157,0.003131740267803,0.014776390149418,0.00258098589873827
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,42356,-0.00888725787645573,0.00295125777106452,-0.0146717231077422,-0.00310279264516927,0.00260585992573029
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F13B,Coagulation factor XIII B chain,40380,0.00797481241221611,0.00265429484414827,0.0027723945176855,0.0131772303067467,0.0026661231748308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PER3,Period circadian protein homolog 3,40104,0.037982407063428,0.0126486583484026,0.0131910367005588,0.0627737774262971,0.00268043665856398
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VIM,Vimentin,42237,0.0356685871337173,0.0119227068328751,0.0123000817412822,0.0590370925261524,0.00277991350344984
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40385,0.00869587741250267,0.00290705256096021,0.00299805439302066,0.0143937004319847,0.00278394089585032
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42455,-0.0105102789943154,0.00351483312530193,-0.0173993519199072,-0.00362120606872361,0.00279248126618786
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,42202,-0.00890314659009029,0.00298169130131319,-0.0147472615406641,-0.00305903163951644,0.0028323588845654
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC4A1,Band 3 anion transport protein,40428,0.014333621940957,0.00481474238718383,0.00489672686207671,0.0237705170198373,0.00291678281929831
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42307,-0.0526542523426064,0.0176885248213908,-0.0873237609925324,-0.0179847436926805,0.00291856882298211
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40329,0.0210521199381731,0.00707490630291099,0.00718530358446756,0.0349189362918787,0.00293040127233141
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42631,0.0220909230241625,0.00742709617186582,0.0075338145273055,0.0366480315210195,0.00294113665123714
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40187,0.0190328488974434,0.00640405986524345,0.00648089156156622,0.0315848062333206,0.00296510046977254
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42475,-0.014639797829979,0.00492681178852282,-0.0242963489354837,-0.00498324672447424,0.00296923577189397
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPB2,Carboxypeptidase B2,40417,0.00675111457215387,0.00227416713827889,0.00229374698112724,0.0112084821631805,0.00299782312727861
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42475,0.036358860332348,0.0122576664782524,0.0123338340349733,0.0603838866297226,0.00302027359425667
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42623,0.0159910787784669,0.00539468922916038,0.00541748788931257,0.0265646696676213,0.00303978039411354
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40206,0.0275787776069431,0.00933331932894572,0.00928547172220946,0.0458720834916767,0.00313459514283353
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENG,Endoglin,42673,-0.00527913125079194,0.00178679500818509,-0.00878124946683472,-0.00177701303474915,0.00313691690376356
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42341,0.00899723011018535,0.00305512931127313,0.00300917666009002,0.0149852835602807,0.00323563346589367
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42498,0.0177141462648623,0.00602085417485601,0.00591327208214448,0.0295150204475801,0.0032652341989884
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40089,0.0117141503302044,0.00398209112002876,0.00390925173494804,0.0195190489254608,0.00327094450533938
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD72,B-cell differentiation antigen CD72,40187,0.0133702388427774,0.00455036982627387,0.00445151398328057,0.0222889637022741,0.0033072961342379
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42568,0.00954682557084225,0.00325533760667601,0.00316636386175727,0.0159272872799272,0.00336632546921165
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42475,-0.0173988429940557,0.00593601552970824,-0.0290334334322838,-0.00576425255582752,0.00338378587936702
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42191,0.0115300534365717,0.00393569496121215,0.00381609131259585,0.0192440155605475,0.00339977052188079
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42631,-0.0109788128983576,0.00375088875474269,-0.0183305548576532,-0.00362707093906191,0.0034283377977462
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40350,0.0350240486341014,0.0119883952465255,0.0115267939509114,0.0585213033172915,0.0034905322562077
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TJP3,Tight junction protein ZO-3,40042,-0.0126538755098556,0.0043329595785338,-0.0211464762837818,-0.00416127473592933,0.00350328057406826
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOE,Apolipoprotein E,40440,-0.0217114845299513,0.00745115177356008,-0.0363157420061291,-0.00710722705377357,0.00357713043401003
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX2,Peroxiredoxin-2,40235,0.0186739002467106,0.00642201138442743,0.00608675793323285,0.0312610425601884,0.00364710389555407
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42657,0.0071075788680612,0.00245087548911973,0.00230386290938652,0.0119112948267359,0.00373746761009255
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42237,0.0274281593362659,0.00947010607631683,0.00886675142668489,0.0459895672458469,0.00378232536799613
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40384,0.0370722160610058,0.0128705633028104,0.0118459119874974,0.0622985201345141,0.00397940167512503
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JCHAIN,Immunoglobulin J chain,42256,-0.0185071924153241,0.00643047576263922,-0.031110924910097,-0.00590345992055128,0.00400798178448362
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLMP,CXADR-like membrane protein,42599,0.0064882025999867,0.0022544594735413,0.00206946203184575,0.0109069431681276,0.00400911706283035
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42631,-0.00754677940590838,0.00262517566774554,-0.0126921237146896,-0.00240143509712713,0.00404955106363552
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA5,Annexin A5,42142,0.00904672167767012,0.00316491967254501,0.0028434791194819,0.0152499642358583,0.00426413833197271
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40019,-0.00609718021576724,0.00214370239239978,-0.0102988369048708,-0.00189552352666367,0.00446025261520749
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,42012,0.00982504876968496,0.00346391418716156,0.00303577696284831,0.0166143205765216,0.00456966772553343
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40350,-0.0163300676524526,0.00576318856096077,-0.0276259172319357,-0.00503421807296948,0.0046122106874638
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42518,-0.0136912609893826,0.00483272213873687,-0.0231633963813069,-0.00421912559745835,0.00461778682047202
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40411,0.00824674304027161,0.00291229773458609,0.00253863948048288,0.0139548466000603,0.00463842344698934
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40042,-0.0228173418266129,0.00805900234184917,-0.0386129864166373,-0.00702169723658852,0.00464465396997366
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40019,-0.0141024532569686,0.00498202305871245,-0.023867218452045,-0.00433768806189218,0.00465365061170864
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42485,0.0277324767897605,0.00980034229814818,0.00852380588539006,0.0469411476941309,0.00466548390799418
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTP1,Glutathione S-transferase P,42117,-0.0204604475398808,0.00724302984413186,-0.0346567860343793,-0.00626410904538237,0.00473757402264708
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLTA,Clathrin light chain A,42237,0.0137844103213031,0.0048808676033558,0.00421790981872578,0.0233509108238805,0.00474748093802403
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42229,0.0144042419916244,0.00510335372127151,0.00440166869793229,0.0244068152853166,0.00477222183167919
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNF,Tumor necrosis factor,42220,0.0111465362392096,0.0039578204421327,0.00338920817262949,0.0189038643057897,0.00486484740173291
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH17,Protocadherin-17,42518,0.0107772461808155,0.00382826659973634,0.00327384364533228,0.0182806487162987,0.00488219965597274
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELOB,Elongin-B,40019,0.0116286846008307,0.0041360120669197,0.00352210094966809,0.0197352682519933,0.00493891191890441
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42357,-0.00990376028364979,0.00352304793097643,-0.0168089342283636,-0.00299858633893598,0.00494401586786298
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDHR1,Cadherin-related family member 1,42191,0.0123316625638942,0.00439946600421099,0.00370870919564064,0.0209546159321477,0.0050706111601948
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40350,0.0278573864664237,0.00994345315238444,0.00836821828775021,0.0473465546450972,0.00509405161019873
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42424,0.00813631269652226,0.00290517207428407,0.00244217543092549,0.013830449962119,0.00510769119019893
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40385,0.0155183344797501,0.00555238910964251,0.00463565182485078,0.0264010171346494,0.00520052488538372
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD276,CD276 antigen,42496,-0.0104749900859424,0.00375195752580132,-0.0178288268365129,-0.00312115333537178,0.00524786265107222
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42518,0.0167079546770206,0.00598836112429292,0.00497076687340647,0.0284451424806347,0.00527713066336095
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HLA_A,,40384,-0.0095008161262964,0.00341163086863431,-0.0161876126288196,-0.00281401962377315,0.0053645595585483
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40042,-0.017630581247792,0.00633416285438182,-0.0300455404423804,-0.00521562205320365,0.00538836246084982
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40104,0.00811528547888434,0.00291568401173276,0.00240054481588813,0.0138300261418805,0.0053898052176975
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40104,0.0105667363826373,0.00380164076033295,0.00311552049238473,0.0180179522728899,0.0054532499999799
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK1,Kallikrein-1,42391,-0.0370618932169905,0.0133399039590067,-0.0632081049766435,-0.0109156814573374,0.00547259133337905
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL34,Interleukin-34,42172,0.0104494456546409,0.00377083651339859,0.00305860608837964,0.0178402852209021,0.00559431146019472
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42490,-0.0179364206250707,0.00647355703534845,-0.0306245924143537,-0.00524824883578775,0.00560099919795897
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40089,-0.0103459851622477,0.00374010892864341,-0.0176765986623888,-0.00301537166210662,0.0056804830568868
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS1,Galectin-1,42518,0.00993441390166061,0.0036006412831957,0.00287715698659704,0.0169916708167242,0.0058045596872817
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40104,0.0069166000634454,0.00250689962683306,0.0020030767948526,0.0118301233320382,0.00580706384631111
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42554,0.00787939111245245,0.0028614780787207,0.00227089407815988,0.013487888146745,0.00590218400366954
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,40271,0.0184690658450898,0.00671934623111885,0.00529914723209691,0.0316389844580828,0.00599399364116738
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40384,-0.0115388480595584,0.00420515360882929,-0.0197809491328638,-0.00329674698625295,0.006079636698047
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42377,0.0112531207865109,0.00410146537211908,0.00321424865715747,0.0192919929158643,0.00608363117655805
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TYMP,Thymidine phosphorylase,42446,0.0183126265738875,0.00667836615709918,0.00522302890597312,0.0314022242418019,0.00611330630749542
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYBB1,Beta-crystallin B1,40411,0.0178823923833748,0.00653776040029478,0.00506838199879704,0.0306964027679526,0.00624313558363552
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,40428,0.015458376737223,0.00565186969685912,0.00438071213137911,0.0265360413430669,0.00624609069601776
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX18,Sorting nexin-18,40350,0.0123073111717323,0.00450409745992165,0.00347928015028589,0.0211353421931787,0.00629603602018404
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40206,0.0242659988696993,0.00889191294025227,0.00683784950680481,0.0416941482325937,0.0063628245619841
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41838,0.0122813180169624,0.00450088237840821,0.00345958855528226,0.0211030474786424,0.00636826784256991
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40411,0.0146914913962403,0.00538496664020899,0.00413695678143071,0.0252460260110499,0.00637720468036343
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40206,0.0123490544811066,0.00453824647893046,0.00345409138240293,0.0212440175798103,0.00651659168088258
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GZMH,Granzyme H,42237,0.0217192329856118,0.00799751263585611,0.00604410821933385,0.0373943577518898,0.00662132247435141
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAYN,Layilin,42358,0.010514323184436,0.0038757908780002,0.00291777306355561,0.0181108733053164,0.00668000495977742
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,42237,0.0141873951181282,0.00522980585864384,0.00393697563518626,0.0244378146010701,0.00668057485851879
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42490,-0.0111790127976804,0.00412210984806062,-0.0192583480998792,-0.00309967749548153,0.00669718797871532
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42256,0.0198608336660828,0.0073381596623748,0.00547804072782824,0.0342436266043374,0.00680820039845844
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLNK,B-cell linker protein,40104,0.0113207147575998,0.00418792174317925,0.00311238814096851,0.0195290413742312,0.0068785490573759
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GKN1,Gastrokine-1,41903,0.00780859822076556,0.00289023528740326,0.00214373705745517,0.013473459384076,0.00690739494505187
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40428,0.011344958926333,0.00420293819055948,0.00310720007283639,0.0195827177798295,0.00695910767793216
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42237,-0.00985369929853646,0.00365083511462951,-0.0170093361232103,-0.00269806247386263,0.0069632308491215
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40350,0.0261631601148648,0.0097071036576664,0.00713723694583863,0.0451890832838909,0.00704393112911712
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RP2,Protein XRP2,42466,0.0116225890114824,0.00431386926756115,0.00316740524706253,0.0200777727759022,0.00706385919636082
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL7,Interleukin-7,42475,0.0174996296767106,0.00650664570551545,0.00474660409390034,0.0302526552595209,0.00716483410706144
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42180,0.0155813227591841,0.00580659676105317,0.00420039310751993,0.0269622524108484,0.00729738398785338
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42500,0.0205524195617726,0.00766953359621298,0.00552013371319512,0.03558470541035,0.00737682183560871
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42172,0.011872965673503,0.00443271178457528,0.00318485057573549,0.0205610807712706,0.00740485299220566
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42466,0.0145191346908497,0.00542863447118735,0.00387901112732248,0.0251592582543769,0.00749221182512459
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40385,-0.0112786425436207,0.00422005252479851,-0.0195499454922258,-0.00300733959501562,0.0075368111541106
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH4,Cadherin-4,40042,-0.0136998626083827,0.00512820956083465,-0.0237511533476186,-0.00364857186914677,0.00756323783747191
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42623,0.0110612974449405,0.00414633990166439,0.00293447123767828,0.0191881236522027,0.0076458222218509
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBQLN3,Ubiquilin-3,40019,0.0149510733981124,0.00560857472204235,0.00395826694290942,0.0259438798533154,0.00769302284759317
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40350,-0.0096831920026146,0.00364055028246579,-0.0168186705562475,-0.00254771344898165,0.00782952205144403
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42256,0.0104644871917379,0.00394764761721476,0.002727097861997,0.0182018765214788,0.00803944288839053
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40350,0.0135774427406128,0.00513249766059748,0.00351774732584172,0.0236371381553838,0.00817119123080521
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMOX1,Heme oxygenase 1,42384,-0.0130726540116587,0.00495669622539355,-0.0227877786134301,-0.00335752940988735,0.00836490318756398
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDM1,Nuclear protein MDM1,40089,0.00842965386232612,0.00320595699915617,0.00214597814398003,0.0147133295806722,0.00856628597041699
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40042,-0.00779529011064704,0.00298760392055811,-0.0136509937949409,-0.00193958642635315,0.00908757253253795
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGL1,Fibrinogen-like protein 1,40432,-0.0175280411512908,0.0067265812134501,-0.030712140329653,-0.00434394197292859,0.00917841891600244
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX5,Syntaxin-5,40104,0.0110000050906707,0.00422672669150491,0.00271562077532106,0.0192843894060203,0.00926752283749713
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PI3,Elafin,42329,0.015171283078797,0.00584650947021443,0.00371212451717668,0.0266304416404172,0.00947153367212541
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINI1,Neuroserpin,40171,-0.00805196647445351,0.00311110660663337,-0.0141497354234549,-0.00195419752545211,0.00966240830534033
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GM2A,Ganglioside GM2 activator,40175,-0.0108567591538537,0.0041972014921845,-0.0190832740785353,-0.00263024422917204,0.00970368282125312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,42237,-0.00931475072093768,0.00361134765476587,-0.0163929921242788,-0.00223650931759657,0.0099109095737229
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40019,0.0266726225925671,0.0103521459347775,0.00638241656040327,0.046962828624731,0.00999285648280948
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAL,Galanin peptides,42554,-0.0170384205237635,0.00661439139044619,-0.030002627649038,-0.00407421339848897,0.0100068073713335
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42466,0.0100233799451097,0.00389495295630886,0.00238927215074437,0.0176574877394751,0.0100804218379437
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42617,-0.00916684032262525,0.0035663354842393,-0.0161568578717343,-0.00217682277351623,0.0101693597648583
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN3,CCN family member 3,42659,0.00934804652501879,0.00363808424233113,0.00221740141004979,0.0164786916399878,0.0101952906875324
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40352,0.013739167917376,0.00535140182744174,0.00325042033559022,0.0242279154991619,0.0102594596828972
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD109,CD109 antigen,42490,-0.00884824473479523,0.00345534979875711,-0.0156207303403592,-0.0020757591292313,0.0104559576022948
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,40125,-0.010528922796559,0.00411286408371523,-0.0185901364006408,-0.00246770919247712,0.0104806080038071
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTX2,Neuronal pentraxin-2,40428,-0.00862874149917585,0.0033708255351655,-0.0152355595481002,-0.00202192345025147,0.0104852949158482
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,42336,-0.00653955085012356,0.00255475560561201,-0.0115468718371231,-0.00153222986312401,0.0104856551646775
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FADD,FAS-associated death domain protein,42518,0.0197686873578541,0.00774491920615957,0.00458864571378136,0.0349487290019269,0.0107072121346329
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40352,0.011948782840687,0.0047046777208348,0.0027276145078508,0.0211699511735232,0.0111060988568864
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSL3,Insulin-like 3,40385,-0.0203969151533296,0.00803196067557238,-0.0361395580774515,-0.00465427222920776,0.0111155032753712
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTC,Probetacellulin,42229,0.0194838249276132,0.00767793657305365,0.00443506924442806,0.0345325806107984,0.0111718780005367
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42485,-0.00784855588282905,0.00309585747771086,-0.0139164365391423,-0.00178067522651577,0.0112503226579953
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B2M,Beta-2-microglobulin,40440,0.00812358458150602,0.00321354709543317,0.00182503227445701,0.014422136888555,0.0114876798383381
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,42466,0.0218185387313286,0.00866224677137505,0.00484053505943355,0.0387965424032237,0.0117869308933485
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39987,0.0169391187050096,0.00672628887800678,0.00375559250411631,0.0301226449059029,0.0118051051039966
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBM25,RNA-binding protein 25,39987,-0.0123165952629903,0.00489127336764371,-0.021903491063572,-0.00272969946240866,0.0118141526064197
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS53,Serine protease 53,40385,-0.0096349595389443,0.00383308612771612,-0.0171478083492679,-0.00212211072862071,0.0119635049675044
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42229,-0.00786762792827227,0.00314156019402483,-0.0140250859085609,-0.00171016994798361,0.0122790942596687
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42518,0.0161770177538777,0.00647576247559682,0.00348452330170798,0.0288695122060475,0.0124985126214602
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42475,0.0179830611277027,0.00720445009361259,0.00386233894422203,0.0321037833111834,0.0125685850290188
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLPS,Colipase,42469,-0.0186279155428032,0.00747191795394012,-0.0332728747325258,-0.00398295635308053,0.0126769456440973
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NLGN2,Neuroligin-2,40042,-0.012335191987225,0.00494981317007748,-0.0220368258005769,-0.00263355817387319,0.012715553843966
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPM1F,Protein phosphatase 1F,40411,0.0132891779468456,0.0053360010081399,0.0028306159708914,0.0237477399227998,0.012771596669242
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40019,0.0103316002214167,0.00416270448819872,0.00217269942454719,0.0184905010182862,0.013081826665251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40385,0.0119885733851346,0.00483046084658279,0.00252087012583229,0.0214562766444368,0.0130840753382747
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WNT9A,Protein Wnt-9a,42256,-0.0075592101271028,0.00304983476516113,-0.0135368862668186,-0.00158153398738698,0.01320378355972
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42518,-0.00445212894387483,0.0017970871535238,-0.00797441976478147,-0.000929838122968189,0.0132461341269502
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42172,0.0118906667389722,0.00482834966521571,0.00242710139514937,0.021354232082795,0.0138032916420504
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF19,Fibroblast growth factor 19,42554,0.0195718051568963,0.00795314809186544,0.00398363489684,0.0351599754169525,0.0138719231413874
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39987,-0.0106897635272916,0.0043460624955292,-0.0192080460185288,-0.00217148103605434,0.0139230819513435
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP5,Platelet glycoprotein V,40187,0.00910475484839143,0.00370171281037809,0.00184939774005037,0.0163601119567325,0.013924247033661
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40042,-0.00763700193419926,0.00311112779079903,-0.0137348124041653,-0.00153919146423317,0.0141143412473699
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACRBP,Acrosin-binding protein,40352,0.00984566978928833,0.0040290338218994,0.00194876349836552,0.0177425760802112,0.0145536940725913
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,42229,0.0119322105487245,0.00488793373704241,0.00235186042412135,0.0215125606733276,0.0146535260823783
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,42172,-0.0141587711626365,0.00580238523565967,-0.0255314462245294,-0.00278609610074351,0.0146938857723327
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,42229,0.00790089198574271,0.00323786263794578,0.00155468121536898,0.0142471027561164,0.0146941244494663
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42496,0.0744340549173137,0.0305214463132966,0.0146120201432523,0.134256089691375,0.0147513118760139
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BSG,Basigin,42623,0.00541972312238831,0.0022267657767134,0.00105526220003003,0.00978418404474658,0.0149501081271114
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42490,0.00956834757942587,0.00393940993523078,0.00184710410637353,0.0172895910524782,0.015158776684997
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40042,-0.0104536992235926,0.00431631039671791,-0.0189136676011597,-0.00199373084602547,0.0154556154371681
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA2,Integrin alpha-2,40187,0.00867874139170314,0.00358699921468552,0.00164822293091951,0.0157092598524868,0.0155580178861514
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42229,0.00743389134574883,0.0030773557262588,0.00140227412228158,0.0134655085692161,0.0157197334310458
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD1,Programmed cell death protein 1,42567,-0.0111920286175081,0.00463823076614608,-0.0202829609191544,-0.00210109631586177,0.015835389446582
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39987,0.0152279947318763,0.00631640825852839,0.00284783454516068,0.027608154918592,0.0159314290400578
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBX2,Chromobox protein homolog 2,40019,-0.00995125188719048,0.0041450491445627,-0.0180755482105334,-0.00182695556384757,0.0163780077054417
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40440,-0.00486473102195057,0.00202683687223838,-0.0088373312915378,-0.000892130752363347,0.0164040991284244
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRP15,RRP15-like protein,40042,-0.0226669343211103,0.00944570225946081,-0.0411805107496535,-0.00415335789256709,0.0164248769204997
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABO,Histo-blood group ABO system transferase,40432,-0.0357955949976217,0.0149376837564145,-0.0650734551601941,-0.00651773483504937,0.0165764916607678
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHCY,Adenosylhomocysteinase,42518,0.0165213842372827,0.00689495223440478,0.00300727785784939,0.0300354906167161,0.0165817201320935
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,40030,0.0243179948571988,0.0101540283116847,0.00441609936629675,0.0442198903481009,0.0166412731186725
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,40019,-0.010833626321693,0.00452410283627586,-0.0197008678807937,-0.00196638476259228,0.016653302278325
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,42256,0.0138656426475713,0.00579261145799092,0.00251212418990906,0.0252191611052335,0.0166944384275711
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL20,Interleukin-20,42256,-0.0121026137982672,0.00506082306098937,-0.0220218269978064,-0.00218340059872805,0.0167968579953439
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,42256,0.0162642749160808,0.00680583911643989,0.00292483024785864,0.029603719584303,0.0168737955089312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERVV_1,,40019,-0.0107317450891712,0.00450130832247589,-0.0195543094012239,-0.00190918077711847,0.0171362552949938
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40206,0.0178967827323472,0.00750725877664359,0.00318255553012575,0.0326110099345686,0.0171456773878569
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSTN1,Calsyntenin-1,42191,-0.0130693736954659,0.00548480516792834,-0.0238195918246054,-0.00231915556632635,0.0171942804021175
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRTN,Neurturin,42256,0.0120448783178179,0.00505560851070995,0.0021358856368264,0.0219538709988094,0.0172107591450756
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN1,Tetraspanin-1,42237,0.0166693213625799,0.00700326697348512,0.00294291809454908,0.0303957246306108,0.0173165510008913
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWC2,Brorin,42338,0.0100500119024139,0.00422286134485937,0.00177320366648949,0.0183268201383382,0.0173312449049524
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD83,CD83 antigen,42475,0.00862530034682499,0.00362712919285683,0.0015161271288256,0.0157344735648244,0.0174210578263804
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LIF,Leukemia inhibitory factor,42191,0.0126081929240544,0.00530909628975349,0.00220236419613759,0.0230140216519713,0.0175715361931701
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42518,-0.0062391206691612,0.00262739170818863,-0.0113888084172109,-0.00108943292111149,0.0175799473793748
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST1,Cystatin-SN,38956,0.0268969898707501,0.0113314523826744,0.00468734320070818,0.049106636540792,0.0176321055986746
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX1,Peroxiredoxin-1,42144,-0.0218044892709037,0.0091914508688705,-0.0398197329738898,-0.0037892455679175,0.0176942859725145
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42237,0.0141806423154373,0.00597930914173286,0.00246119639764092,0.0259000882332337,0.0177247839712353
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40019,0.00958603567726316,0.00404193942729484,0.00166383439976527,0.017508236954761,0.0177266043111012
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN2,Contactin-2,42599,-0.0108614897565861,0.00458278740991284,-0.0198437530800153,-0.00187922643315693,0.0177991799075994
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40089,-0.00905275613153602,0.00382175062798612,-0.0165433873623888,-0.00156212490068322,0.017865853284835
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42191,-0.0137359140876412,0.00580739595373934,-0.0251184101569703,-0.00235341801831213,0.0180327476732606
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,40352,-0.010139443152789,0.00431451784775567,-0.0185958981343901,-0.00168298817118789,0.0187869203224806
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTNNA1,Catenin alpha-1,40042,-0.00847665908558587,0.00362412380479911,-0.0155799417429921,-0.00137337642817961,0.0193558671516191
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,40440,0.00443337751201177,0.00189622903348229,0.000716768606386473,0.00814998641763706,0.0194048480558341
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42554,0.0067198106017202,0.00287623726781866,0.00108238555679563,0.0123572356466448,0.0194892773060841
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42466,-0.00813661993588075,0.00348510263124353,-0.0149674210931181,-0.00130581877864342,0.0195746685770946
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA13,Carbonic anhydrase 13,42367,0.0246138184067417,0.0105544779730029,0.00392704157965596,0.0453005952338275,0.0197118150351962
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42490,-0.0141166438148019,0.00605946042751032,-0.0259931862527221,-0.00224010137688167,0.0198376141749725
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDC1,Syndecan-1,42518,-0.00972196055442269,0.00418288587532822,-0.017920416870066,-0.00152350423877937,0.0201284899183625
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB116,Beta-defensin 116,40042,-0.0183671837484792,0.00793179914863467,-0.0339135100798031,-0.00282085741715522,0.0205965415209888
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40352,0.00974714245832348,0.00422178446528749,0.00147244490636,0.018021840010287,0.0209743583077233
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,42237,0.0131256674966077,0.00569515786445091,0.00196315808228391,0.0242881769109315,0.0211986429149642
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40384,0.00697386581987084,0.0030321546108849,0.00103084278253644,0.0129168888572052,0.0214682119866704
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40350,-0.0109840939379411,0.00478343144362705,-0.0203596195674501,-0.00160856830843208,0.0216783718530679
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42532,-0.00502923783271032,0.00219135153033422,-0.0093242868321654,-0.000734188833255239,0.0217463239018757
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDSN,Corneodesmosin,42588,-0.010481577760374,0.00456860360285758,-0.0194360408219748,-0.00152711469877312,0.0217908014127482
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINC1,Antithrombin-III,40417,0.00345279428804419,0.00150633429860045,0.000500379062787304,0.00640520951330108,0.0219134911038769
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42561,-0.0189090449989795,0.00825118521537011,-0.0350813680211049,-0.00273672197685409,0.0219398085504653
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL31,Interleukin-31,40104,-0.0132898790394132,0.00580637701995503,-0.024670377998525,-0.0019093800803013,0.022107560894604
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSL4,Early placenta insulin-like peptide,40352,0.0114113560973065,0.00498965149267941,0.00163163917165484,0.0211910730229581,0.0222141890295966
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42554,-0.00995354891791025,0.00435818018430993,-0.0184955820791577,-0.00141151575666279,0.0223943601909923
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOM2,Myomesin-2,40019,-0.0118722168128429,0.00520131240884331,-0.0220667891341758,-0.00167764449151,0.0224766346978586
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENSA,Alpha-endosulfine,40352,0.0124378128741692,0.00544958984787272,0.00175661677233864,0.0231190089759997,0.0224880516968656
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42461,0.00633899304106847,0.00277774656562834,0.000894609772436925,0.0117833763097,0.0225013729821632
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,40432,-0.00619947056875477,0.00271679698326103,-0.0115243926559464,-0.000874548481563162,0.0225136032530099
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42496,0.00687060918073642,0.00301106356377045,0.000968924595746335,0.0127722937657265,0.0225175736352228
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCN1,Transcobalamin-1,40239,-0.008021956143047,0.00352069444483926,-0.014922517254932,-0.00112139503116204,0.0227148996216547
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42397,-0.00976136996202292,0.00428604142684876,-0.0181620111586465,-0.00136072876539935,0.0227735454888612
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL11,Interleukin-11,42256,-0.0146420701184154,0.00643771197229467,-0.027259985584113,-0.00202415465271789,0.0229568025922835
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,40019,-0.0167319082007145,0.00738123199683876,-0.0311991229145185,-0.00226469348691057,0.0234209989186288
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB2A2,Mammaglobin-A,40019,-0.00739130065727274,0.00326240398049738,-0.0137856124590476,-0.000996988855497881,0.0234955865775103
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA4,Annexin A4,42467,0.016581305483818,0.00732829044437286,0.00221785621284714,0.0309447547547888,0.0236737930718863
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42553,0.0166395983660136,0.00737285387309499,0.00218880477474744,0.0310903919572798,0.0240320690834771
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RILPL2,RILP-like protein 2,40411,0.0223298362462963,0.00991291976479155,0.00290051350730489,0.0417591589852878,0.0243036720919355
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40104,0.00820999820016232,0.00364493554713712,0.00106592452777356,0.0153540718725511,0.0243142803095696
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRTAP,Cartilage-associated protein,40089,0.0110286019874496,0.00493291301654275,0.00136009247502586,0.0206971114998734,0.0253904274604442
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42256,0.00851425803418174,0.00381102529525528,0.00104464845548139,0.0159838676128821,0.0254925464192282
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40042,-0.00778490611701117,0.00349678648776783,-0.0146386076330361,-0.000931204600986237,0.0260143536313563
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD2,T-cell surface antigen CD2,40019,0.00884055672816957,0.00397800691591567,0.00104366317297487,0.0166374502833643,0.0262796854876891
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HCG22,Protein PBMUCL2,40019,-0.0130697918749804,0.00588448594120623,-0.0246033843197446,-0.00153619943021617,0.0263675617116976
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA9,Carbonic anhydrase 9,42599,0.0110192291890959,0.00498051760372546,0.001257414685794,0.0207810436923978,0.0269512276675151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42229,-0.0118517407332781,0.00536532885210658,-0.022367785283407,-0.00133569618314918,0.0271954792011632
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR15L,Protein GPR15L,40350,0.0137583995235102,0.00624892760060166,0.00151050142633091,0.0260062976206894,0.027705367172231
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THBS4,Thrombospondin-4,42531,-0.010323233878216,0.00469735687027075,-0.0195300533439467,-0.00111641441248531,0.0279898557941572
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GZMB,Granzyme B,42475,0.0149159698094121,0.00682623403920688,0.00153655109256661,0.0282953885262576,0.0288992955789267
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,42191,-0.00909793808270598,0.0041637583754628,-0.0172589044986131,-0.000936971666798883,0.0289044221177359
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD7,T-cell antigen CD7,40071,0.010011242440057,0.00459028550715875,0.00101428284602586,0.0190082020340882,0.0292075071718413
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40042,-0.0132800973715317,0.00609268326574523,-0.0252217565723924,-0.00133843817067105,0.0293026512324906
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF7,Fibroblast growth factor 7,39987,-0.0177704361535471,0.00815600996195196,-0.0337562156789729,-0.00178465662812125,0.029366978467521
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCRN1,Secernin-1,42475,0.0122552595426702,0.00567665320943479,0.00112901925217805,0.0233814998331624,0.0308766955899963
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42475,-0.00923213742388785,0.00427836390738201,-0.0176177306823566,-0.000846544165419108,0.0309560958254113
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42518,-0.00639980207646005,0.00296757484657937,-0.0122162487757556,-0.000583355377164483,0.031056513413772
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40428,0.0139811863004481,0.00649022553528462,0.00126034425129021,0.0267020283496059,0.031246384441335
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALCAM,CD166 antigen,42673,-0.00433907378846131,0.00201629968760593,-0.00829102117616894,-0.000387126400753684,0.0314151803781143
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMS1,PMS1 protein homolog 1,40089,0.0115133741809646,0.00535092706343199,0.00102555713663789,0.0220011912252913,0.0314460748346553
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42466,0.00851256429024861,0.00396397491993563,0.000743173447174762,0.0162819551333225,0.0317729930395708
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,40219,0.00296867794078256,0.00138245331763591,0.000259069438216178,0.00567828644334894,0.031783319723448
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42377,-0.00638496322383124,0.00297512944095237,-0.0122162169280979,-0.00055370951956459,0.031882183382463
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL24,C-C motif chemokine 24,42532,-0.0182320845044602,0.00850055606408751,-0.0348931743900718,-0.0015709946188487,0.0319859857913059
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDI2,Protein DDI1 homolog 2,40187,0.0172587682691852,0.00805852830733354,0.00146405278681147,0.0330534837515589,0.0322413606503673
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,40125,0.00967887125640842,0.00452271309848316,0.00081435358338142,0.0185433889294354,0.0323720977143897
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42475,0.0179070402160827,0.00836873612865117,0.00150431740392646,0.034309763028239,0.0323927871321675
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42599,-0.00745586046400665,0.00348750707083122,-0.0142913743228358,-0.000620346605177464,0.0325447754864551
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RCC1,Regulator of chromosome condensation,40352,0.0113181083800122,0.00530850968602341,0.00091342939540633,0.0217227873646181,0.0330229601209182
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40359,0.00830617127862776,0.00389591815588007,0.00067017169310282,0.0159421708641527,0.0330270541343989
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMPA1,Inositol monophosphatase 1,42377,0.0131835141067092,0.00620263326708057,0.00102635290323131,0.0253406753101871,0.0335659120796106
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40352,0.00750838067776191,0.00353781233451858,0.000574268502105481,0.0144424928534183,0.0338325846959721
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,40104,0.00471590424963235,0.00222426897193734,0.000356337064635159,0.00907547143462954,0.0340113417714308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40042,-0.00707003469154189,0.00334380702070435,-0.0136238964521224,-0.000516172930961368,0.0345066986625434
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40206,-0.015214088946366,0.00720070925784175,-0.0293274790917358,-0.00110069880099613,0.0346352133319572
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,42256,0.00638779952667919,0.0030235578139272,0.000461626211381888,0.0123139728419765,0.0346473888217821
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRTG,Protogenin,42599,0.00538582390704753,0.00255076510543389,0.000386324300397112,0.010385323513698,0.03475174120395
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,40384,0.0127812348909798,0.00608400805016314,0.000856579112660034,0.0247058906692995,0.0356815512993122
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40125,0.00800510952661728,0.00381488597656095,0.000527933012557819,0.0154822860406767,0.0358938071575533
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42516,0.00776970450704982,0.00370315065974781,0.000511529213944113,0.0150278798001555,0.0359121380329365
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42478,0.0103822204554094,0.00495114218121071,0.000677981780236451,0.0200864591305824,0.0360182391978285
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40187,0.0189646712989743,0.0090448184021548,0.00123682723075088,0.0366925153671977,0.0360390100770518
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACRV1,Acrosomal protein SP-10,40104,0.0172608857624653,0.00825568193910221,0.00107974916182497,0.0334420223631056,0.0365700980708858
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL8,C-C motif chemokine 8,42584,0.0129589410109327,0.0062053684330974,0.000796418882061787,0.0251214631398036,0.0367857012857907
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGFLAM,Pikachurin,40350,0.00664047589673001,0.00318466129907657,0.000398539750539924,0.0128824120429201,0.0370789515795732
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42631,0.0140721102004299,0.00676503372327792,0.000812644102805208,0.0273315762980547,0.0375330500831765
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSLNL,Mesothelin-like protein,40089,-0.00841748742120492,0.00404754047590521,-0.0163506667539791,-0.000484308088430708,0.0375805223529376
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,42256,0.0119098543605022,0.00572985079502451,0.000679346802254116,0.0231403619187502,0.0376770318426953
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40411,0.00743791491714813,0.00357943091135803,0.000422230330886387,0.0144535995034099,0.0377357138539854
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40019,-0.0128500653002459,0.00618544433514371,-0.0249735361971276,-0.000726594403364228,0.0377818649794726
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOP1,DNA topoisomerase 1,40350,0.0239572802398471,0.0115380622609391,0.00134267820840634,0.0465718822712878,0.0378826335007431
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK11,Kallikrein-11,42426,0.00696920789056916,0.00336352991136547,0.000376689264292844,0.0135617265168455,0.0382854900478693
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42631,0.00581655335506943,0.00281194825683412,0.000305134771674555,0.0113279719384643,0.0386108323182592
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYT1,Synaptotagmin-1,40385,-0.00901162910485269,0.00435767040916803,-0.017552663106822,-0.00047059510288335,0.0386636656132446
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40019,-0.0108605928420309,0.00525731170628327,-0.0211649237863461,-0.000556261897715645,0.0388704200283802
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40089,0.0117053045624466,0.00566651114627603,0.000598942715745567,0.0228116664091476,0.0388805304846298
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,40019,-0.0101630585516964,0.00492704975217223,-0.019820076065954,-0.00050604103743882,0.0391643016485728
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JUN,Transcription factor AP-1,42256,0.0101240812290521,0.00492143717169638,0.000478064372527206,0.019770098085577,0.0396926496082912
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARFIP1,Arfaptin-1,40384,0.014402963004187,0.00700584724381106,0.00067150240631734,0.0281344236020567,0.0398202350043042
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40385,0.00800761156490622,0.00390063402929285,0.00036236886749223,0.0156528542623202,0.0401054764756268
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42490,0.00793888121898161,0.00387152000134726,0.000350702016340985,0.0155270604216222,0.0403269296771887
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,42317,0.007188508763628,0.00351322968890004,0.000302578573383922,0.0140744389538721,0.0407639142342881
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42234,0.0115125379801345,0.00563785321003303,0.000462345688469729,0.0225627302717992,0.041170873939565
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40428,-0.00585981650075836,0.00287202741461858,-0.0114889902334108,-0.000230642768105947,0.0413431321246571
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40019,-0.015106106007514,0.00740434315071702,-0.0296186185829194,-0.000593593432108633,0.0413577870905542
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42617,0.00888612420944379,0.0043708226488156,0.000319311817765218,0.0174529366011224,0.0420665712238785
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPS10,40S ribosomal protein S10,40019,-0.00851664938560403,0.00419119284276162,-0.0167313873574168,-0.000301911413791245,0.042174508649503
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OTOA,Otoancorin,40042,-0.0113629595192162,0.00560049510206089,-0.0223399299192555,-0.000385989119176811,0.0424907573729184
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40352,-0.0110002318008639,0.00542866676059287,-0.0216404186516259,-0.000360044950101855,0.0427554465724098
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41998,-0.0101514221847328,0.00502597202672666,-0.0200023273571171,-0.000300517012348572,0.0434256711336809
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40125,0.00830487635453215,0.00411527596214281,0.000238935468732248,0.0163708172403321,0.0436093297041378
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL22,Interleukin-22,40352,0.0145156450921213,0.00720380731207589,0.000396182760452553,0.02863510742379,0.0439289748610409
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40352,0.0109598530429649,0.00544412857081552,0.00028936104416648,0.0216303450417633,0.044122713235655
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40019,-0.00853920271779787,0.0042421848176028,-0.0168538849602994,-0.000224520475296379,0.0441471610942489
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42256,0.011969372217214,0.00595052249186899,0.000306348133150756,0.0236323963012772,0.0442950110974965
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40089,0.0157167392854481,0.00782718400611682,0.00037545863345915,0.0310580199374371,0.0446712742469166
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COPB2,Coatomer subunit beta',40019,0.00895157704035921,0.00446677723350835,0.000196693662682837,0.0177064604180356,0.0450912008272264
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBLN1,Cerebellin-1,40042,-0.0196069775914877,0.00978646051775615,-0.0387884402062898,-0.000425514976685672,0.0451506213312738
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFIC,Nuclear factor 1 C-type,40384,0.00977639334489262,0.00489171505681325,0.000188631833538653,0.0193641548562466,0.0456799702583843
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADA2,Adenosine deaminase 2,42451,-0.00910754969198488,0.00456664806679899,-0.0180581799029109,-0.00015691948105887,0.0461329444317103
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,40384,0.0156476078691877,0.00785235144365273,0.000256999039628327,0.031038216698747,0.0463153857902287
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNU13,NHP2-like protein 1,40019,0.0130212950526524,0.00653776687369248,0.000207271980215116,0.0258353181250896,0.0464286508792212
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40019,-0.00839112861666566,0.00421716181436824,-0.0166567657728274,-0.000125491460503901,0.0466427909666535
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNW1,Interferon omega-1,40019,-0.00745184370818414,0.0037463522273323,-0.0147946940737554,-0.00010899334261283,0.0467160457392341
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40432,0.0146916505393555,0.00739223515394931,0.000202869637614806,0.0291804314410961,0.0468974905176843
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40019,0.0091740620792083,0.00461929752957358,0.000120238921244084,0.0182278852371725,0.0470552069115912
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMY2B,Alpha-amylase 2B,41667,-0.0101757551948913,0.00514537057271219,-0.0202606815174072,-9.08288723753745e-05,0.0479898944028167
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,40019,0.00731268182973068,0.00369818758157529,6.42341698431142e-05,0.0145611294896182,0.0480252523330099
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42514,0.0132622087102705,0.00671471265870996,0.000101371899198949,0.026423045521342,0.0482777575949286
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UPK3A,Uroplakin-3a,40042,-0.0103815260502387,0.00526325253073449,-0.0206975010104783,-6.55510899990868e-05,0.0485831037748007
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,40104,0.00419204707707428,0.0021318347746632,1.36509187344128e-05,0.00837044323541416,0.0492773470986612
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EXOSC10,Exosome component 10,40019,-0.0122388117930955,0.0062291789259681,-0.024448002487993,-2.96210981980179e-05,0.0494681139023869
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42518,0.00586168021304371,0.00298714709607423,6.87190473821261e-06,0.0117164885213492,0.049748291218424
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42444,-0.00527598090787437,0.00268935370873021,-0.0105471141769856,-4.84763876315054e-06,0.0498063829915616
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHC1,SHC-transforming protein 1,39987,-0.0238244992469319,0.0121665860044607,-0.0476710078156748,2.20093218109979e-05,0.0502333266369107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD82,CD82 antigen,40206,-0.00826823640943675,0.00422250365851813,-0.0165443435801323,7.87076125878181e-06,0.050239268343104
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NID1,Nidogen-1,42531,0.00769768188803894,0.0039371625377844,-1.91566860184905e-05,0.0154145204620964,0.0505880657681034
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42475,0.0174179250968341,0.00892253590247844,-7.02452720236953e-05,0.0349060954656918,0.0509440874156064
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40432,-0.00539536263782904,0.00276950424547466,-0.0108235909589594,3.2865683301294e-05,0.0514239106087595
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42498,0.0185423997749398,0.00954913769765118,-0.000173910112456484,0.0372587096623361,0.0521838678226952
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAM,Signal transducing adapter molecule 1,40352,0.00746754294708243,0.00384770748695447,-7.39637273483255e-05,0.0150090496215132,0.0523104607665436
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40350,0.0162109835289753,0.00835355614012059,-0.000161986505661071,0.0325839535636116,0.0523309205091369
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42229,0.00948046494493936,0.00488842157486134,-0.000100841341788862,0.0190617712316676,0.0524776807167577
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40104,0.00861749404819035,0.00445190685610684,-0.000108243389779055,0.0173432314861598,0.0529319666221752
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A11,Protein S100-A11,42414,0.00905001918562536,0.00468457451799633,-0.000131746869647445,0.0182317852408982,0.0533961010254911
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42377,0.0116205576688498,0.00601615766987534,-0.000171111364105889,0.0234122267018055,0.0534354878355095
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40384,-0.0088534892837034,0.00460074433470936,-0.0178709481797338,0.000163969612326953,0.0543347780361616
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40411,-0.00551506491665853,0.00286905019532681,-0.0111384032994991,0.000108273466182021,0.0545981521034303
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,40104,0.0112539121115132,0.00585709993444624,-0.000226003760001427,0.0227338279830278,0.0547055946864941
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THPO,Thrombopoietin,42237,0.0076733133314593,0.00400516761936242,-0.000176815202491039,0.0155234418654096,0.0554056170558584
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRC1,Macrophage mannose receptor 1,40432,-0.00575253025616393,0.00300357671192344,-0.0116395406115339,0.000134480099206017,0.0554889552530585
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39987,-0.00933566866415635,0.00489564563901649,-0.0189311341166287,0.000259796788315971,0.0565557761383659
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD27,CD27 antigen,42561,0.00866055818001233,0.0045498220391277,-0.000257093016677975,0.0175782093767026,0.0569975950522244
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFDN2,Prefoldin subunit 2,42191,0.0108594793184879,0.00571042764889124,-0.000332958873338904,0.0220519175103148,0.0572334136333755
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40104,0.0162386794051466,0.00854418516120184,-0.000507923510809062,0.0329852823211022,0.0573868779428495
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42237,-0.00598827712095572,0.00315967181468386,-0.0121812338777361,0.000204679635824653,0.0580851879775221
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40385,-0.00730811324364332,0.0038712678255797,-0.0148957981817795,0.000279571694492882,0.0590809490377221
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40089,0.0208240155119087,0.0110368476229863,-0.000808205829144447,0.0424562368529618,0.0592175584686239
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42341,-0.00803997656326804,0.00426924970222991,-0.0164077059796387,0.000327752853102596,0.0596913418966942
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CABP2,Calcium-binding protein 2,40089,0.0124917898711658,0.0066436119840146,-0.000529689617502799,0.0255132693598344,0.0600978315017327
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,40125,0.0182687258258873,0.00973045025832328,-0.000802956680426327,0.0373404083322009,0.0604789413722646
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH7,Protocadherin-7,40350,0.00699232401394818,0.00372756457139489,-0.000313702545985811,0.0142983505738822,0.0607030030656214
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROBO4,Roundabout homolog 4,40125,-0.00351086675130815,0.00187342394952834,-0.00718277769238369,0.000161044189767384,0.0609519088485476
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42237,-0.00597664717115621,0.00319387625420466,-0.0122366446293973,0.00028335028708491,0.0613281981872071
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRTN3,Myeloblastin,42161,-0.00935295677089857,0.00501166757851604,-0.01917582522479,0.000469911682992865,0.0620308466648265
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42377,0.00908765961918875,0.00487114005018847,-0.00045977487918066,0.0186350941175581,0.0621177978700023
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42490,-0.00637743719963929,0.00342612090219468,-0.0130926341679409,0.000337759768662273,0.0627074654561854
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NINJ1,Ninjurin-1,42229,-0.0102868758178082,0.00554089776966689,-0.0211470354463553,0.00057328381073893,0.0633997521243366
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40352,0.0105170574440202,0.00567141496484435,-0.000598915887074726,0.0216330307751151,0.0637086854889606
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40350,0.00409994702724923,0.00221293081589073,-0.000237397371896593,0.00843729142639506,0.0639485148747094
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VGF,Neurosecretory protein VGF,40384,0.00599966062398657,0.00323833076840296,-0.000347467682083233,0.0123467889300564,0.0639514512600106
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TUBB3,Tubulin beta-3 chain,40042,-0.00535177510669571,0.00289254357491373,-0.0110211605135266,0.000317610300135199,0.0643123518123587
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MN1,Transcriptional activator MN1,40089,-0.0112793802633445,0.00610035398364795,-0.0232360740712945,0.000677313544605464,0.0644890096175405
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN9,Septin-9,42466,0.00539733924940194,0.0029247220103425,-0.000335115890869361,0.0111297943896732,0.0649987883206931
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40019,-0.0209711194258326,0.0113675986705485,-0.0432516128201077,0.00130937396844251,0.0650917180396203
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,40089,-0.00958033046235723,0.00521115557636874,-0.01979419539204,0.000633534467325499,0.0660266761309417
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALLD,Palladin,40104,-0.00735911495265293,0.00401641471465969,-0.0152312877933859,0.000513057888080068,0.0669399760458719
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40042,-0.0146846016814718,0.0080260178989731,-0.030415596763459,0.00104639340051552,0.0673334878484082
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40089,0.00962474710464254,0.00527374618761549,-0.000711795423083826,0.0199612896323689,0.0680238093851806
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42554,-0.00543135195550154,0.00297951072597416,-0.0112711929784109,0.000408489067407817,0.0683407819927247
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS27,Serine protease 27,42485,0.0075383777047215,0.0041414195031854,-0.000578804521521885,0.0156555599309649,0.0687449341148491
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSG4,Desmoglein-4,42422,-0.00936787116415608,0.00515291918202942,-0.0194675927609337,0.00073185043262159,0.0690907727901655
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40042,-0.00959578685269171,0.0052938510949606,-0.0199717349988145,0.000780161293431059,0.0699167266096503
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGMA,Repulsive guidance molecule A,42590,-0.0059463597102666,0.00328813769964811,-0.0123911096015769,0.000498390181043696,0.0705623544261036
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASQ2,Calsequestrin-2,40019,-0.00913160483052238,0.0050638241726737,-0.0190567002089628,0.00079349054791808,0.0713685759739823
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42474,0.00537620759360624,0.0029994686112902,-0.000502750884522543,0.011255166071735,0.0730938003505944
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,40104,0.00581637092793295,0.00326181465095596,-0.000576785787940724,0.0122095276438066,0.074586382491326
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHGA,Chromogranin-A,40428,0.0179316292252462,0.0100691938630025,-0.00180399074623859,0.037667249196731,0.0749655093534473
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42444,-0.00552235964560562,0.00310488317245656,-0.0116079306636205,0.000563211372409242,0.0753275240855849
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40352,0.00611641532614542,0.00344856748560788,-0.000642776945646014,0.0128756075979369,0.0761548773526835
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42425,0.00511258667466928,0.00288431924123754,-0.000540679038156295,0.0107658523874949,0.0763270787602172
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42518,0.0089480896617835,0.00504820830766172,-0.00094639862123346,0.0188425779448005,0.0763298265508134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42661,0.0107924677643799,0.00609186038936639,-0.00114757859877824,0.022732514127538,0.0764801017513199
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39987,0.00669568883028411,0.00379137546733537,-0.000735407085693219,0.0141267847462614,0.0774188157258577
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DGCR6,Protein DGCR6,40042,0.00802045245877666,0.00455273720350854,-0.00090291246010008,0.0169438173776534,0.0781520485768347
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPC1,Glypican-1,42599,0.00541520863734539,0.00307534259175785,-0.000612462842499993,0.0114428801171908,0.0782870531454152
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40042,-0.0060134834219654,0.00342639535730469,-0.0127292183222826,0.000702251478351797,0.0792795679710668
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42191,-0.0111155664081444,0.006335000619084,-0.0235321676215491,0.00130103480526021,0.0793466034327864
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LHB,Lutropin subunit beta,42229,-0.0151793982784816,0.00865921181850282,-0.0321514534427471,0.00179265688578394,0.0796294783111757
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFD,Complement factor D,40440,-0.0037743328096791,0.00215372055995845,-0.00799562510719765,0.00044695948783946,0.0797201028208515
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYB5A,Cytochrome b5,39987,0.0131761260097288,0.00753340436769149,-0.00158934655094654,0.0279415985704041,0.0803148141575291
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39987,-0.009447667920698,0.00542682379419645,-0.020084242557323,0.00118890671592704,0.0817260386000126
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42191,0.0117441697266848,0.0067568898406917,-0.00149933436107096,0.0249876738144405,0.0822163700704001
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40089,0.00715434078067241,0.00411802881186437,-0.000916995690581759,0.0152256772519266,0.0823586641901212
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40206,-0.0132353213316625,0.00762301799444887,-0.0281764366007823,0.00170579393745726,0.0825509388231775
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERC2,ERC protein 2,40089,0.0135530467410459,0.00781163846909634,-0.00175776465838291,0.0288638581404747,0.0827723946268604
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSP90B1,Endoplasmin,42127,-0.0119000113418189,0.00688585861486349,-0.0253962942269513,0.00159627154331359,0.0839796140877116
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42599,0.00607285671396465,0.00351626402425843,-0.000819020773581867,0.0129647342015112,0.0841769742105615
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40089,-0.00669053136682075,0.00388128644739195,-0.014297852803709,0.000916790070067473,0.0847737292525125
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40191,-0.00891207300022475,0.00517595832014376,-0.0190569513077065,0.00123280530725701,0.0851300958043487
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40089,-0.00901510787515904,0.00524137168193226,-0.0192881963717463,0.0012579806214282,0.085462623148497
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCN,Decorin,42237,-0.00424881264178091,0.00247081544639609,-0.00909161091671725,0.000593985633155425,0.08552901800083
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41995,-0.00663700545056243,0.0038693565640636,-0.0142209443161271,0.000946933415002228,0.0863192631178202
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,42229,0.00763491069528801,0.0044520060706539,-0.00109102120319363,0.0163608425937696,0.0863805147178208
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40352,0.0115310595127552,0.00677852108758297,-0.00175484181890742,0.0248169608444178,0.0889488248050047
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP7,Retinoid-binding protein 7,40350,0.010441356277858,0.0061646933765668,-0.0016414427402129,0.0225241552959289,0.0903435863272978
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40385,0.00848244426060542,0.00500920430159582,-0.00133559617052238,0.0183004846917332,0.0904125893077185
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39987,0.0101256971698007,0.00598322154748501,-0.0016014170632699,0.0218528114028713,0.0906083721088066
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD99,CD99 antigen,42490,-0.00349912353016805,0.00207586664194521,-0.00756782214838066,0.000569575088044561,0.0918923675784503
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42191,0.00486140442603192,0.00289407490682418,-0.00081098239134348,0.0105337912434073,0.0930244792122332
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,40042,-0.00831841270273388,0.00496365581898102,-0.0180471781079367,0.00141035270246893,0.0937936284319375
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40411,0.00903348005198014,0.0053929377210639,-0.0015366778813051,0.0196036379852654,0.0939508511165509
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREML1,Trem-like transcript 1 protein,40432,0.00902168503447295,0.00538590738019061,-0.00153469343070065,0.0195780634996466,0.0939514836042181
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42490,-0.00597717002797063,0.00357328925039726,-0.0129808169587493,0.00102647690280799,0.0944027799819395
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,40104,0.00505713640149647,0.00303771638897482,-0.000896787720894187,0.0110110605238871,0.0959849158452925
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",42237,0.0144645352821265,0.00870217654133044,-0.00259173073888119,0.0315208013031341,0.096501836367031
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42466,0.00602629271846051,0.00362730725712504,-0.00108322950550457,0.0131358149424256,0.0966631506250413
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,40089,-0.0115285363717554,0.00694328624643945,-0.0251373774147767,0.00208030467126596,0.0968655694858318
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40019,0.00667356534355284,0.0040292566326696,-0.00122377765647957,0.0145709083435853,0.0976947060446678
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,42191,-0.00842939115230637,0.00509185089603553,-0.018409418908536,0.00155063660392326,0.0978539466811817
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEG1,Protein LEG1 homolog,39835,-0.0118965308987559,0.00718765569235849,-0.0259843360557785,0.00219127425826676,0.0979268772857968
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EP300,Histone acetyltransferase p300,40104,0.00526028994386032,0.00318760467595784,-0.000987415221017054,0.0115079951087377,0.0989241060990771
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40206,0.00918243862841066,0.00557307290415546,-0.00174078426373405,0.0201056615205554,0.0994543313674772
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP12,Macrophage metalloelastase,42471,0.00948846649856391,0.00576549409054298,-0.00181190191890034,0.0207888349160282,0.0998423183784048
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEX33,Testis-expressed protein 33,40206,-0.00646059088389786,0.00394005504417083,-0.0141830987704727,0.00126191700267697,0.101091759958756
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFDN4,Prefoldin subunit 4,39987,-0.00884802454744578,0.00539967208800086,-0.0194313818399275,0.00173533274503591,0.10132103662321
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42340,0.00582664380747019,0.00355590223108249,-0.00114292456545149,0.0127962121803919,0.101323898042423
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40385,0.0057100030060337,0.00348516376569858,-0.00112091797473551,0.0125409239868029,0.101371733183305
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,40019,0.00742986183621419,0.00454978162352247,-0.00148771014588985,0.0163474338183182,0.102494916044353
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KITLG,Kit ligand,42518,-0.00629167756055401,0.00385596422055534,-0.0138493674328425,0.00126601231173447,0.102771758211672
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42322,-0.0100025583854993,0.00614766812738162,-0.0220519879151673,0.00204687114416863,0.103750652354029
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40104,0.00501393812356032,0.00308429801439298,-0.00103128598464993,0.0110591622317706,0.104056531017317
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NLGN1,Neuroligin-1,40089,-0.0116591176399641,0.00718780584608289,-0.0257472170982866,0.00242898181835837,0.104817491752273
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40089,-0.0131379858857156,0.00811882643229918,-0.029050885693022,0.00277491392159078,0.105645770889941
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRN,Progranulin,42431,0.00407979534414539,0.00252283747207849,-0.000864966101128456,0.00902455678941923,0.105870698604111
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAG,S-arrestin,40042,-0.00870781038872622,0.0053847504121989,-0.0192619211966361,0.00184630041918361,0.105880542198353
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFRC,Transferrin receptor protein 1,42552,-0.006291800292032,0.00389622145613076,-0.0139283943460483,0.00134479376198429,0.106367518678498
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPL,Periplakin,40104,0.00547710690872975,0.00340557067566647,-0.00119781161557653,0.012152025433036,0.107803080264889
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40206,-0.00479912303551811,0.00298409568523563,-0.0106479505785799,0.00104970450754372,0.107812687610545
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40417,-0.00301072032197008,0.00187897567311629,-0.00669351264127802,0.000672071997337854,0.109113005075642
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK3,Prostate-specific antigen,40428,-0.0160758249359459,0.0100688103630148,-0.0358106932474548,0.00365904337556303,0.110383860759256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR1,Toll-like receptor 1,40104,0.00439246702816995,0.00275830904644411,-0.0010138187028605,0.0097987527592004,0.111312779604286
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42256,0.00534011761145144,0.00336561895817872,-0.00125649554657886,0.0119367307694817,0.112612217291479
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40104,0.0105001295212983,0.00662334146817406,-0.00248161975632283,0.0234818787989195,0.112922155381553
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40019,0.0136816910736848,0.00863621379686988,-0.00324528796818018,0.0306086701155498,0.113172125459625
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL5,Interleukin-5,42256,-0.0226411027364381,0.0143245794313714,-0.0507172784219261,0.00543507294904993,0.113998969844022
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40019,-0.00706936933469466,0.00447503114205763,-0.0158404303731276,0.00170169170373829,0.114196476351121
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40206,0.00930615345521088,0.00589806163501944,-0.00225404734942722,0.020866354259849,0.114632814233127
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL6,Interleukin-6,42466,0.012440280750361,0.007904549566019,-0.00305263639903627,0.0279331978997582,0.115554585617282
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,42191,-0.00576504088555418,0.00366631628767575,-0.0129510208093986,0.00142093903829028,0.115874244120229
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42475,0.00788212953127001,0.00501770639920446,-0.00195257501117072,0.0177168340737107,0.116238287120724
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40352,0.00644548959850992,0.00410379209596081,-0.00159794290957326,0.0144889221065931,0.116299768713396
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGLON5,IgLON family member 5,39987,-0.0153066075951885,0.00974773037271972,-0.0344121591257191,0.0037989439353422,0.11638069330951
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH9,Protocadherin-9,40350,0.00553892653797203,0.00353563369824642,-0.00139091551059096,0.012468768586535,0.117236396072425
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP8,Caspase-8,42553,0.00983090218275411,0.00629516929526222,-0.00250762963595984,0.022169434001468,0.118392239547743
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42590,0.00738244206729448,0.00473008988803153,-0.00188853411324732,0.0166534182478363,0.118608652920965
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39987,-0.0128952244160869,0.00826573976181967,-0.0290960743492534,0.00330562551707967,0.118770035701529
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABHD14B,Protein ABHD14B,42342,0.00910285316786396,0.00583625786608153,-0.00233621224965585,0.0205419185853838,0.118853167966393
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39987,0.00431324554638723,0.00276576149130714,-0.00110764697657475,0.00973413806934922,0.118903941028358
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTF3,Neurotrophin-3,42475,0.0057348407359924,0.0036828419367061,-0.00148352945995154,0.0129532109319364,0.119452038647797
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,40042,-0.00976035807777805,0.00627179114119304,-0.0220530687145164,0.00253235255896031,0.119682257564085
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,42256,0.0104886376279589,0.00676757207808987,-0.00277580364509728,0.023753078901015,0.121204728133274
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAT1,Diamine acetyltransferase 1,40019,-0.00818663405749715,0.00529848920386187,-0.0185716728970664,0.00219840478207212,0.122354121108586
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,40352,0.00959149748051568,0.00621067343875286,-0.00258142245943993,0.0217644174204713,0.122530211431397
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD48,CD48 antigen,42532,-0.00492325518480998,0.00318838544678999,-0.0111724906605184,0.00132598029089841,0.122582574700278
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40042,-0.0118097102781756,0.00764904645186832,-0.0268018413238375,0.0031824207674863,0.122630723602757
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,40089,-0.00678657067177458,0.00441521305945878,-0.0154403882683138,0.00186724692476463,0.124300819136092
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,40187,-0.00838380358792769,0.00545522896707938,-0.0190760523634033,0.00230844518754789,0.124361746878557
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40206,0.00828781196834745,0.00540083223785258,-0.00229781921784361,0.0188734431545385,0.12492473036844
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELAVL4,ELAV-like protein 4,40042,0.01338086983175,0.0087422416506433,-0.00375392380351084,0.0305156634670109,0.125897588632814
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42673,-0.00544050656495301,0.00355540406995885,-0.0124090985420724,0.00152808541216634,0.125988801213036
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECTIN4,Nectin-4,42561,-0.0054185571724859,0.00354636468731844,-0.01236943195963,0.00153231761465825,0.126556368445513
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40019,0.0096654527849131,0.00633230859265162,-0.00274587205668408,0.0220767776265103,0.126946688081365
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RLN1,Prorelaxin H1,40384,0.00749996374965872,0.00492947848897455,-0.0021618140887314,0.0171617415880488,0.128174762495093
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSC2,Desmocollin-2,42367,-0.00553115182781759,0.00364015858323686,-0.0126658626509618,0.00160355899532666,0.128665464929713
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,42191,-0.0104881400795716,0.00690919435415938,-0.024030161013724,0.00305388085458081,0.129039339570799
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL9,Interleukin-9,40206,-0.0087905593180811,0.00580620591675256,-0.0201707229149161,0.00258960427875392,0.130056130724732
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARG1,Arginase-1,42369,0.00804940958321973,0.0053187919355135,-0.00237542261038674,0.0184742417768262,0.130204464586301
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSV,Cathepsin L2,42556,-0.00650164166798594,0.00429932021913555,-0.0149283092974916,0.00192502596151974,0.13049424034101
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42191,0.0131293580961007,0.00868785270946824,-0.003898833214457,0.0301575494066585,0.130753749697096
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN7,Tetraspanin-7,40042,-0.0146459441740345,0.00970399623198204,-0.0336657767887193,0.00437388844065029,0.131259085335074
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRR5,Proline-rich protein 5,40104,0.00742679080099269,0.00492097877421793,-0.00221832759647446,0.0170719091984598,0.131274061453758
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42256,-0.00607648358487174,0.00403242489017728,-0.0139800363696192,0.00182706919987574,0.131859042824451
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEFL,Neurofilament light polypeptide,42142,-0.00717829615885342,0.00476594231669548,-0.0165195430995766,0.00216295078186973,0.132049181279595
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALM3,Paralemmin-3,40019,0.0110755681363668,0.00736424534245403,-0.00335835273484308,0.0255094890075767,0.13261952114047
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40352,0.00723959854230948,0.0048144779252125,-0.00219677819110703,0.016675975275726,0.132683288438922
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF20,Fibroblast growth factor 20,40104,-0.0069555045157576,0.00462650150017981,-0.01602344745611,0.00211243842459484,0.132763636890063
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42229,-0.00492431862519155,0.00327647820444911,-0.0113462159059118,0.0014975786555287,0.132881223687422
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,40089,0.00855318495591985,0.00569232510284077,-0.00260377224564806,0.0197101421574878,0.132975863246256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42475,-0.00551604606394562,0.00369072889302276,-0.0127498746942702,0.00171778256637898,0.135050926934527
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40125,-0.0117168773422428,0.00784351627880148,-0.0270901692486937,0.00365641456420806,0.135249007866707
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,42229,0.0113486793037748,0.00760041861733659,-0.00354814118620493,0.0262454997937545,0.135418196264459
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40089,-0.00707627889648354,0.00474445863149376,-0.0163754178142113,0.00222286002124424,0.135863710739107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRH,Corticoliberin,42206,0.0131536486908878,0.00882311772777395,-0.00413966205554918,0.0304469594373247,0.136033942402989
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42357,0.00407446720646178,0.002735091260234,-0.00128631166359686,0.00943524607652042,0.136326924886782
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40104,0.00951285745869255,0.00639179572122131,-0.00301506215490122,0.0220407770722863,0.136702846592089
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42518,0.00573732090670108,0.00385729829423338,-0.00182298374999634,0.0132976255633985,0.136934542374892
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STC2,Stanniocalcin-2,42470,0.00379899255220861,0.00255621478836791,-0.0012111884329925,0.00880917353740973,0.137255545867364
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRXN3,Neurexin-3,40089,0.00543985364139884,0.00366556132240348,-0.00174464655051198,0.0126243538333097,0.137826223101846
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40019,-0.0134763743099033,0.00908955032596263,-0.03129189294879,0.0043391443289835,0.138203773645616
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDNRB,Endothelin receptor type B,40104,0.00679320651698872,0.00458496196595458,-0.00219331893628226,0.0157797319702597,0.138468272461636
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42237,0.00422074968843679,0.00285322683975524,-0.00137157491748348,0.00981307429435706,0.139086997584346
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,40019,-0.00759528591762476,0.00513604572802839,-0.0176619355445604,0.00247136370931089,0.139217589809282
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL36A,Interleukin-36 alpha,40104,-0.00874859635046899,0.00593191102306167,-0.0203751419556699,0.00287794925473188,0.140285476243196
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB6,Integrin beta-6,42256,-0.0047203528371928,0.00321046922185629,-0.0110128725120311,0.00157216683764554,0.141504612731741
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRDT,Bromodomain testis-specific protein,40019,0.00563427509462317,0.00383496572567589,-0.00188225772770157,0.0131508079169479,0.141811608248723
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40384,-0.00675487998471176,0.00460325057391277,-0.0157772511095808,0.00226749114015726,0.142291239336456
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40042,-0.0110844273724047,0.00755793784458912,-0.0258979855477994,0.00372913080298998,0.142515481489335
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGN,Cingulin,40089,0.00622012756285156,0.00424183576644209,-0.00209387053937495,0.0145341256650781,0.14257465228843
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH12,Protocadherin-12,40384,0.00387661755782082,0.00265102981719026,-0.0013194008838721,0.00907263599951373,0.143685380711845
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42466,0.0109090085330209,0.00746821884457202,-0.00372870040234027,0.0255467174683821,0.144114797265559
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42617,0.00466940926244535,0.0031989074748517,-0.00160044938826398,0.0109392679131547,0.144399036231619
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42561,-0.00564125425382558,0.00386838589431299,-0.013223290606679,0.00194078209902788,0.144782283394613
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42599,0.00591330970218063,0.00407304905934509,-0.00206986645413574,0.013896485858497,0.14657672924186
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK8,Kallikrein-8,42041,0.00557333789335002,0.00383940336268374,-0.00195189269751011,0.0130985684842101,0.146632931612001
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39987,0.0097213368752465,0.00670608174516426,-0.00342258334527545,0.0228652570957684,0.147190797883405
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40352,0.00746479369246653,0.00515064568835581,-0.00263047185671086,0.0175600592416439,0.147283935384613
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH3,Cadherin-3,42590,0.00557107468192727,0.00385194625353376,-0.00197873997499889,0.0131208893388534,0.148116121207852
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42377,0.00538841591697789,0.00374025999910639,-0.00194249368127063,0.0127193255152264,0.149706554087239
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTTG1,Securin,40206,0.00606300434108212,0.00422144568398361,-0.00221102919952576,0.01433703788169,0.150962791203024
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40019,-0.00482592317191362,0.0033614688674824,-0.0114144021521791,0.00176255580835188,0.151128279514031
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40104,0.00458513846398215,0.00319641730958813,-0.00167983946281058,0.0108501163907749,0.151469190440781
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42462,0.00484363932737249,0.00338626051196332,-0.00179343127607561,0.0114807099308206,0.152631532521988
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEBP1,Heme-binding protein 1,42237,-0.00775293801462147,0.00543068552350607,-0.0183970816406934,0.00289120561145042,0.153426119658675
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42461,-0.00499211462372205,0.00350078988170063,-0.0118536627918553,0.0018694335444112,0.153892839276516
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUCA2A,Guanylin,42442,0.00532142039149984,0.00373584353207222,-0.00200083293136171,0.0126436737143614,0.154347696537861
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,40019,-0.0109391700463042,0.00767978323862275,-0.0259915451940048,0.00411320510139643,0.154356270641063
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK10,Kallikrein-10,42518,-0.00594249478601425,0.00417809745510419,-0.0141315657980185,0.00224657622598996,0.154963506355634
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40042,-0.0110739479197752,0.00779051092919961,-0.0263433493410064,0.00419545350145608,0.155210021281426
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40350,0.00630523357372307,0.00445758214638218,-0.002431627433186,0.0150420945806321,0.157244133320299
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,40019,0.00586578273193728,0.00416051059135693,-0.0022888180271223,0.0140203834909969,0.158606542127909
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPC5,Glypican-5,42377,0.00812699325517843,0.00577239941115644,-0.0031869095906882,0.0194408961010451,0.159182614730931
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42673,0.00333342773846255,0.00236779376191349,-0.0013074480348879,0.007974303511813,0.159207397453489
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42372,0.014546371969221,0.0103764873148159,-0.00579154316781817,0.0348842871062601,0.160980913308912
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42475,0.00508484020234212,0.00362743439412074,-0.00202493121013453,0.0121946116148188,0.161006362995254
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40042,-0.00921210903542984,0.00657438854270289,-0.0220979105791275,0.00367369250826782,0.161179433859296
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40042,-0.00455823687196438,0.00326020188205215,-0.0109482325607866,0.00183175881685783,0.162097936803875
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42172,0.00696513159479777,0.00498867475684804,-0.00281267092862438,0.0167429341182199,0.162681542508418
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOM1,Myomesin-1,40042,0.00693085511725044,0.00496688210020355,-0.00280423379914852,0.0166659440336494,0.16291969833943
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40019,0.00575680394441942,0.00412704541977038,-0.00233220507833054,0.0138458129671694,0.163075472834916
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REST,RE1-silencing transcription factor,39987,-0.00492220708501672,0.00353565696828756,-0.0118520947428603,0.00200768057282688,0.163902046730915
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK7,Kallikrein-7,39916,0.0055921516966767,0.0040217806844217,-0.00229053844478984,0.0134748418381432,0.164416095960849
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42553,-0.00498754393699377,0.00358734196046006,-0.0120187341794955,0.00204364630550795,0.164455679501847
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42578,-0.00314735397728796,0.00226650406942823,-0.0075897019533673,0.00129499399879138,0.164965924020899
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCN15,Lipocalin-15,40384,0.00889907788313596,0.00643291707664522,-0.00370943958708866,0.0215075953533606,0.166580309583726
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAG,Myelin-associated glycoprotein,40089,-0.00696515163088063,0.00504843535683253,-0.0168600849302724,0.00292978166851112,0.167718002016317
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39742,-0.0160467355010041,0.0116315735996461,-0.0388446197563105,0.00675114875430221,0.167743940579842
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39986,-0.0125105461841011,0.00907153734744598,-0.0302907593850952,0.00526966701689304,0.167892876096385
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40125,-0.00980309510377756,0.00711476029012241,-0.0237480252724175,0.00414183506486237,0.16827682789316
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRR4,Proline-rich protein 4,40102,-0.00983404503823623,0.00715310526446934,-0.0238541313565961,0.00418604128012368,0.169223608057994
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40350,0.00804743938691151,0.00586444820059492,-0.00344687908625454,0.0195417578600776,0.170015849661366
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42334,0.00308034224961961,0.00224618460424674,-0.001322179574704,0.00748286407394322,0.170284162265352
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40187,-0.00528988265538545,0.00388218173510427,-0.0128989588561898,0.00231919354541893,0.173034749608709
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39845,0.0147916818338872,0.0109061246103554,-0.00658432240240936,0.0361676860701838,0.175041087024336
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40019,-0.00507339937012765,0.00374188287977899,-0.0124074898144945,0.00226069107423918,0.175177948808141
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42191,0.00672813761820304,0.00499236905610692,-0.00305690573176652,0.0165131809681726,0.177783420147435
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRX,Cone-rod homeobox protein,42237,-0.0147297805057989,0.0109499654077924,-0.036191712705072,0.00673215169347433,0.178587373892121
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40206,-0.0111787447358521,0.00834681299999472,-0.0275384982158417,0.00518100874413758,0.180506203033269
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40384,0.00445744960715956,0.00332928743942452,-0.00206795377411249,0.0109828529884316,0.18064346812623
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,40089,0.0071633536384764,0.00536135018238811,-0.0033448927190043,0.0176715999959571,0.181541224649311
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42568,0.00940770490553797,0.00704249140127354,-0.00439557824095817,0.0232109880520341,0.181621373066734
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,40104,0.00873600817073568,0.00656743157017555,-0.00413615770680839,0.0216081740482798,0.183479652891639
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL10,Interleukin-10,42256,0.0115812063141479,0.00871806724110737,-0.00550620547842252,0.0286686181067184,0.184064443773488
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPON2,Spondin-2,42444,0.00486322517798867,0.00368027661762336,-0.00235011699255311,0.0120765673485305,0.186381094389
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42237,-0.00814693282937029,0.0061710317005922,-0.020242154962531,0.00394828930379043,0.186794838857901
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA8,Carbonic anhydrase-related protein,40104,0.00389129474137908,0.00295283374632239,-0.00189625940141281,0.00967884888417097,0.187592559429019
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDRG1,Protein NDRG1,42191,0.00881475230183244,0.0066901833552809,-0.00429800707451812,0.021927511678183,0.187672489698615
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FZD10,Frizzled-10,40089,0.00821655821388619,0.00624329823131112,-0.0040203063194836,0.020453422747256,0.188181424622838
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,40019,0.0125096167728558,0.00952003555755476,-0.00614965291995155,0.0311688864656631,0.188863795869553
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTO1,Protein LTO1 homolog,42256,0.00568511648533972,0.00432833057025341,-0.00279841143235695,0.0141686444030364,0.189048928569312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42590,0.00389348724431728,0.00296754821305591,-0.0019229072532723,0.00970988174190686,0.1895353410603
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,40042,-0.00774348390964947,0.00592743132857308,-0.0193612493136527,0.00387428149435377,0.191450706644488
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42229,-0.00774152282571017,0.00592695499830117,-0.0193583546223805,0.00387530897096012,0.191522847265658
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39987,0.00459805884140142,0.00352249274783257,-0.00230602694435041,0.0115021446271533,0.191804136582812
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42059,0.00893622366775358,0.00685750385074437,-0.00450448387970539,0.0223769312152126,0.192553472487427
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42577,0.00875486661436681,0.00672937824430529,-0.00443471474447156,0.0219444479732052,0.193283624625901
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40089,0.008988483003195,0.00695131226014018,-0.00463608902667976,0.0226130550330698,0.196016771846325
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42495,0.00431869670123936,0.00334162469880485,-0.00223088770841814,0.0108682811108969,0.196243082266341
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40385,0.0317660397597259,0.0246178813709536,-0.0164850077273432,0.0800170872467949,0.196950797706734
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40019,-0.00813665970269718,0.00632432343196138,-0.0205323336293415,0.00425901422394712,0.198273103108195
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40019,-0.0051578675816841,0.00401533890897064,-0.0130279318432666,0.00271219667989836,0.198980204418057
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C7,Complement component C7,40153,-0.00433416010425771,0.00338378998450789,-0.0109663884738932,0.00229806826537775,0.200270067742355
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42191,0.00396268607776048,0.00310045930233417,-0.00211421415481448,0.0100395863103354,0.20123823995803
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40384,-0.00469407894835892,0.00369186752845009,-0.0119301393041211,0.00254198140740326,0.203589832463111
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRNN,Cornulin,42091,-0.00902945585229431,0.0071049023355364,-0.0229550644299456,0.00489615272535703,0.203795388012683
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL28,C-C motif chemokine 28,42419,0.0076571510539695,0.00603925779463267,-0.00417979422351053,0.0194940963314495,0.20485739891892
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40125,0.00645487853449281,0.0050929750455151,-0.0035273525547168,0.0164371096237024,0.205036354154682
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR4,Toll-like receptor 4,40104,-0.00382274821270769,0.00301718266547687,-0.00973642623704236,0.00209092981162698,0.205184969005438
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YY1,Transcriptional repressor protein YY1,40104,0.00365850764317388,0.00290180889446207,-0.00202903778997178,0.00934605307631954,0.207419426332612
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42590,0.0165005169810911,0.0131014307091679,-0.00917828720887795,0.0421793211710602,0.207891984643382
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRN1,Neuritin,40384,0.00471671386155914,0.0037483663926948,-0.00263008426812267,0.0120635119912409,0.208295605931509
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40352,0.00695517075599129,0.005533815647399,-0.00389110791291074,0.0178014494248933,0.208834622120161
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39987,0.0111599576251089,0.00891714687911473,-0.006317650257956,0.0286375655081737,0.210773173642253
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40384,0.00464872117523677,0.00371636391150044,-0.0026353520913041,0.0119327944417776,0.21100481868463
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,40019,-0.00503640630690747,0.00402646715480022,-0.0129282819303159,0.00285546931650096,0.211025317897477
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40411,-0.00507329873843697,0.00406196129911149,-0.0130347428846955,0.00288814540782155,0.211699325098324
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40089,-0.00641603886132704,0.00514502459747925,-0.0165002870723864,0.0036682093497323,0.212410536728293
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPM1B,Protein phosphatase 1B,40104,0.00781677901953882,0.00626984899225221,-0.0044721250052755,0.0201056830443531,0.212525024475024
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBR1,T-box brain protein 1,40089,-0.0062242965266633,0.00500215872252167,-0.0160285276228058,0.00357993456947917,0.213407817195994
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTN,Neuroplastin,42229,-0.0100622123179191,0.00809596621830455,-0.025930306105796,0.0058058814699578,0.213939064057556
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP4,Caspase-4,40206,-0.022126043148352,0.0178141492457906,-0.0570417756701016,0.0127896893733976,0.214244999204973
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42405,0.00736708003874571,0.00594443193512308,-0.00428400655409553,0.019018166631587,0.215247370940959
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDHB15,Protocadherin beta-15,40352,0.00514184243970703,0.00415195037056405,-0.0029959802865985,0.0132796651660126,0.215587844787743
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDAN1,Codanin-1,40385,0.00287769405658444,0.00232530563918641,-0.00167990499622093,0.0074352931093898,0.215907003744084
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMOD2,Leiomodin-2,40042,-0.00792538746271052,0.00641374288909896,-0.0204963235253445,0.00464554859992344,0.216601182115133
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLR1,Folate receptor alpha,42483,0.00385484851989485,0.00312124308646005,-0.00226278792956685,0.00997248496935655,0.216838828986973
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40019,-0.00714959487258447,0.00582913890431171,-0.0185747071250354,0.00427551737986649,0.220027187892659
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40019,-0.00850751377706156,0.00694504655804379,-0.0221198050308274,0.00510477747670426,0.220611002803913
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDHB,Succinate dehydrogenase,40350,0.00829856195757081,0.0067859928384112,-0.00500198400571514,0.0215991079208568,0.221394897764491
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD177,CD177 antigen,42474,-0.0165236803789986,0.0135574330444824,-0.043096249146184,0.0100488883881868,0.222945093676673
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42229,-0.00472133222280053,0.00389717516106635,-0.0123597955384906,0.00291713109288953,0.225735180746972
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42475,0.00299634635639028,0.00247837550904237,-0.00186126964133277,0.00785396235411333,0.226685861539735
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42490,0.00452392582429106,0.00374471411228397,-0.00281571383578553,0.0118635654843676,0.227036787192277
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOB,Apolipoprotein B-100,40432,-0.00277111070644994,0.0022972642240263,-0.00727374858554147,0.0017315271726416,0.227740507541646
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40104,0.00662379073808764,0.00550582498514981,-0.00416762623280599,0.0174152077089813,0.228982516708027
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF16,Fibroblast growth factor 16,40104,0.0058587717572571,0.00487010409877453,-0.00368663227634098,0.0154041757908552,0.228999523331498
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3GL3,Endophilin-A3,40154,0.0105679840792961,0.00878582086952544,-0.00665222482497374,0.027788192983566,0.229062141989584
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POMC,Pro-opiomelanocortin,40125,0.00862956392218243,0.00717687188079058,-0.00543710496416711,0.022696232808532,0.229229607268085
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40104,-0.00606612850927382,0.00504644501852385,-0.0159571607455806,0.00382490372703291,0.229366463822333
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40089,-0.0088307688319797,0.00734876616343443,-0.0232343505123112,0.00557281284835178,0.22951874165038
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40373,0.00848469280079215,0.00707253315710554,-0.00537747218713471,0.022346857788719,0.23029367036456
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1A,Interleukin-1 alpha,42256,0.0072066362167744,0.00600980823845519,-0.00457258793059778,0.0189858603641466,0.230493016450262
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39987,-0.00722620786726826,0.00605380314567273,-0.0190916620327868,0.0046392462982503,0.232635599767238
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMBN,Ameloblastin,42256,-0.00349548843333885,0.00293087567745189,-0.00924000476114455,0.00224902789446685,0.233030872519812
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MELTF,Melanotransferrin,40411,-0.00369902813846524,0.0031028925865702,-0.00978069760814284,0.00238264133121237,0.233238426344269
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40206,-0.00451246407243494,0.00378555265512303,-0.0119321472764761,0.00290721913160619,0.233278096627108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROK1,Prokineticin-1,42475,-0.00676818497021472,0.00568106137218881,-0.0179030652597048,0.00436669531927534,0.233533876146811
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40104,0.00542792213853357,0.00458180316951309,-0.00355241207371208,0.0144082563507792,0.236173980802528
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSCA,Prostate stem cell antigen,40350,0.0323976485402053,0.0273635889354487,-0.0212349857732741,0.0860302828536848,0.236450451354467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42377,0.00550549771199863,0.00465450419224593,-0.0036173305048034,0.0146283259288007,0.23689696397146
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RYR1,Ryanodine receptor 1,40019,-0.00419186828307515,0.00355358988094459,-0.0111569044497266,0.00277316788357625,0.23817925787318
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40350,0.00330501021367925,0.00281314729026747,-0.00220875847524498,0.00881877890260348,0.240082066442974
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39987,-0.00798697112655186,0.00680523765219318,-0.0213252369248505,0.00535129467174677,0.240560910293427
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39987,-0.0101846493610112,0.00870376474187613,-0.0272440282550884,0.00687472953306605,0.241969265140475
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42490,0.00441378358742548,0.00377553181499797,-0.00298625876997055,0.0118138259448215,0.242404645872302
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNF75D,Zinc finger protein 75D,40206,0.00738545426592641,0.00632172185241004,-0.00500512056479727,0.0197760290966501,0.242724677154116
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,40206,0.00850377088313914,0.00728036584218095,-0.00576574616753552,0.0227732879338138,0.242815233173006
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40352,-0.00540033913712794,0.00462815375524253,-0.0144715204974033,0.00367084222314741,0.243297813805789
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42532,0.0105833822408596,0.00907604827923673,-0.00720567238644444,0.0283724368681636,0.243603670955263
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17D,Interleukin-17D,42256,-0.00408142657424202,0.00350429010818982,-0.0109498351862941,0.00278698203781003,0.244164043910526
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40019,-0.00578048683789316,0.0049732591558142,-0.015528074783289,0.00396710110750268,0.245133721692721
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40350,-0.0121433973789208,0.0104531491408269,-0.0326315696949415,0.00834477493709981,0.245383209081553
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX6,Peroxiredoxin-6,42599,-0.00723461528792915,0.00623650962316029,-0.0194581741493233,0.00498894357346502,0.246052223715081
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40411,0.00886383186891404,0.00766323569831931,-0.00615611009979181,0.0238837738376199,0.24743200161868
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHGB,Secretogranin-1,42543,0.00510765172780583,0.00441597202466811,-0.00354765344054366,0.0137629568961553,0.24744370206046
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,40019,-0.0032491849170321,0.00281365510334295,-0.00876394891958428,0.00226557908552009,0.248201321344277
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA6C,Semaphorin-6C,40104,0.00311588180933675,0.0027005709338675,-0.00217723722104356,0.00840900083971706,0.248613057067813
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42673,-0.00384337754100602,0.00333119653415911,-0.0103725227479579,0.00268576766594584,0.248621961018238
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40019,-0.00570700428003639,0.00495700586681177,-0.0154227357789875,0.00400872721891469,0.249633981305596
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA3,Carbonic anhydrase 3,42649,0.0070376425445083,0.00612550883993063,-0.00496835478175573,0.0190436398707723,0.250614581919148
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAX,Integrin alpha-X,40206,-0.00642663319312572,0.00560004740926205,-0.0174027261152793,0.0045494597290279,0.251157275214134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GH2,Growth hormone variant,42229,-0.0196742709475109,0.017146251406348,-0.053280923703953,0.0139323818089312,0.251221449289687
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42561,0.0114750837018582,0.0100224601297933,-0.00816893815253655,0.031119105556253,0.252255826630448
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42191,0.00619847491375803,0.00545232864817178,-0.00448808923665865,0.0168850390641747,0.255622333101126
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM171A2,Protein FAM171A2,40384,-0.0186688378185309,0.0164357824446114,-0.0508829714099692,0.0135452957729074,0.256037196238452
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39749,-0.00600660093513549,0.00531213305146779,-0.0164183817160124,0.00440517984574137,0.258193433367102
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40019,-0.00623523340972878,0.00551567030674343,-0.0170459472109459,0.00457548039148834,0.258308348713953
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,40206,-0.00428993660529826,0.00380201625594968,-0.0117418884669596,0.00316201525636311,0.259204315504792
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F2,Prothrombin,40440,0.00172259219754527,0.00152669598247549,-0.0012697319281067,0.00471491632319724,0.259211472702147
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA7A,Semaphorin-7A,42639,0.00329551244486491,0.00292593814712815,-0.00243932632350626,0.00903035121323609,0.260054566486351
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNL1,Interferon lambda-1,42191,0.00529805519785814,0.00471737596478579,-0.00394800169312202,0.0145441120888383,0.261418449088354
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,42191,-0.00374448728839741,0.00333711505459464,-0.0102852327954029,0.00279625821860808,0.261852056749713
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENO1,Alpha-enolase,42468,0.00905783020669593,0.00808493574486524,-0.00678864385323994,0.0249043042666318,0.262591632843148
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40019,-0.00802821907119258,0.00717316937951765,-0.0220876310550472,0.00603119291266202,0.263079188944651
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39987,-0.00353206891567098,0.00315592609754546,-0.00971768406686009,0.00265354623551812,0.263085620971567
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BGLAP,Osteocalcin,40428,-0.0103307511322387,0.00926585172618582,-0.0284918205155629,0.00783031825108551,0.26490542330323
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLR3,Folate receptor gamma,42512,-0.0212042606734247,0.0190756447572289,-0.0585925243975933,0.016184003050744,0.266335335782199
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPM1A,Protein phosphatase 1A,42229,0.00362382691891089,0.00326825506264371,-0.00278195300387079,0.0100296068416926,0.267538814556352
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40350,-0.00633570011973562,0.00571502766987876,-0.017537154352698,0.00486575411322675,0.267625132847628
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUC16,Mucin-16,42466,0.0218983957575386,0.0197544191855137,-0.0168202658460683,0.0606170573611455,0.267652434053269
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40042,-0.00574450577921506,0.00518417121005318,-0.0159054813509193,0.00441646979248918,0.26784939035233
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42568,0.0036790549670473,0.00332236737267593,-0.00283278508339751,0.0101908950174921,0.268158458268112
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40384,0.00560602730276492,0.00508251135935231,-0.00435569496156561,0.0155677495670954,0.270049409670047
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNPO1,Transportin-1,40206,-0.00401191464962363,0.00365418058162558,-0.0111741085896098,0.00315027929036251,0.272273383398203
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL24,Interleukin-24,42256,-0.00570723626119686,0.00520309848087035,-0.0159053092837027,0.00449083676130902,0.272708897950567
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GC,Vitamin D-binding protein,40440,0.00290772942498287,0.00265743314607056,-0.00230083954131543,0.00811629839128117,0.273896303929689
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40428,0.00261074608200668,0.00238615500477549,-0.00206611772735328,0.00728760989136665,0.27392467700984
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40089,-0.0045993029677894,0.00420550588089178,-0.0128420944943373,0.00364348855875848,0.274137754195
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42490,-0.00606198466547151,0.00555616674890409,-0.0169520714933235,0.0048281021623805,0.275276280630005
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1R,Complement C1r subcomponent,40440,-0.00216655718727374,0.00198628436983329,-0.00605967455214698,0.00172656017759951,0.275402391939869
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLASP1,CLIP-associating protein 1,39987,0.00811254979001268,0.00748188871165852,-0.00655195208483801,0.0227770516648634,0.278259706522153
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CORO6,Coronin-6,40042,-0.00415850009676784,0.00383786493059619,-0.0116807153607364,0.0033637151672007,0.278590584760751
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40428,0.00325535820953327,0.00301251489964749,-0.00264917099377581,0.00915988741284235,0.279893167522073
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40019,-0.0111260682746778,0.0103151773718788,-0.0313438159235602,0.00909167937420457,0.280785014604306
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEDD9,Enhancer of filamentation 1,40104,0.00369191528772767,0.00342343930320101,-0.0030180257465463,0.0104018563220016,0.280868921284731
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40390,0.00248209416591452,0.00231089196815949,-0.00204725409167808,0.00701144242350712,0.282807779880201
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300E,CMRF35-like molecule 2,42557,0.00476481838641482,0.0044370625320293,-0.00393182417636261,0.0134614609491922,0.282901347006479
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40019,-0.00358979626080675,0.00334800608606777,-0.0101518881894996,0.00297229566788607,0.28364551103107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,40042,-0.0092823632262254,0.00866322797575568,-0.0262622900587065,0.00769756360625573,0.283983320382568
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB5,Integrin beta-5,42561,-0.00409439367491664,0.00382931912413765,-0.0115998591582264,0.00341107180839315,0.284988787865224
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY96,Lymphocyte antigen 96,42377,0.00390206619979081,0.00366799240115629,-0.00328719890647553,0.0110913313060571,0.287431893274074
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBLN4,Cerebellin-4,42599,0.00354993583468182,0.00334182440912588,-0.0030000400072049,0.0100999116765685,0.288130090605114
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM171B,Protein FAM171B,40352,-0.0028780829934338,0.00270975498468495,-0.0081892027634163,0.0024330367765487,0.288204528978327
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42673,-0.0071309068628696,0.00672324116277642,-0.0203084595419114,0.00604664581617219,0.288874680933227
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40089,0.00594968276241019,0.00561356098727588,-0.00505289677265053,0.0169522622974709,0.289224170923724
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40019,-0.00282921841288418,0.0026712972865986,-0.00806496109461744,0.00240652426884907,0.289569781901571
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGM2,Phosphoglucomutase-2,40089,-0.0064996160181712,0.0061450910090195,-0.0185439943958494,0.00554476235950702,0.290219154478804
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGN,Mimecan,42490,0.00479091066296357,0.00455230834169086,-0.00413161368675052,0.0137134350126777,0.292629012345989
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH22,Cadherin-22,40206,-0.00304679691843604,0.00289542880893295,-0.00872183738394463,0.00262824354707254,0.292694971894345
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40206,0.00585872481488589,0.00558822856378986,-0.00509420317014224,0.016811652799914,0.294475220842069
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40042,0.00349140497089906,0.00333500060441452,-0.00304519621375339,0.0100280061555515,0.2951700174701
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40042,-0.00580648364996977,0.00555538476739194,-0.016695037794058,0.00508207049411843,0.295954207551992
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL36G,Interleukin-36 gamma,40059,0.00737920955289378,0.00708967110915982,-0.00651654582105945,0.021274964926847,0.297973216062218
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VIT,Vitrin,40411,-0.00411929578533403,0.00395843971710407,-0.011877837630858,0.00363924606018994,0.298066838736042
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40089,0.00822908970673287,0.00792880239454464,-0.00731136298657463,0.0237695424000404,0.299352231333068
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNN,Tenascin-N,40428,0.0046923517774585,0.00452413441786991,-0.00417495168156652,0.0135596552364835,0.299673266749864
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40173,0.00677455855796168,0.00653500119440827,-0.00603404378307853,0.0195831608990019,0.299918296984605
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40019,-0.00529634712372708,0.00511155069474714,-0.0153149864854315,0.00472229223797731,0.300154048290887
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,40042,-0.00642554549752774,0.00621268760546501,-0.0186024132042392,0.00575132220918368,0.301036843104439
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PVALB,Parvalbumin alpha,42533,0.0116722621264383,0.0112898123020264,-0.0104557699855334,0.03380029423841,0.301213039277318
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAPS,Calcyphosin,40385,-0.0109592434274371,0.010615757935605,-0.0317661289812228,0.00984764212634867,0.301927595906818
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTR,Methionine synthase,40019,0.00707192657858859,0.00685042805060632,-0.0063549124005998,0.020498765557777,0.301938961229684
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYBB2,Beta-crystallin B2,40385,0.00866821835830304,0.00839729222513926,-0.00779047440296991,0.025126911119576,0.301970996861953
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,40089,-0.00752478774522112,0.00731242223224692,-0.0218571353204251,0.00680755982998284,0.30348290220455
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTF,Ciliary neurotrophic factor,40042,-0.00363406217640027,0.00353734554673961,-0.0105672594480099,0.00329913509520937,0.304282554193013
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40352,-0.00385892742317614,0.00375895126770649,-0.0112264719078809,0.00350861706152859,0.304632605577213
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40104,0.00616866369245012,0.00600951833938921,-0.00560999225275273,0.017947319637653,0.304687100419031
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42256,0.00638192086337499,0.00621996621347153,-0.00580921291502921,0.0185730546417792,0.304892735853953
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA3G,Semaphorin-3G,40187,-0.00470778716719392,0.0046020118161676,-0.0137277303268824,0.00431215599249456,0.306337643057932
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOS,Proto-oncogene c-Fos,39972,0.00375765492464901,0.00368560021625,-0.00346612149920098,0.010981431348499,0.307964655286124
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL13,Interleukin-13,42256,-0.00496242779082592,0.00488054725951279,-0.014528300419471,0.00460344483781916,0.30927839845964
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,40042,0.00494269994154209,0.0048687508721008,-0.00460005176777548,0.0144854516508597,0.31003861799395
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE3,Eosinophil cationic protein,42460,0.0113943598998809,0.0113085831896434,-0.0107704631518203,0.033559182951582,0.313672063339277
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKKL1,Dickkopf-like protein 1,42466,-0.00910476179734783,0.0090363113824292,-0.0268159321069091,0.0086064085122134,0.313676885653124
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,40104,0.0105036997337538,0.0104251309756771,-0.00992955697857333,0.0309369564460809,0.31369938258478
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,42191,0.00888593649106422,0.00883715652626358,-0.00843489030041239,0.0262067632825408,0.314665305561244
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCP11,T-complex protein 11 homolog,40206,-0.00612898721007931,0.00610844223199488,-0.0181015339847893,0.00584355956463066,0.315707615476401
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39987,-0.00713164337136343,0.00710883464927217,-0.0210649592839369,0.00680167254121002,0.315782761429833
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40440,0.00192385486252971,0.00192280985166165,-0.00184485244672712,0.00569256217178654,0.317069093660111
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGMB,RGM domain family member B,42590,-0.00292446490756535,0.00292377653491192,-0.00865506691599272,0.00280613710086201,0.317214649138854
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40350,0.0115741519048048,0.011592801507865,-0.0111477390506106,0.0342960428602201,0.318111316012742
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42639,0.00467659445355083,0.00469665599805813,-0.0045288513026431,0.0138820402097448,0.319399975456979
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42229,0.00420871844152604,0.00423230263904009,-0.00408659473099253,0.0125040316140446,0.320033208958264
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40420,-0.00201070249309444,0.00203403125094869,-0.00599740374495386,0.00197599875876499,0.322914074510108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40104,-0.00922633532671069,0.0093359758137434,-0.0275248479216477,0.00907217726822636,0.323049141166647
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LUZP2,Leucine zipper protein 2,40352,0.00466399724324763,0.00472580546446717,-0.00459858146710803,0.0139265759536033,0.323702707341219
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40042,-0.00922367679733433,0.00935147074224331,-0.0275525594521312,0.00910520585746255,0.323991068123961
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTPN,Myotrophin,42237,0.00337310278259373,0.00342017020601023,-0.00333043082118631,0.0100766363863738,0.324034492946086
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39987,0.00936907062060142,0.00952363884327785,-0.00929726151222316,0.028035402753426,0.32525064245272
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPHS1,Nephrin,40104,0.00338226522789772,0.00345309487177086,-0.00338580072077318,0.0101503311765686,0.327360599763209
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMA1,Laminin subunit alpha-1,40019,-0.00543714390888023,0.00556541574377219,-0.0163453587666737,0.00547107094891326,0.328614759618948
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSG3,Desmoglein-3,42529,-0.00352000671356301,0.00361267338998186,-0.0106008465579275,0.00356083313080145,0.32990068084652
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42229,0.012703044909397,0.0130426830349599,-0.0128606138391244,0.0382667036579184,0.330094727323205
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP6,Guanylate-binding protein 6,40019,0.00459313893097641,0.00473059179748817,-0.00467882099210039,0.0138650988540532,0.331597942954537
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42452,0.0183064034360546,0.018855859187419,-0.0186510805712866,0.0552638874433957,0.33163560542182
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40385,-0.00271500417806634,0.00279689470522129,-0.00819691780030007,0.0027669094441674,0.331708254999375
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53BP1,TP53-binding protein 1,40104,0.00861606697372007,0.0089276251096489,-0.00888207824119177,0.0261142121886319,0.334515221933632
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HK2,Hexokinase-2,42237,0.00274456262691823,0.00284467935440837,-0.00283100890772216,0.00832013416155863,0.334660068295355
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,40125,-0.00549817141464362,0.00574477490999978,-0.0167579302382432,0.00576158740895594,0.338551360815891
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECTIN1,Nectin-1,40104,0.00321783728117403,0.00336584963449074,-0.00337922800242782,0.00981490256477588,0.33908065421619
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,40042,-0.00958387960364743,0.0100259639715434,-0.0292347689878725,0.0100670097805777,0.339141003969802
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARTN,Artemin,42256,-0.00439913157097295,0.00460221592901519,-0.0134194747918427,0.00462121164989682,0.339154352316505
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42256,0.00360018273978614,0.00376856514581211,-0.0037862049460056,0.0109865704255779,0.339433966878896
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40330,0.00844808557416125,0.00885974273070249,-0.00891701017801562,0.0258131813263381,0.340339151427594
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40432,-0.00267062165112796,0.00280454057214101,-0.00816752117252434,0.00282627787026841,0.340991069965921
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42490,-0.0115731765947231,0.0121890503627681,-0.0354637153057486,0.0123173621163024,0.342397255910375
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40089,-0.00362469701914877,0.00382255693828757,-0.0111169086181924,0.00386751457989487,0.343028901805921
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EVI2B,Protein EVI2B,39987,-0.00400511893848603,0.00422492305592383,-0.0122859681280967,0.00427573025112467,0.343163706290921
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42191,-0.00399605090338738,0.00422417537688643,-0.0122754346420848,0.00428333283531001,0.34416846726499
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPN1,Epsin-1,40206,0.00433533978401548,0.00458642866073613,-0.00465406039102734,0.0133247399590583,0.344549984339247
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42466,0.00441428636156619,0.00469006638971876,-0.00477824376228259,0.013606816485415,0.346619957609456
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CR2,Complement receptor type 2,42568,-0.00459434504801885,0.00492210653241871,-0.0142416738515595,0.00505298375552182,0.350625003518021
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCLN,Nicalin,42256,0.00496994074317152,0.00532527798600899,-0.0054676041094061,0.0154074855957491,0.350696032588601
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMI,N-myc-interactor,40322,-0.00687289027209811,0.0074010123394386,-0.0213788744573978,0.00763309391320154,0.353094834266055
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A3,Protein S100-A3,40352,0.00414387848044158,0.00448554417481654,-0.00464778810219883,0.012935545063082,0.355595018530302
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,40104,0.00839441273858496,0.00909540772193808,-0.00943258639641368,0.0262214118735836,0.356064777913148
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39987,0.00560116849287818,0.00608539922792311,-0.00632621399385112,0.0175285509796075,0.357370000985017
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39987,0.00427873332399593,0.0046652238782398,-0.00486510547735407,0.0134225721253459,0.359081925943102
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2,Interleukin-2,42256,0.0030204090658345,0.00329773303355922,-0.00344314767994157,0.00948396581161056,0.359733808910569
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40125,-0.00222256646498743,0.00242673448801923,-0.00697896606150513,0.00253383313153027,0.359756768009605
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42631,0.0057278700290366,0.00625557878970785,-0.00653306439879078,0.017988804456864,0.359871180606977
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,40104,0.00206724812625093,0.00226123046155382,-0.00236476357839455,0.00649925983089641,0.360624710031704
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40384,0.00253076442094895,0.00279532885103471,-0.00294808012707908,0.00800960896897697,0.365296940367668
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40411,0.00294246264231275,0.00326756873890896,-0.00346197208594882,0.00934689737057432,0.36787079164
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40019,0.00559006451144829,0.00623520083216779,-0.00663092911960058,0.0178110581424972,0.369987997312333
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLINT1,Clathrin interactor 1,39987,0.00424772455191116,0.00476165256678667,-0.00508511447899071,0.013580563582813,0.372375622272432
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40042,-0.00653010003605763,0.00733185518896336,-0.0209005362064258,0.00784033613431055,0.373137947410209
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40125,0.0023417514688237,0.00263024193378822,-0.00281352272140122,0.00749702565904861,0.37331480787291
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40125,-0.00234287281959922,0.00263706365739747,-0.00751151758809826,0.00282577194889981,0.374323669478258
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42191,0.00461672555166706,0.00520630222270046,-0.00558762680482585,0.01482107790816,0.375226087256038
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42618,0.00475731833149501,0.00538775131491915,-0.00580267424574652,0.0153173109087365,0.377258709985814
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42518,-0.00287551045422822,0.00325680914956976,-0.00925885638738494,0.0035078354789285,0.377294012482128
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39987,-0.00237406417583121,0.0026924201578097,-0.00765120768513822,0.00290307933347581,0.377927091235241
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39987,0.00377722192663786,0.00428981664690523,-0.00463081870129639,0.0121852625545721,0.378603267584239
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RALB,Ras-related protein Ral-B,40104,0.00271166530912461,0.00308195715163327,-0.00332897070807661,0.00875230132632582,0.378959020197284
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40089,-0.00710836228204452,0.0081011476877619,-0.0229866117500578,0.0087698871859688,0.380260926816636
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,40188,-0.00482314988592597,0.00551201042646872,-0.0156266903218047,0.00598039054995271,0.381579126033182
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40042,-0.00506654686734016,0.00579286538986769,-0.0164205630314808,0.00628746929680051,0.381800915834472
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40350,-0.00394839339379991,0.00451574101257442,-0.0127992457784458,0.00490245899084596,0.38193984017278
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EVPL,Envoplakin,40206,-0.00316451543606243,0.00362044488600517,-0.0102605874126326,0.00393155654050771,0.382100221601748
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLHL41,Kelch-like protein 41,40384,-0.00430210973006355,0.00493492960454656,-0.0139745717549748,0.0053703522948477,0.383354098778562
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42191,0.0133995574296724,0.0153933575775588,-0.0167714234223429,0.0435705382816877,0.38405608328206
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BSND,Barttin,39987,0.00306302860530357,0.00351974231088631,-0.0038356663240336,0.00996172353464075,0.384187363890749
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42229,0.00471593951990914,0.0054382869921025,-0.00594310298461175,0.01537498202443,0.385862800030362
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40019,0.00438595844161311,0.00506802137996755,-0.00554736346312329,0.0143192803463495,0.386828419408508
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLMH,Bleomycin hydrolase,42673,0.00278043500910894,0.00321571410996356,-0.00352236464641964,0.00908323466463752,0.387251804361253
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYH4,Myosin-4,40019,-0.00404577379673343,0.00468647096442347,-0.0132312568870034,0.00513970929353657,0.387998307420539
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,40206,0.00397188779092154,0.00460585818141529,-0.00505559424465243,0.0129993698264955,0.388510620917677
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,40019,0.00296637134504826,0.0034521127922473,-0.00379976972775645,0.00973251241785298,0.390198713992762
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,40089,0.0043489330270428,0.00506431094470838,-0.00557711642458563,0.0142749824786712,0.390502144744049
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40411,0.00261010617498607,0.0030407056245325,-0.00334967684909764,0.00856988919906977,0.390696419653876
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39987,-0.00511652112521845,0.00598028357375181,-0.016837876929772,0.0066048346793351,0.392257446422107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSH,Pro-cathepsin H,42213,0.0065390758339467,0.00766680258814891,-0.00848785723882517,0.0215660089067186,0.39372611879883
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40385,0.00476011188545083,0.00559147547417532,-0.0061991800439328,0.0157194038148345,0.394612119311989
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40125,-0.00741131187023981,0.00872981792739766,-0.0245217550079392,0.0096991312674596,0.395919232284365
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSPN,Claspin,42172,-0.00302556678399602,0.00357959958092811,-0.0100415819626151,0.00399044839462307,0.39800085083556
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,40352,-0.00475365515638651,0.00564645643483911,-0.0158207097686712,0.00631339945589815,0.39987154223833
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY75,Lymphocyte antigen 75,42475,0.00337003208067911,0.00400355183441475,-0.0044769295147738,0.011216993676132,0.399937142382619
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,40206,0.00743599376345074,0.00891929186805134,-0.0100458182979299,0.0249178058248314,0.404469396533913
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40019,0.00287083671918119,0.00344411472650933,-0.0038796281447771,0.00962130158313949,0.404553839291021
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RETN,Resistin,42481,0.00369297992462206,0.00443391172295367,-0.00499748705236713,0.0123834469016113,0.404919299424989
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40089,-0.00614625232987797,0.00738189024584474,-0.0206147572117337,0.00832225255197772,0.405081691952371
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA4D,Semaphorin-4D,42590,0.00254803472195656,0.00306438859962582,-0.00345816693331005,0.00855423637722316,0.405706859525642
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AFP,Alpha-fetoprotein,42341,-0.00570581599679855,0.00686932212057926,-0.0191696873531339,0.00775805535953679,0.406201799154582
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40428,0.00215585382933269,0.00259909409477246,-0.00293837059642134,0.00725007825508672,0.406859775114489
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42466,-0.00223249909638483,0.00269223969103272,-0.00750928889080896,0.0030442906980393,0.406986416480147
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OMP,Olfactory marker protein,40042,-0.00428693929738115,0.0051717342589437,-0.0144235384449108,0.0058496598501485,0.407169519768754
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42475,-0.00481387364556804,0.00583937214627395,-0.016259043052265,0.00663129576112889,0.409737309311637
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,40089,-0.00246440370970655,0.002991233062515,-0.00832722051223595,0.00339841309282285,0.410028322968148
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40125,0.00386249910491395,0.00469669450261713,-0.00534302212021563,0.0130680203300435,0.410874783385989
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42466,0.00383553981390969,0.0046689343923147,-0.00531557159502713,0.0129866512228465,0.411375035311218
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,40187,0.00208935208470148,0.00254367947071565,-0.0028962596779012,0.00707496384730416,0.411442148677315
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42123,0.00338494203033461,0.00413694752554617,-0.00472347511973589,0.0114933591804051,0.413245438416109
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNLZ,DNL-type zinc finger protein,40042,-0.00767215174332769,0.00938142380960608,-0.0260597424101556,0.0107154389235002,0.413487938172599
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40385,0.00335180563571297,0.00411235250813388,-0.00470840528022943,0.0114120165516554,0.415056480506691
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42590,0.00252084369812505,0.0030935719096719,-0.00354255724483186,0.00858424464108197,0.415164034025557
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAGLN3,Transgelin-3,39987,0.00514475158166347,0.00631368625346497,-0.00723007347512788,0.0175195766384548,0.415172135764528
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40104,0.00243186525846506,0.00299689211532188,-0.00344204328756583,0.00830577380449595,0.417117881646961
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39987,0.00463985047621388,0.00572024220126222,-0.00657182423826008,0.0158515251906878,0.417309867190282
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40042,-0.00447455536464269,0.00552325770668009,-0.0153001404697357,0.00635102974045029,0.417883380165593
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",40352,0.0035459213944699,0.00439032131864589,-0.00505910839007605,0.0121509511790158,0.419299031445046
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40083,0.00315809708052596,0.00391435007751406,-0.00451402907140159,0.0108302232324535,0.419799422873579
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCL2,Phosducin-like protein 2,39987,0.00440900524589279,0.00546575645411868,-0.00630387740417982,0.0151218878959654,0.419880365246961
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MB,Myoglobin,42673,0.00439268526259678,0.00545413069735353,-0.00629741090421614,0.0150827814294097,0.420610671747438
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SKIV2L,Helicase SKI2W,40019,0.00329714843164659,0.0040941556318202,-0.004727396606721,0.0113216934700142,0.420646670107451
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42518,-0.00379763362856688,0.00471599045266617,-0.0130409749157926,0.00544570765865881,0.420679727780826
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42191,-0.00328424863895848,0.00408010143581996,-0.0112812474531656,0.00471275017524864,0.42086736133621
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEX101,Testis-expressed protein 101,40089,0.00437368597625903,0.00544742390660982,-0.00630326488069622,0.0150506368332143,0.42205542783302
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40019,-0.00429350570621498,0.00536775352647407,-0.0148143026181042,0.0062272912056742,0.423803597929538
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBH,Dopamine beta-hydroxylase,40415,0.00900022498643349,0.0112847234709721,-0.0131178330166718,0.0311182829895388,0.425143728570427
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPT,Microtubule-associated protein tau,42191,-0.00437247962562794,0.00549156198104784,-0.0151359411084817,0.00639098185722583,0.425919971882602
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL21R,Interleukin-21 receptor,40104,-0.00456696725186095,0.00576321713105749,-0.0158628728287336,0.00672893832501174,0.428125088866119
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCC,Netrin receptor DCC,40089,0.00188617603410639,0.00238624877706084,-0.00279087156893286,0.00656322363714564,0.429290610403061
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40206,-0.00575324554749889,0.00727914196807057,-0.0200203638049172,0.00851387270991943,0.42932632206102
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF5,Fibroblast growth factor 5,42256,0.00268159172281111,0.00339470632481695,-0.00397203267383011,0.00933521611945232,0.429581036005796
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ISM2,Isthmin-2,40428,-0.00351598984442332,0.00446009237693694,-0.0122577709032197,0.00522579121437308,0.430524898232637
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,40104,0.00518877679374771,0.00659058727900905,-0.00772877427311002,0.0181063278606054,0.431122712649982
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40352,0.00361399138846522,0.00459170449313264,-0.00538574941807475,0.0126137321950052,0.431257793859046
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCP1,Plastin-2,40428,-0.00385537697590403,0.00492162647726192,-0.0135017648713374,0.00579101091952933,0.43343563309154
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",42191,0.00438138466675187,0.00559377916694056,-0.00658242250045162,0.0153451918339554,0.433488593782878
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42054,-0.00691614533609304,0.00884709517381604,-0.0242564518767725,0.0104241612045864,0.434380641064738
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40042,0.0048532243497379,0.00623928332408432,-0.00737577096546736,0.0170822196649432,0.436674617655379
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17A,Interleukin-17A,42233,0.00344002808122318,0.00443497866442039,-0.00525253010104077,0.0121325862634871,0.437964825859858
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAEP,Glycodelin,42377,-0.00719109700070213,0.00927326408533632,-0.0253666946079613,0.0109845006065571,0.438078513815435
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40187,0.00212062474152633,0.00274504238109582,-0.00325965832542149,0.00750090780847414,0.439817808578152
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40125,0.00513672554757623,0.00665360794005107,-0.00790434601492386,0.0181777971100763,0.440118635968538
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42440,-0.00278331792389619,0.00361422922447333,-0.00986720720386391,0.00430057135607154,0.44125430998256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40042,0.00556322344102814,0.00722830313040183,-0.00860425069455944,0.0197306975766157,0.44152758373377
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40042,0.00951123052476489,0.0124212489897692,-0.0148344174951828,0.0338568785447126,0.443858062679731
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42229,0.00444431905177303,0.00580620876829033,-0.00693585013407601,0.0158244882376221,0.44402194248749
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42451,0.00676679749333562,0.00889630579947913,-0.0106699618736435,0.0242035568603147,0.446891595952332
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANK2,Ankyrin-2,40019,-0.00576799794342763,0.00758776335339718,-0.0206400141160861,0.00910401822923084,0.44716891005583
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IKZF2,Zinc finger protein Helios,42229,-0.00686256884143704,0.00904053452507078,-0.0245820165105758,0.0108568788277017,0.447813142275285
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEO1,Neogenin,40384,-0.00173119783788965,0.00228489734979567,-0.00620959664348916,0.00274720096770987,0.448664605921742
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40206,0.00340133970757292,0.00450065318420757,-0.00541994053347391,0.0122226199486198,0.449819120331744
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNM1,Dynamin-1,40350,-0.00880610018385175,0.0116750701355357,-0.0316892376495016,0.0140770372817981,0.450705859139356
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH1,Protocadherin-1,42601,0.00166942671862037,0.00221405129478274,-0.00267011381915379,0.00600896725639453,0.450853773887357
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42543,-0.00381211910861674,0.0050678423226755,-0.0137450900610607,0.00612085184382725,0.451933602461253
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40330,-0.00303756617250136,0.00405185662398547,-0.0109792051555129,0.00490407281051017,0.453467708283053
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42466,-0.00428232949748038,0.00573589512888418,-0.0155246839500934,0.00696002495513262,0.455327726644205
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,42191,-0.00378917690064672,0.00508573605419303,-0.0137572195668651,0.00617886576557162,0.456249111844137
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP2BP,LRP2-binding protein,40089,0.00658107505707906,0.00887711789561975,-0.0108180760183357,0.0239802261324938,0.458495612691441
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROBO1,Roundabout homolog 1,42516,0.00187045969992764,0.00252387410186601,-0.00307633353972975,0.00681725293958503,0.458641884091248
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40384,0.00259233218283842,0.0035300223202745,-0.00432651156489961,0.00951117593057644,0.462740432576197
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42466,0.00240403397398823,0.00327903714716462,-0.00402287883445442,0.00883094678243088,0.463478428703443
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40185,-0.00408883329953891,0.00561525302917934,-0.0150947292367304,0.00691706263765259,0.466527819764482
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40384,-0.00177239205291157,0.00244210717653685,-0.0065589221189238,0.00301413801310066,0.467998994539537
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42516,0.00259433486719815,0.00358007786997422,-0.00442261775795132,0.00961128749234761,0.468674114436514
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40019,-0.00362277688454786,0.00501806974723629,-0.013458193589131,0.00621263982003528,0.470343088114337
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40206,0.00497631589747871,0.00690623105432398,-0.00855989696899629,0.0185125287639537,0.471198948553211
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40104,0.00451151788242157,0.0062959007185077,-0.00782844752585352,0.0168514832906967,0.473648495538479
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STEAP4,Metalloreductase STEAP4,40042,-0.00535885210750215,0.00749556389603515,-0.020050157343731,0.00933245312872674,0.4746636760021
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40019,-0.00706338750197464,0.00988183470255719,-0.0264317835189867,0.0123050085150375,0.47475730155074
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42603,-0.00208302039956019,0.00291451226384511,-0.00779546443669661,0.00362942363757622,0.474802960043318
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PZP,Pregnancy zone protein,40440,0.00373493386769472,0.00522853515616649,-0.0065129950383916,0.013982862773781,0.4750339104416
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FZD8,Frizzled-8,40042,-0.00336358306778267,0.00471152602916874,-0.0125981740849534,0.00587100794938806,0.47530114317083
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DRAXIN,Draxin,42377,-0.00320062838294908,0.00449974647312852,-0.012020131470281,0.00561887470438282,0.476916620639791
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39987,0.00567092397263023,0.00801607390001886,-0.0100405808714067,0.0213824288166672,0.479305830874612
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUC2,Mucin-2,40428,0.00675044341689223,0.00954278687278194,-0.0119534188537604,0.0254543056875448,0.479340684604844
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL25,Interleukin-25,39943,0.00254231010894954,0.00359929970448618,-0.00451231731184337,0.00959693752974245,0.479995357318213
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40050,0.00276680793788013,0.00394338498860407,-0.00496222663978385,0.0104958425155441,0.482923281140009
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP6,Gastrotropin,42215,-0.00421482351895527,0.00604007826805035,-0.016053376924334,0.00762372988642342,0.485308846697235
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDK2,Protein sidekick-2,40187,-0.00289758074265588,0.00415596068841081,-0.0110432636919411,0.00524810220662931,0.485685615040821
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP73,Tumor protein p73,40089,-0.00246479218521381,0.0035555310349058,-0.00943363301362918,0.00450404864320155,0.488181518136355
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,40206,0.00309137317571518,0.00446121336859171,-0.00565260502672458,0.0118353513781549,0.48835900794044
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40206,0.00502277555285466,0.00727655159883846,-0.00923926558086873,0.0192848166865781,0.490039797279534
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,40042,-0.005257394478287,0.00763986706858466,-0.0202315339327129,0.00971674497613894,0.49137139641631
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN15,Tetraspanin-15,40019,-0.00370391663086737,0.00538255743765243,-0.0142537292086661,0.0068458959469314,0.491383631916616
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDAC9,Histone deacetylase 9,40042,-0.00461798808325347,0.00676311493899472,-0.0178736933636831,0.00863771719717618,0.494735363773821
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TTN,Titin,40019,-0.00452822485494095,0.00677188103313134,-0.0178011116798784,0.00874466196999648,0.503713562193396
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40206,0.0036146675781555,0.00542147496902397,-0.00701142336113149,0.0142407585174425,0.504957688931207
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40411,0.00228155894581979,0.00342579337683699,-0.0044329960727807,0.00899611396442028,0.505428423741816
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42590,0.00487118603161229,0.00733279593335001,-0.00950109399775374,0.0192434660609783,0.506508908981935
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40019,-0.00358919827414641,0.00540450789827963,-0.0141820337547745,0.00700363720648165,0.506632807558256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAND5,DAN domain family member 5,40104,0.00377830672510542,0.00570647385432013,-0.00740638202936203,0.0149629954795729,0.507915462359488
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,40328,-0.00188404409646739,0.00285268963438252,-0.00747531577985713,0.00370722758692235,0.508982080195335
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42229,0.00303929270259182,0.00463374079420003,-0.00604283925404023,0.0121214246592239,0.511896973843629
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,40089,0.00244200867053502,0.00373417622233306,-0.00487697672523777,0.00976099406630781,0.513150207752884
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESPL1,Separin,39987,-0.00386547674795417,0.00592214583834825,-0.0154728825911167,0.0077419290952084,0.513953569997728
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39987,-0.00346126352735185,0.00530944226765918,-0.0138677703719638,0.00694524331726014,0.514474935532302
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRD3,Bromodomain-containing protein 3,40019,0.00334620558313872,0.00514020131159832,-0.006728588987594,0.0134210001538714,0.515068526737379
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40042,-0.00271486530523308,0.00417504025865141,-0.0108979442121898,0.00546821360172368,0.5155374996277
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB1A1,Uteroglobin,42524,-0.00371028342905439,0.0057279589619317,-0.0149370829944405,0.00751651613633175,0.517158039671239
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,40385,-0.00189708634887686,0.00295330210209368,-0.00768555846898048,0.00389138577122676,0.520651917963629
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42599,0.00270914428229073,0.00422019146282527,-0.0055624309848468,0.0109807195494282,0.520917798688998
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,40206,0.00359049500160526,0.00561916186797026,-0.00742306225961645,0.014604052262827,0.522853521971386
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,42339,0.00286184607724796,0.00452642254886097,-0.00600994211851953,0.0117336342730155,0.527232300519023
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40206,-0.0041015138303165,0.00648723767144852,-0.0168164996663556,0.00861347200572261,0.527240904783295
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNL2,Interferon lambda-2,40042,0.00400843097337778,0.00634178449035346,-0.00842146662771501,0.0164383285744706,0.52735659542104
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42536,0.00422544830346981,0.0066937134810041,-0.00889423011929822,0.0173451267262378,0.527883818342528
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,40125,-0.00277335385783973,0.00439794405586828,-0.0113933242073415,0.0058466164916621,0.528313744927891
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40125,0.00183392101232609,0.00291231725119708,-0.00387422080002018,0.00754206282467237,0.528896215668847
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH23,Cadherin-23,40385,-0.00169095916346302,0.00268671087345806,-0.0069569124754408,0.00357499414851477,0.529113868784531
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL3,Fc receptor-like protein 3,42256,0.00365076522352455,0.00580120998274901,-0.00771960634266351,0.0150211367897126,0.529156480853827
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39987,0.00406854778165457,0.00651098615200328,-0.00869298507627185,0.016830080639581,0.532066784126986
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39987,-0.00305316235287617,0.00488842019428704,-0.0126344659336788,0.00652814122792643,0.532266281394307
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39987,0.00493949834117192,0.00793219078871842,-0.0106075956047162,0.02048659228706,0.533484635937069
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THBD,Thrombomodulin,42518,-0.00192441519511463,0.00310217030073729,-0.00800466898455972,0.00415583859433046,0.53504141984854
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42256,0.00189161562800744,0.00306294308254003,-0.00411175281377102,0.0078949840697859,0.536862300439059
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MLLT1,Protein ENL,39987,-0.00421536679599659,0.00683338599392396,-0.0176088033440875,0.00917806975209436,0.537328084330487
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCN2,Transcobalamin-2,42651,0.00195522156977164,0.00316989716147029,-0.00425777686671013,0.00816822000625342,0.537371051644514
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOX2,Transcription factor SOX-2,40363,-0.00151896208012954,0.00246309639043033,-0.00634663100537299,0.00330870684511392,0.537453082302094
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC1,Sialoadhesin,42554,-0.00273826871550862,0.00444267957041937,-0.0114459206735306,0.00596938324251335,0.537670606909515
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40104,-0.00222927249429207,0.00362868290551341,-0.00934149098909835,0.00488294600051422,0.538998490448024
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,40104,0.00463968945709019,0.00756138038134376,-0.0101806160903436,0.019459995004524,0.539490163557371
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39987,-0.0031892656973903,0.00519761773275898,-0.0133765964535979,0.0069980650588173,0.539491666490255
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST6,Cystatin-M,42216,-0.00319549081392164,0.00520985083245844,-0.0134067984455402,0.00701581681769691,0.539651996803298
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALM,Paralemmin-1,40285,0.00197549838030101,0.00323475361839462,-0.00436461871175245,0.00831561547235446,0.541403689992024
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17F,Interleukin-17F,42256,-0.00471376655347676,0.00776234329639286,-0.0199279594144068,0.0105004263074532,0.54368842551053
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HBZ,Hemoglobin subunit zeta,40411,-0.00661046519077849,0.0109411569673021,-0.0280551328466906,0.0148342024651337,0.545733949031805
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPT,Dermatopontin,42673,0.00156435655318757,0.00259105572708238,-0.00351411267189389,0.00664282577826904,0.546018317829383
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42229,0.00245238324441831,0.00406717074357707,-0.00551927141299275,0.0104240379018294,0.54653892431528
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42191,-0.00415190586105637,0.00689760312402782,-0.0176712079841509,0.00936739626203817,0.547228182759773
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39987,-0.0015611686872563,0.00259572023977317,-0.00664878035721172,0.00352644298269913,0.547559927123735
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDC4,Syndecan-4,42518,0.00290496374768886,0.00483613011236444,-0.00657385127254544,0.0123837787679232,0.548063757560914
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPSD1,Tryptase delta,40384,-0.00236699964680173,0.00395515975777306,-0.0101191127720369,0.00538511347843346,0.54954604169832
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40104,0.00245646669421604,0.0041215444728356,-0.00562176047254174,0.0105346938609738,0.551183346392351
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RSPO3,R-spondin-3,42599,0.00181891948635494,0.00305415017651909,-0.00416721485962249,0.00780505383233236,0.551481489527778
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40042,0.00270795206780263,0.00459455657124733,-0.00629737881184214,0.0117132829474474,0.55561686588961
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,42229,-0.00196766567188819,0.00334492250745816,-0.00852371378650619,0.00458838244272981,0.556371681729904
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42538,0.00319514597434812,0.00543239714274241,-0.007452352425427,0.0138426443741232,0.556431487902701
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40206,0.00224464983176283,0.00382083572392011,-0.00524418818712058,0.00973348785064624,0.55689601420894
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1S,Complement C1s subcomponent,40440,-0.00125044233348364,0.00213384679589566,-0.00543278205343913,0.00293189738647185,0.557884720600357
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40089,0.00180872641114189,0.00309444156326078,-0.00425637905284924,0.00787383187513301,0.558890565230468
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA12,Carbonic anhydrase 12,42466,-0.00197420521592081,0.00340131515700067,-0.00864078292364213,0.00469237249180051,0.561638525676399
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF9,Fibroblast growth factor 9,39972,-0.00246178483005937,0.00424240248110444,-0.0107768936930241,0.00585332403290534,0.561737384191819
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39987,-0.00183479054467437,0.00316562533925398,-0.00803941620961218,0.00436983512026344,0.562197748109831
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,42256,-0.00380719002374258,0.00663573004019897,-0.0168132209025326,0.00919884085504741,0.566152994819569
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42406,0.00254849003941967,0.00445428181713612,-0.00618190232216713,0.0112788824010065,0.567234244522839
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XG,Glycoprotein Xg,42614,-0.00201961711192059,0.00353946910794985,-0.00895697656350231,0.00491774233966112,0.568281130758833
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD22,B-cell receptor CD22,42631,-0.00254338956889868,0.004474790107502,-0.0113139781796026,0.00622719904180523,0.569785196565828
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSMB,Beta-microseminoprotein,42441,-0.00420768671792656,0.00744077597248986,-0.0187916076240067,0.0103762341881536,0.57174989006793
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40352,0.00243508758305837,0.00431988708878536,-0.00603189111096094,0.0109020662770777,0.572974809010886
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOX9,Transcription factor SOX-9,40089,0.00160621094753011,0.00285055010558695,-0.00398086725942031,0.00719328915448053,0.573123737797983
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42229,-0.00711691862076035,0.0126342126023329,-0.0318799753213329,0.0176461380798122,0.573236715183759
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39987,-0.00556896501014311,0.00992086688785637,-0.0250138641103416,0.0138759340900554,0.574578422460496
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40104,-0.00315213250644712,0.00562688102723457,-0.0141808193198269,0.00787655430693263,0.575360134297392
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FBN2,Fibrillin-2,40089,0.00349863160694376,0.00626170945574265,-0.00877431892631185,0.0157715821401994,0.576354576283086
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40019,0.0034481041333931,0.00617844192248003,-0.00866164203466776,0.015557850301454,0.576796959230658
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,42191,0.00332893496999027,0.0060047369452041,-0.00844034944260977,0.0150982193825903,0.579325056062812
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,40019,0.00256203732269194,0.00463148548034984,-0.00651567421879374,0.0116397488641776,0.580152739695157
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",42237,-0.00248019176119523,0.00451057992960437,-0.0113209284232198,0.00636054490082933,0.582424165566961
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42673,0.00154391636683028,0.00280850238075277,-0.00396074829944515,0.00704858103310571,0.582514087263358
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40384,-0.00515525401893037,0.00941138673810977,-0.0236015720256255,0.0132910639877648,0.583862319684765
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTA,Lymphotoxin-alpha,42475,0.00229531183446308,0.00419570053137129,-0.00592826120702465,0.0105188848759508,0.584344754695737
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40385,0.00146514726826806,0.00268519492448329,-0.00379783478371918,0.00672812932025531,0.585324935907978
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40089,-0.00311615539868891,0.005714288193956,-0.0143161602588427,0.00808384946146486,0.585539829717547
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR2,Toll-like receptor 2,40206,-0.00131435761176917,0.00241427606616337,-0.00604633870144938,0.00341762347791104,0.586169939275629
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40352,0.00350712364609821,0.00644889253420874,-0.00913270572095092,0.0161469530131473,0.586566935575742
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMP4,Bone morphogenetic protein 4,42357,-0.00259797733867081,0.00478664875457989,-0.0119798088976474,0.00678385422030577,0.587307719240777
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40019,0.00391932034856232,0.0072283308401704,-0.0102482080981717,0.0180868487952963,0.587680521624427
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHIT1,Chitotriosidase-1,42580,-0.00857544397991316,0.0159015639602934,-0.0397425093420882,0.0225916213822619,0.589700528967383
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,40206,-0.00417079551140167,0.00773494288225038,-0.0193312835606124,0.0109896925378091,0.589749565602378
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42191,-0.00429788831568129,0.00797912670619017,-0.019936976659814,0.0113412000284514,0.590143511298181
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF6,Fibroblast growth factor 6,40104,-0.00229496744530502,0.00426425902549598,-0.0106529151352771,0.0060629802446671,0.590459147692125
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",40019,0.00219847580820081,0.0041070737680901,-0.00585138877725579,0.0102483403936574,0.592460287267604
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40206,0.00358510468213436,0.00670315267754978,-0.00955307456586321,0.0167232839301319,0.592772279148158
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42377,0.00339506160360943,0.0063482049279716,-0.00904742005521491,0.0158375432624338,0.592792650116881
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40125,-0.00181569514682583,0.00344315860321243,-0.00856428600912218,0.00493289571547052,0.59797225912109
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFP,Properdin,40440,0.0011927767541523,0.00228408606688023,-0.00328403193693295,0.00566958544523755,0.601533139114861
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD160,CD160 antigen,42631,0.00261975210082749,0.00503703235478245,-0.00725283131454612,0.0124923355162011,0.603003612692597
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,40042,0.00413713754024653,0.00806709878633332,-0.0116743760809668,0.0199486511614598,0.60807311700259
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,40019,0.00183567890571226,0.0035825874167608,-0.00518619243113891,0.00885755024256342,0.608389140037312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,40190,0.00541488246010972,0.0105681038856112,-0.0152986011556883,0.0261283660759077,0.608395549476681
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPT1,Translationally-controlled tumor protein,42256,-0.00344681603952561,0.0067306936122013,-0.0166389755194402,0.00974534344038894,0.608586787864869
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39987,-0.00223383862876081,0.00436834946505176,-0.0107958035802623,0.00632812632274064,0.609103137548435
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40089,0.00442865499166992,0.00866196233395244,-0.0125487911828769,0.0214061011662167,0.609168044502097
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,40244,0.00223609523022881,0.00442999317926595,-0.00644669140113246,0.0109188818615901,0.613735596485065
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A13,Protein S100-A13,40104,-0.00184121655827414,0.00365235038816192,-0.0089998233190715,0.00531739020252323,0.614188448988372
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40384,0.0059725710508909,0.011852425824384,-0.0172581835649018,0.0292033256666836,0.614333644998568
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40384,0.00201938663628442,0.00401301286913377,-0.00584611858721778,0.00988489185978661,0.614826814316562
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40206,-0.00341115831592247,0.00678020484159823,-0.016700359805455,0.00987804317361007,0.614900165474117
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,42358,-0.0017264977233498,0.00344142030607233,-0.00847168152325158,0.00501868607655197,0.615899801757882
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL3,Myosin light chain 3,40125,-0.00377130582010478,0.007552785825942,-0.0185747660389511,0.0110321543987415,0.617559465724087
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL26,C-C motif chemokine 26,42475,-0.00473639152858859,0.00956655534473564,-0.0234868400042704,0.0140140569470933,0.62053846401208
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL4,Interleukin-4,42256,0.0047253786801139,0.00962041557990271,-0.0141306358564954,0.0235813932167232,0.623305708108812
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HLA_DRA,,42430,0.00185122883212257,0.00380358496133146,-0.00560379769208708,0.00930625535633223,0.626474526076204
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40089,-0.00181624771951869,0.00373775975183755,-0.00914225683312029,0.00550976139408291,0.627034513415459
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMEM132A,Transmembrane protein 132A,40125,-0.00308418635099228,0.00645295754936109,-0.01573198314774,0.00956361044575545,0.632695869774615
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42191,-0.00222830844522023,0.00470928745745579,-0.0114585118618336,0.00700189497139313,0.636097588696479
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39987,-0.00270298810224902,0.00572226544407561,-0.0139186283726372,0.00851265216813918,0.636677056614325
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF12,Fibroblast growth factor 12,40104,-0.00226788202213069,0.00482000918508375,-0.0117151000248948,0.00717933598063347,0.637997207553663
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42256,0.00217566712767645,0.00463156765978975,-0.00690220548551146,0.0112535397408644,0.638543299839093
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNPY2,Protein canopy homolog 2,42237,-0.00293773926140093,0.00633430760987364,-0.0153529821767533,0.00947750365395141,0.642811520885678
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40089,0.00245108992954208,0.00533512576723797,-0.00800575657424433,0.0129079364333285,0.645938195698715
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40089,-0.00149438032419318,0.00326497181783311,-0.00789372508714607,0.00490496443875972,0.647176515978947
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42229,-0.00170368015946462,0.00372290001565484,-0.0090005641901481,0.00559320387121886,0.647231815117534
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40042,-0.00242672265242109,0.00532143200890523,-0.0128567293898753,0.00800328408503317,0.648378883694886
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCIN,Adseverin,40042,-0.00342196032799166,0.00752103923876006,-0.0181631972359614,0.011319276579978,0.649129107525068
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRR1B,Cornifin-B,40206,0.00389394428904308,0.00856883998555948,-0.0129009820826535,0.0206888706607397,0.649527788942739
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX1B,Syntaxin-1B,40089,0.00190039916086158,0.00418217902078037,-0.00629667171986795,0.0100974700415911,0.649547077425334
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39987,0.0066943063150059,0.0147691901880368,-0.0222533064535463,0.0356419190835581,0.65036951479999
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMNB1,Lamin-B1,40335,-0.00277404044664574,0.00614521546081051,-0.0148186627498343,0.00927058185654286,0.651699494420365
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,42191,-0.00159844706557463,0.00355002207035138,-0.00855649032346335,0.00535959619231408,0.652527618360951
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40384,0.003340418151676,0.00742891092174757,-0.0112202472549492,0.0179010835583012,0.65297072756697
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42673,-0.00322567165082694,0.00722029214855088,-0.0173774442619867,0.0109261009603328,0.655062140284767
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42560,0.00137187257178361,0.00308982418873058,-0.00468418283812833,0.00742792798169554,0.65705196363276
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,40089,-0.00191302646092905,0.00432258678742922,-0.0103852965642903,0.00655924364243221,0.658089050532735
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39987,-0.00157395440686912,0.00356754480709982,-0.00856634222878477,0.00541843341504653,0.659086457970824
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPGN,Epigen,40352,0.00206457720025864,0.00468640128600063,-0.00712076932030259,0.0112499237208199,0.659549950591568
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTKN2,Rhotekin-2,40019,-0.00234267689606892,0.00533456495164481,-0.0127984242012927,0.0081130704091549,0.660561250649561
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40089,-0.00166758265402987,0.00380157127423121,-0.00911866235152303,0.0057834970434633,0.660919396056169
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40352,-0.0040845149220939,0.00932784580972789,-0.0223670927091606,0.0141980628649728,0.661478812808131
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",40042,0.0038388988816405,0.00880308521002487,-0.0134151481300082,0.0210929458932892,0.662783287012999
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40019,-0.00169640829474375,0.00389975992108819,-0.0093399377400766,0.00594712115058909,0.663568730085257
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40352,-0.00342832531834657,0.007884556910114,-0.01888205686217,0.0120254062254769,0.663704968130979
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECM1,Extracellular matrix protein 1,40172,0.00165514897876674,0.00383602750225207,-0.00586346492564732,0.0091737628831808,0.666131686643187
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C5,Complement C5,40440,0.000665467001543128,0.00154478769880143,-0.00236231688810768,0.00369325089119393,0.666635019010539
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40042,-0.00191659611389314,0.00445524871589319,-0.0106488835970438,0.0068156913692575,0.667067178089016
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,42229,0.00201473362399317,0.00473949848379942,-0.00727468340425369,0.01130415065224,0.670774975530069
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40350,0.00380683525086151,0.00899257939241345,-0.0138186203582689,0.0214322908599919,0.672062132979928
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39966,-0.00115055465192841,0.00272884362371844,-0.00649908815441656,0.00419797885055973,0.673305574621585
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,40089,-0.00181788725633954,0.00432774534103208,-0.0103002681247624,0.00666449361208334,0.674454202284961
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40104,-0.0017736441333007,0.00422288590054457,-0.0100505004983681,0.00650321223176665,0.674488179433281
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD59,CD59 glycoprotein,42016,0.00106991120443556,0.00256963902737409,-0.00396658128921766,0.00610640369808878,0.677148922206466
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKD1,Polycystin-1,40411,-0.00114269537616419,0.00275530919872972,-0.00654310140567445,0.00425771065334607,0.678351221480566
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTF4,Neurotrophin-4,42229,-0.00165398229937203,0.00401452545478884,-0.00952245219075816,0.0062144875920141,0.680346597442214
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,42323,0.0012301691195791,0.00298815343611512,-0.00462661161520654,0.00708694985436473,0.680579206850358
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSTN3,Calsyntenin-3,40385,-0.00129288110488472,0.003145479818187,-0.00745802154853124,0.0048722593387618,0.681059681075848
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42469,0.000992482513960037,0.00242404154807102,-0.00375863892025917,0.00574360394817924,0.682228559133812
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40428,-0.00125174379079552,0.00309147297757726,-0.00731103082684694,0.00480754324525591,0.685557210265405
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42256,-0.00150273015053929,0.00371545967573085,-0.00878503111497175,0.00577957081389317,0.685885990490054
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40104,-0.00176424088656006,0.00437043084946281,-0.0103302853515072,0.00680180357838704,0.686458423518453
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,42229,0.00200023489098575,0.00495565939143745,-0.00771285751623166,0.0117133272982032,0.686494100315397
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40042,-0.0025757438806566,0.00644502167884613,-0.015207986371195,0.0100564986098818,0.689423224553116
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPSG1,Tryptase gamma,40104,-0.00108806799011598,0.00273045498096354,-0.00643975975280453,0.00426362377257256,0.690274401251623
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPPB,Natriuretic peptides B,42237,-0.00579865078747284,0.0145747954043201,-0.0343652497799402,0.0227679482049945,0.690743808195343
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40089,0.00174420643364886,0.00441151531809452,-0.0069023635898164,0.0103907764571141,0.692573301003712
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRING1,SREBP regulating gene protein,39987,0.0023919614943103,0.00609745113076457,-0.00955904272198825,0.0143429657106089,0.69485261973605
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42590,-0.00190646240437088,0.00488079261561462,-0.0114728159309755,0.00765989112223378,0.696095379129255
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAP1,Antigen peptide transporter 1,40206,-0.00241796720227747,0.00634882363344047,-0.0148616615238208,0.0100257271192658,0.703319830891868
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSLN,Mesothelin,42432,0.00233490666270055,0.00614105502028188,-0.00970156117705193,0.014371374502453,0.703793686719209
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42568,-0.00167131699479651,0.00443895167372228,-0.0103716622752922,0.00702902828569915,0.706542533099664
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRD1,Bromodomain-containing protein 1,40206,-0.00118090490322959,0.00315359552087165,-0.00736195212413802,0.00500014231767884,0.708067074572867
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42554,0.00108726608528219,0.00291190041536579,-0.00462005872883476,0.00679459089939914,0.708866274819712
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40019,-0.00145187733175082,0.00389502067302669,-0.00908611785088314,0.0061823631873815,0.709340216579755
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42490,0.00168276989740631,0.00452495968284483,-0.00718615108096956,0.0105516908757822,0.709983533649805
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1B,Interleukin-1 beta,42180,0.00216107266891196,0.00584391230872992,-0.0092929954561987,0.0136151407940226,0.711538323668214
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40019,-0.00185283470679322,0.00502553957728013,-0.0117028922782623,0.00799722286467584,0.712370682846594
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42466,0.000820309469707926,0.00223467651578737,-0.00355965650123533,0.00520027544065118,0.71356372430074
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40042,-0.00188323196871721,0.00514956684157877,-0.0119763829782116,0.00820991904077718,0.714590950289171
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42466,0.000940211119239026,0.00257687937110076,-0.00411047244811846,0.00599089468659651,0.715218566734286
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MATN2,Matrilin-2,42516,-0.00110652613411688,0.00303816555885885,-0.00706133062948023,0.00484827836124648,0.715707998889833
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFNA1,Ephrin-A1,42469,0.00113273569586703,0.00311134687682844,-0.00496550418271671,0.00723097557445078,0.715814503295098
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40019,0.00140500362031902,0.0039005954170344,-0.00624016339706839,0.00905017063770644,0.718702847871713
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39987,-0.00180430166870266,0.00503394689205643,-0.0116708375771333,0.00806223423972794,0.720030920086782
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAGE2A,G antigen 2A,39987,-0.00246530345377437,0.00687895208838498,-0.0159480495470089,0.0110174426394602,0.720063289596425
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39987,-0.00229105598460471,0.00644207272542878,-0.0149175185264451,0.0103354065572357,0.72211745497023
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BEX3,Protein BEX3,39987,-0.00174983068144807,0.00492885451856111,-0.0114103855378279,0.00791072417493172,0.722583254907282
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,40104,0.0025783623484877,0.00731971200996813,-0.0117682731910498,0.0169249978880252,0.724658221939049
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL3,Interleukin-3,39987,0.00223993149163077,0.00636601419247839,-0.0102374563256269,0.0147173193088884,0.72495180807743
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBM19,Probable RNA-binding protein 19,40019,0.00172741844646637,0.00493839817385818,-0.00795184197429567,0.0114066788672284,0.726500654894842
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39987,-0.0020397645335009,0.00594351848247937,-0.0136890607591605,0.00960953169215866,0.731461145017945
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42475,0.0011656091077522,0.00339877674706312,-0.00549599331649152,0.00782721153199591,0.731641808424927
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40042,0.00133650807746148,0.00390120132347535,-0.00630984651655021,0.00898286267147317,0.731914428500566
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAPPA,Pappalysin-1,42256,-0.00164616781781789,0.00480656666279284,-0.0110670384768919,0.00777470284125607,0.731992875977992
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA7,Carbonic anhydrase 7,40206,-0.00124333585106516,0.00363255377049239,-0.00836314124123024,0.00587646953909991,0.732149752971893
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40206,-0.00142901356846918,0.0041761894441316,-0.0096143448789671,0.00675631774202875,0.732221053092962
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40384,-0.00130602403623293,0.0038192682187974,-0.00879178974507582,0.00617974167260997,0.73238996321701
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42229,0.00281702998993113,0.00827751328645144,-0.0134068960515137,0.019040956031376,0.733618615321431
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUCL3,Mucin-like protein 3,39987,0.00148285983773699,0.00436828980153873,-0.00707898817327892,0.0100447078487529,0.734269798913535
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,40206,-0.00154986986374859,0.00459763718974223,-0.0105612387556434,0.0074614990281462,0.736046897962347
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,40104,0.00302796975410174,0.00898786259949997,-0.0145882409409182,0.0206441804491217,0.736202217494595
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300A,CMRF35-like molecule 8,40187,-0.00107786548582804,0.00320180055310573,-0.00735339456991528,0.00519766359825919,0.736392052765947
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAD2,Glutamate decarboxylase 2,40104,-0.00159029856776851,0.00474526544066592,-0.0108910188314737,0.00771042169593669,0.737530643372485
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40384,0.000688699406173547,0.00205768034785966,-0.00334435407563139,0.00472175288797848,0.737859950028383
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39987,0.00220340731847075,0.00659413911596936,-0.0107211053488292,0.0151279199857707,0.73827564080368
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,40089,0.0021055014795083,0.00631830044711528,-0.0102783673968376,0.0144893703558543,0.738960609292725
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLL4,Delta-like protein 4,40125,0.00294398660205207,0.00885595560163598,-0.0144136863771544,0.0203016595812586,0.739570853805717
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB118,Beta-defensin 118,40042,-0.00194597564585226,0.00587544674499835,-0.013461851266049,0.0095698999743445,0.740496258822531
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACTN4,Alpha-actinin-4,42256,-0.00111288190290849,0.00336540446470269,-0.00770907465372576,0.00548331084790878,0.740889280369637
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40350,0.00100399816673176,0.00305051858272201,-0.00497501825540338,0.0069830145888669,0.742068319044993
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,40125,-0.0013364854932125,0.00408265981294425,-0.00933849872658323,0.00666552774015823,0.743404482848842
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40352,0.00323924454531111,0.00995169292004848,-0.0162660735779839,0.0227445626686061,0.744811181148469
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP1,Retinol-binding protein 1,40089,0.00229158563540509,0.00704203685891421,-0.0115108066080668,0.0160939778788769,0.744873123202981
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40125,-0.00146272811708312,0.00449752872351831,-0.010277884415179,0.00735242818101276,0.745013759530244
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42229,0.0025798508003194,0.0079567960525013,-0.0130154694625831,0.0181751710632219,0.745767323296592
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMEM25,Transmembrane protein 25,40384,0.00148885281989961,0.00469438944569405,-0.00771215049366073,0.01068985613346,0.751131306607109
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFNB2,Ephrin-B2,40089,-0.0017620505688232,0.00562435025936936,-0.0127857770771871,0.00926167593954074,0.754066630846129
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42229,0.00152959852333613,0.00490392342418919,-0.00808209138807468,0.0111412884347469,0.755111467540587
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK15,Kallikrein-15,40330,-0.00167330945655089,0.00549415097867757,-0.0124418453747589,0.00909522646165715,0.760705477897015
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42229,0.0016311762811391,0.00535955257264679,-0.0088735467612486,0.0121358993235268,0.760866618379116
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NXPH1,Neurexophilin-1,42191,0.0012050634668142,0.0040076750188036,-0.00664997957004086,0.00906010650366926,0.763656529365318
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL6B,Myosin light chain 6B,40089,0.00279321112205455,0.00937434679522699,-0.0155805085965904,0.0211669308406995,0.765736871023933
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB5,Serpin B5,42237,0.00148646315572319,0.00501778759496829,-0.00834840053041466,0.011321326841861,0.767052469715578
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CENPJ,Centromere protein J,40206,0.00215817334284394,0.00730826876948362,-0.0121660334453439,0.0164823801310318,0.767765938618351
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40421,0.000755313994948463,0.00260077528120701,-0.00434220555621727,0.0058528335461142,0.771501238993889
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFHR2,Complement factor H-related protein 2,40352,0.00171426313714419,0.00593909161651286,-0.00992635643122101,0.0133548827055094,0.772861762853072
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39987,-0.00126449742299047,0.0044009170863584,-0.00989029491225293,0.007361300066272,0.773868316014582
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPHS2,Podocin,40104,-0.00305844836516241,0.0107650145084187,-0.0241578768016631,0.0180409800713383,0.776331468730222
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,42357,0.00116951800719567,0.00416874171231738,-0.0070012157489464,0.00934025176333774,0.779064116031627
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40187,0.00108579759504838,0.0038723596500474,-0.00650402731904452,0.00867562250914128,0.779178300644235
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40384,-0.00216120324687965,0.00771359126228341,-0.0172798421209551,0.0129574356271958,0.779343669566527
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRELP,Prolargin,42496,0.00070182977015205,0.00250661801955744,-0.00421114154818052,0.00561480108848462,0.779488982572491
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40104,-0.00120084107791369,0.0042952928530161,-0.00961961506982525,0.00721793291399787,0.779811644225711
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL18,C-C motif chemokine 18,42357,0.00198550480604327,0.00716816180475411,-0.0120640923312748,0.0160351019433613,0.781792598151598
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300C,CMRF35-like molecule 6,42590,0.0010174161534917,0.00368619817538671,-0.00620753227026624,0.00824236457724965,0.782547019514943
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEK,Angiopoietin-1 receptor,42561,0.000617684901830075,0.00225425984248994,-0.00380066438945021,0.00503603419311036,0.784082819859107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFDN6,Prefoldin subunit 6,40089,-0.00179483145990867,0.00664265055123968,-0.0148144265403385,0.0112247636205211,0.787012983434311
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40042,-0.00158316508220918,0.00587331879057974,-0.0130948699117455,0.0099285397473271,0.787510025563781
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40042,-0.00170737314176537,0.00634629062074074,-0.0141461027584172,0.0107313564748865,0.787908005654381
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,40042,-0.00309846261281004,0.0115353231789932,-0.0257076960436367,0.0195107708180166,0.788237629069769
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40352,0.00173541132137296,0.00657134504672928,-0.0111444249702164,0.0146152476129624,0.791717227877897
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCUN1D1,DCN1-like protein 1,40042,0.0020313508963728,0.00769684107501188,-0.0130544576106505,0.0171171594033961,0.791846517255903
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGR,Progesterone receptor,40104,-0.00264122744015748,0.010041501020289,-0.0223225694399238,0.0170401145596089,0.792531546180908
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK6,Kallikrein-6,42538,-0.000846765173193742,0.00325636681719153,-0.00722924413488914,0.00553571378850166,0.79484177608238
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN7,Septin-7,40206,-0.00144925458478976,0.00560355548902337,-0.0124322233432756,0.00953371417369605,0.795924599797082
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40432,0.000752580948435764,0.00293393103368896,-0.00499792387759459,0.00650308577446612,0.79756220286632
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42631,0.00125522483152976,0.00492527647412106,-0.00839831705774752,0.010908766720807,0.798840013814952
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NGF,Beta-nerve growth factor,42377,-0.000313136154008488,0.00123262505728022,-0.00272908126627773,0.00210280895826075,0.799468565000969
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,40187,-0.000759227437493136,0.00299573604098098,-0.00663087007781586,0.00511241520282959,0.799936030631611
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40350,0.000662944502336113,0.00263624874668257,-0.00450410304116172,0.00582999204583394,0.801453324034521
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40411,0.00185057873468822,0.00737679538660895,-0.0126079402230653,0.0163090976924418,0.80192318912325
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSR,Insulin receptor,40104,-0.000445831036834632,0.00177846471419417,-0.00393162187665521,0.00303995980298595,0.802063853171365
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYTH3,Cytohesin-3,39987,-0.00192590080672207,0.00770073452248361,-0.0170193404707899,0.0131675388573458,0.802520087926678
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSTN,Osteocrin,40089,-0.00105963774532969,0.00430922928955267,-0.00950572715285292,0.00738645166219355,0.805764587904567
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRND,Prion-like protein doppel,40385,-0.00132185006916339,0.00537996896662217,-0.0118665892437428,0.00922288910541606,0.805920173033968
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42673,-0.000648632440565644,0.00270680546621354,-0.00595397115434418,0.00465670627321289,0.810620564069378
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39966,0.00122787893930601,0.00512768986104615,-0.00882239318834445,0.0112781510669565,0.810753113995805
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40350,-0.00362925735085641,0.0152877823436316,-0.0335933107443743,0.0263347960426615,0.812354003929699
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42237,0.00117302811107877,0.00501265798844018,-0.00865178154626399,0.0109978377684215,0.814978407794367
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42673,0.000755365411802866,0.00323282800442832,-0.00558097747687665,0.00709170830048238,0.815256617749784
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FXN,"Frataxin, mitochondrial",42599,-0.00175191933415243,0.00750472301742257,-0.0164611764483007,0.0129573377799958,0.815421582618033
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42577,-0.000988974885417195,0.00424901133731716,-0.00931703710655883,0.00733908733572444,0.815955902431139
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40019,0.00140952587753273,0.00611465591957819,-0.0105751997248405,0.013394251479906,0.817695206697126
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,40206,-0.000939116933687291,0.00412105230927575,-0.00901637945986775,0.00713814559249317,0.819741586477352
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40428,-0.00332049441547583,0.0145890065735484,-0.0319149472996306,0.025273958468679,0.819959415681245
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42631,-0.000831916959080929,0.00366866162657857,-0.00802249374717493,0.00635865982901307,0.82061143403038
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNF174,Zinc finger protein 174,40104,-0.000861703534397662,0.00383577569998044,-0.00837982390635932,0.00665641683756399,0.822256476740595
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSB,Lupus La protein,42191,0.00133682830685757,0.00602144793782891,-0.0104652096512871,0.0131388662650022,0.824308727145987
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHH,Sonic hedgehog protein,40104,-0.000955771126515251,0.00433308893257599,-0.00944862543436419,0.00753708318133369,0.825427489771224
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39972,-0.00115560834484515,0.00536826776834244,-0.0116774131707963,0.00936619648110603,0.829563600492178
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNF830,Zinc finger protein 830,40352,0.00171899579132892,0.00798642668524963,-0.0139344005117604,0.0173723920944182,0.829584402500186
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40019,-0.00105047749321379,0.00491894066563392,-0.0106916011978563,0.00859064621142869,0.830896036356995
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40104,0.00103473412107421,0.004856253800808,-0.00848352332850948,0.0105529915706579,0.831274397738878
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EXTL1,Exostosin-like 1,40019,0.00103136081072352,0.00488922693859934,-0.0085515239889312,0.0106142456103782,0.832933707496334
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40015,0.000738495427289878,0.00353506966299368,-0.00619024111217774,0.0076672319667575,0.834525957740388
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,42237,-0.00130757592422497,0.00629510584484343,-0.0136459833801181,0.0110308315316682,0.835456234555252
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40372,0.000846965390216525,0.00421263642011137,-0.00740980199320177,0.00910373277363482,0.840660381808986
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FSTL1,Follistatin-related protein 1,40125,0.000465169290614298,0.00232744831901083,-0.00409662941464693,0.00502696799587553,0.841591954401952
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHPK,Sedoheptulokinase,40206,0.000841205156228615,0.00423104118780956,-0.00745163557187812,0.00913404588433535,0.842409153583283
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSC1,Hamartin,40104,0.00147731347186313,0.00754075689518334,-0.0133025700426962,0.0162571969864225,0.844683865462828
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENAH,Protein enabled homolog,42256,-0.000936400153269335,0.00483845027434308,-0.0104197626909818,0.0085469623844431,0.846544515866543
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FRMD7,FERM domain-containing protein 7,40089,0.000648498785670095,0.0034463652711238,-0.00610637714573256,0.00740337471707275,0.850747750255509
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AFAP1,Actin filament-associated protein 1,40187,-0.00160767675100933,0.00855213225108447,-0.0183698559631349,0.0151545024611162,0.850891497305459
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40042,-0.00104222352468929,0.00556337318146629,-0.0119464349603632,0.00986198791098465,0.851400216550042
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42447,0.000728126687453664,0.00397529979117677,-0.00706346090325281,0.00851971427816014,0.854673153390454
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42465,-0.000787333312791744,0.00431348874646752,-0.00924177125586807,0.00766710463028459,0.855171018054892
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN5,CCN family member 5,42490,0.000713340294106405,0.0039634740848422,-0.00705506891218431,0.00848174950039712,0.857172155464678
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAPN3,Calpain-3,40352,-0.000705981709722136,0.00392507133842171,-0.00839912153302868,0.00698715811358441,0.857262068477829
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42673,0.000539440190138733,0.00300159583653059,-0.00534368764946123,0.0064225680297387,0.857376822706892
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39538,-0.00100194741512959,0.00561756222851863,-0.0120123693830261,0.0100084745527669,0.858443891306571
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NXPE4,NXPE family member 4,40019,-0.000618833994160327,0.00348108054599462,-0.00744175186430979,0.00620408387598913,0.858906414689053
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40352,0.000811637866455033,0.00457387989806596,-0.00815316673375426,0.00977644246666432,0.859157662818264
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,METAP1,Methionine aminopeptidase 1,42191,-0.000533648534759319,0.00301100656077902,-0.00643522139388619,0.00536792432436755,0.859328448163044
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40411,-0.000493491521272168,0.00280878288596065,-0.00599870597775504,0.0050117229352107,0.86053606037997
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMOD4,Tropomodulin-4,39987,-0.000741361567223625,0.00425556335260105,-0.00908226573832169,0.00759954260387444,0.861703717207395
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40206,0.000684961572821362,0.00393257267312496,-0.00702288086650357,0.00839280401214629,0.861729989532422
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39987,0.00046441299773479,0.00269149747352289,-0.00481092205037007,0.00573974804583965,0.863009820384536
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDAC8,Histone deacetylase 8,40104,0.00104164670055217,0.00604635379567559,-0.010809206738972,0.0128925001400763,0.863223089828308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40104,-0.000517901061705168,0.00301867290019416,-0.00643449994608572,0.00539869782267538,0.863782070293828
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40089,0.00146010326118133,0.00865971143529276,-0.0155129311519925,0.0184331376743551,0.866107514709905
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F11,Coagulation factor XI,40284,0.000517063207005655,0.00308911124268731,-0.00553759482866147,0.00657172124267278,0.86707213448215
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,40089,0.00172727192460207,0.0106031827555794,-0.0190549662763336,0.0225095101255378,0.870599193020126
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42584,-0.000481510203126772,0.00303162521378395,-0.00642349562214331,0.00546047521588976,0.87380594296005
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLI2,Zinc finger protein GLI2,40104,-0.000513667033794619,0.00328979143767528,-0.00696165825163816,0.00593432418404893,0.87592579835404
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39972,0.00122012842380649,0.00831560705474821,-0.0150784614035,0.017518718251113,0.883349837908626
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUK1,Guanylate kinase,40019,-0.000579545999836408,0.00397130272159081,-0.0083632993341544,0.00720420733448158,0.88397662379886
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42237,0.000493728835731631,0.00342714323892422,-0.00622347191255984,0.0072109295840231,0.885451956718895
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40432,-0.000590578923201464,0.00417569734060718,-0.00877494571079154,0.00759378786438861,0.887530890064884
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40019,0.000560609013813501,0.00407013719562415,-0.00741685988960984,0.00853807791723684,0.890450735765756
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42237,0.00108642016937866,0.00798712020595061,-0.0145683354342845,0.0167411757730419,0.891806373839534
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMCH,Pro-MCH,40019,-0.00118702380709436,0.00873256669219862,-0.0183028545238037,0.0159288069096149,0.891878601905684
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GHRL,Appetite-regulating hormone,42518,0.00118327697620271,0.00873047043590851,-0.015928445078178,0.0182949990305834,0.892191605133989
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42556,0.000794651762502357,0.00590948528141951,-0.0107879393890799,0.0123772429140846,0.893032519003729
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK12,Kallikrein-12,42229,0.00191203505464342,0.0143493846489277,-0.0262127588572549,0.0300368289665417,0.893998853046002
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39987,-0.00119196036184254,0.00905153934305234,-0.0189329774742251,0.01654905675054,0.895235170649143
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOSB,Protein fosB,42191,0.000512591049023121,0.00395486905770798,-0.00723895230408452,0.00826413440213076,0.896876902681496
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40104,0.000369091699837889,0.00291115920751396,-0.00533678034688947,0.00607496374656524,0.899112801386079
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRK1,Protein BRICK1,42191,0.000587150115868243,0.00463603732612209,-0.00849948304333106,0.00967378327506754,0.899220065273536
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYH7B,Myosin-7B,39987,-0.000582486475108288,0.00461132659523492,-0.00962068660176874,0.00845571365155216,0.899483776254395
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40384,0.000975913974674896,0.00776923499247036,-0.014251786610567,0.0162036145599168,0.900040828144042
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKCQ,Protein kinase C theta type,42256,-0.000556014767885438,0.00451341325231451,-0.00940230474242187,0.00829027520665099,0.901957243046777
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40384,0.000892477167722571,0.00743541797027044,-0.0136809420540075,0.0154658963894526,0.904461117363312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEP1B,Meprin A subunit beta,42518,0.00144406348835498,0.0121439295650653,-0.0223580384591731,0.025246165435883,0.905346571325909
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNLY,Granulysin,42490,0.000649230642637056,0.00549985988287719,-0.0101304947278022,0.0114289560130764,0.906033831121065
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39987,-0.000378276660109284,0.00324429553153573,-0.00673709590191931,0.00598054258170074,0.907181209823964
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40206,0.000941861865991168,0.00831488457401137,-0.0153553118990711,0.0172390356310535,0.909815238921982
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEB,Nebulin,40019,-0.00043829437479529,0.0039671005290663,-0.00821381141176524,0.00733722266217466,0.912028937812958
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40206,-0.000710220075046632,0.00650406264910943,-0.0134581828673011,0.0120377427172079,0.91304872375401
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UNG,Uracil-DNA glycosylase,40352,-0.00038281476485374,0.00351653289853169,-0.00727521924597586,0.00650958971626838,0.913314364618128
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUOX2,Dual oxidase 2,42237,0.000791875411977881,0.00736984104887558,-0.0136530130438183,0.015236763867774,0.914435150341133
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39987,-0.00069570441095337,0.0065190098901396,-0.013472963795627,0.0120815549737202,0.91501362525091
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42562,0.000283335538412701,0.00280357314653666,-0.00521166782879916,0.00577833890562456,0.919502524045161
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40042,-0.000582422338836768,0.00602782255437571,-0.0123969545454132,0.0112321098677396,0.923028097195231
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRL,Prolactin,42590,-0.000714514695969243,0.00770951967938088,-0.0158251732675558,0.0143961438756173,0.926159541941931
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYO6,Unconventional myosin-VI,40384,0.000346884460565771,0.00374757430599665,-0.00699836117918766,0.00769213010031921,0.926252875331427
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPLX2,Complexin-2,39987,0.000296877966142627,0.0032373307462986,-0.00604829029660264,0.00664204622888789,0.926934482471296
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NENF,Neudesin,40352,-0.00101590705750706,0.0113264921493928,-0.023215831670317,0.0211840175553028,0.928532788743676
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40206,-0.000423179396471166,0.0048863460139043,-0.0100004175837236,0.00915405879078127,0.930987488966338
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF8,SLAM family member 8,42229,-0.000480694477992729,0.00567880973864358,-0.0116111615657341,0.0106497726097487,0.932543294656569
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40125,0.00233627504326428,0.0278986542592779,-0.0523450873049204,0.057017637391449,0.933263497426318
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,40206,0.000689711902243824,0.0082367508291652,-0.01545431972292,0.0168337435274076,0.93326792005838
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOL1,Apolipoprotein L1,40432,-0.000495692373561554,0.0059713640418246,-0.0121995658955378,0.0112081811484147,0.933843809060875
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39987,0.000297529693658087,0.00401937927309124,-0.00758045368160074,0.00817551306891691,0.940992826025358
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42554,-0.000243612369058437,0.00340536283266954,-0.00691812352109074,0.00643089878297386,0.942970764734447
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COPE,Coatomer subunit epsilon,42191,-0.000343155369500425,0.00490199389672768,-0.00995106340708669,0.00926475266808584,0.944192171724293
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,42256,0.000350241450306084,0.0050175655850669,-0.00948418709642505,0.0101846699970372,0.944351477171079
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40206,-0.000445928268222747,0.00656014438912612,-0.0133038112709099,0.0124119547344644,0.945806471772377
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY6D,Lymphocyte antigen 6D,42428,-0.000282162093741979,0.00419480476450577,-0.00850397943217328,0.00793965524468932,0.946372030782756
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42191,-0.000350203465355416,0.00524400677431071,-0.0106284567430044,0.00992804981229358,0.946756553043107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41831,-0.000181463095886833,0.00302855138110568,-0.00611742380285397,0.0057544976110803,0.952222323993229
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCLRE1C,Protein artemis,39987,0.000189434186368344,0.00321438131361037,-0.00611075318830798,0.00648962156104467,0.953006303792719
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40042,0.000324621098834325,0.00566072841544241,-0.0107704065954328,0.0114196487931014,0.954270498012632
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40104,0.000282195425204591,0.00497274464900166,-0.00946438408683867,0.0100287749372479,0.954746638022064
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40019,0.000195946577987757,0.00350485739036907,-0.00667357390713563,0.00706546706311114,0.95541680889595
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF3,Fibroblast growth factor 3,40104,0.000166014330111894,0.00298114469635141,-0.00567702927473686,0.00600905793496065,0.955591287012017
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESR1,Estrogen receptor,40104,0.000315175817864852,0.00568272921320106,-0.0108229734400092,0.0114533250757389,0.95577137782343
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP2,Guanylate-binding protein 2,42256,0.000340032740596956,0.00623412366010206,-0.0118788496332031,0.012558915114397,0.956502754160353
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,40042,0.0002480453953471,0.00457510566833734,-0.00871916171459408,0.00921525250528828,0.956763816281068
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40350,-0.000962981563805802,0.0180040167799078,-0.0362508544524251,0.0343248913248135,0.957344814244228
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICOSLG,ICOS ligand,42466,0.000106150386310513,0.00198937769455648,-0.00379302989502018,0.00400533066764121,0.957447002639377
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWF,von Willebrand factor,42673,0.000387936105221376,0.00738718318547224,-0.0140909429383042,0.014866815148747,0.958119318045792
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPON1,Spondin-1,42516,0.000170998526049796,0.00348292034025471,-0.00665552534084943,0.00699752239294902,0.960843282499885
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HRAS,GTPase Hras,40190,-0.000415829611232104,0.0102356609754105,-0.0204777251230366,0.0196460659005724,0.967595132751842
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEF,Thyrotroph embryonic factor,40019,0.000181110032917553,0.00449069394859241,-0.00862065010632356,0.00898287017215867,0.967830719020444
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSAP,Gamma-secretase-activating protein,42229,-0.000316606998112046,0.00880732885185551,-0.0175789715477488,0.0169457575515247,0.97132426931014
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42256,0.000377179206198742,0.0117203089164966,-0.0225946262701346,0.0233489846825321,0.974327659244262
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,40019,0.000156815760299248,0.00502059719886368,-0.00968355474947357,0.00999718627007206,0.975083115305779
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40019,0.000173607531627297,0.00590318899053566,-0.0113966428898226,0.0117438579530772,0.976538849736714
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42256,0.00016649944761865,0.0058497134897391,-0.01129893899227,0.0116319378875073,0.977293441794068
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40432,0.000103379409088767,0.00387873777066081,-0.00749894662140641,0.00770570543958394,0.978737094668968
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RUVBL1,RuvB-like 1,42229,-0.00027922858628711,0.0108629185930514,-0.0215705490286679,0.0210120918560937,0.979493230136224
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN2,Ataxin-2,40042,0.000253178746744635,0.0113726398413593,-0.0220371953423196,0.0225435528358089,0.982239297571512
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP350,Centrosome-associated protein 350,39987,8.54170090154902e-05,0.00391805427583029,-0.00759396937161188,0.00776480338964286,0.982607199717229
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40042,0.000129616755321911,0.00598047506196988,-0.0115921143661391,0.0118513478767829,0.982708944202127
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOP56,Nucleolar protein 56,40019,0.000236066099543926,0.0115186272066968,-0.0223404432255818,0.0228125754246696,0.983649443850225
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,40104,-5.77203565911114e-05,0.00304220757214822,-0.00602044719800163,0.00590500648481941,0.984862846529308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTB,Lymphotoxin-beta,40352,6.61937884978793e-05,0.00369169908156485,-0.00716953641136922,0.00730192398836498,0.985694665978285
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP15,Matrix metalloproteinase-15,40411,-7.36177851936739e-05,0.00502928183706329,-0.00993101018583773,0.00978377461545038,0.988321376828853
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42590,-3.37056291740699e-05,0.00239440493614937,-0.00472673930402683,0.0046593280456787,0.988768895921911
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL33,Interleukin-33,42256,-5.05926164010549e-05,0.00398693634758159,-0.00786498785766098,0.00776380262485887,0.989875631811688
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39987,5.03960031248628e-05,0.00590848429139201,-0.0115302332080035,0.0116310252142532,0.993194739654524
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42559,-3.90992404243198e-05,0.00542082058512987,-0.0106639075872789,0.0105857091064302,0.994245183782313
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPA4,Carboxypeptidase A4,39967,3.10015106402952e-05,0.00454858313594246,-0.00888422143580693,0.00894622445708752,0.994562073412604
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRD2,Bromodomain-containing protein 2,40042,2.48283758727856e-05,0.00368809682773921,-0.00720384140649607,0.00725349815824164,0.994628782126276
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40125,4.69678668569985e-05,0.00939175909952355,-0.0183608799682092,0.0184548157019232,0.996009914422166
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42256,1.48835452675695e-05,0.00444348497300601,-0.00869434700182421,0.00872411409235935,0.99732752522886
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B4,Protein ATP1B4,39987,4.48274242644571e-07,0.00435104169379643,-0.00852759344559837,0.00852848999408365,0.999917798348751
